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ABSTRACT 
The liver plays an essential role in the body by regulating several important 
metabolic functions. Liver injury is associated with distortion of these functions causing 
many health problems. Pharmaceutical drugs treat liver disorders but carry the risk of 
causing further damage to the liver. Hence, herbal drugs have been becoming 
increasingly popular worldwide as both patients and doctors strive to find safer 
alternatives. 
The bioactivities of the crude ethanol extracts of Phyllnthus niruri L. (PN) and 
Melastoma malabathricum L. (MM) were investigated in virtue of their in vitro 
antioxidant, immunomodulatory effects and in vivo oral toxicity tests. The 
hepatoprotective activity was evaluated against thioacetamide (TAA) induced liver 
cirrhosis in rats. Antioxidant activity was evaluated by different assays, including: 2,2-
diphenlyl-1-picrylhydrazyl (DPPH), 2,2-azinobis-(3-ethylbenzothiazoline-6-sulfonic 
acid) (ABTS) radical scavenging activities and ferric reducing antioxidant power 
(FRAP). Total phenolic content (TPC) and total flavonoids content (TFC) of the plants 
extracts were also determined. The immunomodulatory effect was studied on human 
peripheral mononuclear cells (PBMC) by 3-(4,5-dimethylthiazol-2-yl)-2‚5-
diphenyltetrazolium bromide (MTT) assay. To induce liver injury, male Sprague 
Dawley rats were administered by intraperitoneal injections (i.p.) of thioacetamide 
(TAA, 200 mg/kg, b.w. thrice weekly) for eight weeks to assess the hepatoprotective 
effect of the extracts. Daily treatments with plant extracts 100 mg/kg b.w., 200 mg/kg 
and silymarin (50 mg/kg) administered orally were carried out for eight weeks. At the 
end of the study, hepatic damage was evaluated by monitoring liver‘s gross 
morphology, histopathology, weight changes, biochemical parameters, endogenous 
antioxidants activities including total antioxidant capacity (TAC), catalase (CAT), 
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superoxide dismutase (SOD), glutathione peroxidase (GPX) and malondialdehyde 
(MDA) in the liver homogenates. Gene expressions were also studied by profiling 
transforming growth factor (TGFβ1), collagen α1 (Collα1), matrix metalloproteinase-2 
(MMP2) and tissue inhibitor of metalloproteinase-1 (TIMP1) by Real Time PCR. 
Besides, different chromatography techniques were used to isolate the active 
constituents of the plants including column chromatography, thin layer chromatography 
and ultra performance liquid chromatography (UPLC) with liquid chromatography 
coupled to mass spectrometry (LC-MS). Our results revealed that treatment with 200 
mg/kg of PN and MM significantly reduced the impact of thioacetamide toxicity and 
they were effectively hepatoprotective, comparable to that of silymarin. The mechanism 
of the hepatoprotective effects of PN and MM, proposed to be through neutralizing the 
reactive oxygen species (ROS) and enhancement of endogenous antioxidant activities 
SOD, GPX and suppression of oxidative stress marker MDA. Additionally, PN and MM 
treatment normalized the expression of TGFβ, Collα1, MMP2 and TIMP1 genes. The 
isolated chemical constituents included in P. niruri were 4-O-caffeolquinic acid and 
quercetin 3-O-rhamnoside while in M. malabathricum were kaempferol, quercetin and 
naringenin. 
In conclusion, the results of the present study indicate that PN and MM ethanol 
extracts were hepatoprotective and toxicologically safe when administered orally. We 
postulated that the hepatoprotective effect of these extracts might be in part due to the 
active components, antioxidant and immunomodulatory properties. 
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ABSTRAK 
Hati memainkan peranan yang penting di dalam regulasi beberapa fungsi 
metabolik yang penting. Kerosakan hati dikaitkan dengan perubahan fungsi-fungsi ini 
yang mengakibatkan banyak masalah kesihatan. Ubat-ubat farmaseutikal yang 
digunakan untuk merawat penyakit hati menambah pula kerosakan pada hati. Oleh itu 
ubatan herba semakin popular di seluruh dunia. 
Bioaktiviti bagi ekstrak etanol kasar Phyllnthus niruri (PN) dan Melastoma 
malabathricum (MM) dikaji dari segi antioksidan in vitro, kesan modulasi imun dan 
ujian ketoksikan oral in vivo. Aktiviti perlindungan ke atas hati dikaji di dalam tikus-
tikus yang mengalami sirosis hati akibat thioacetamide (TAA). Aktiviti antioksidan 
dinilai melalui beberapa asai, iaitu aktiviti memerangkap radikal 2,2-diphenlyl-1-
picrylhydrazyl (DPPH), 2,2-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 
‗ferric reducing antioxidant power‘ (FRAP), dan asai jumlah kandungan fenol (TPC) 
dan jumlah kandungan flavonoid (TFC) manakala aktiviti modulasi imun  dikaji dengan 
asai MTT ke atas sel-sel mononuklear periferi manusia. Di dalam kajian perlindungan 
hati, tikus-tikus Sprague Dawley jantan diberi suntikan thioacetamide (TAA, 200mg/kg 
berat badan, tiga kali seminggu) secara intraperitoneal selama lapan minggu. Ekstrak 
tumbuhan 100 mg/kg berat badan, 200 mg/kg dan silymarin (50mg/kg) diberi secara 
oral sebagai rawatan harian selama lapan minggu. Pada penghujung tempoh kajian, 
kerosakan hati dinilai secara: morfologi kasar, histopatologi, perubahan berat badan, 
parameter-parameter biokimia, aktiviti antioksidan dalaman iaitu jumlah kapasiti 
antioksidan (TAC), catalase (CAT), superoxide dismutase (SOD), glutathione 
peroxidase (GPX) dan pengoksidan lipid (MDA) di dalam homogenat hati. Ekspresi gen 
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juga dikaji dengan menggunakan RT-PCR untuk memperoleh profil gen expressions 
transforming growth factor, (TGFβ), collagen α1 (Collα1), matrix metalloproteinase-2 
(MMP2) dan tissue inhibitor of matrix metalloproteinase-1 (TIMP1). Beberapa teknik 
kromatografi turut dilakukan untuk mengasingkan konstituent aktif tumbuhan iaitu 
kromatografi ‗column‘, kromatografi lapisan nipis dan Ultra Performance Liquid 
Chromatography (UPLC) dengan Liquid Chromatography yang dipadankan ke Mass 
Spectrometry (LC-MS). Keputusan yang diperoleh menunjukkan rawatan dengan PN 
dan MM mengurangkan dengan signifikan ketoksikan hati akibat thioacetamide di mana 
kedua-dua ekstrak telah melindungi hati, setara dengan perlindungan yang diperoleh 
daripada silymarin yang merupakan agen pelindung hati yang standard. Cadangan bagi 
mekanisme PN dan MM di dalam melindungi hati ialah dengan meneutralkan ROS dan 
meningkathan aktiviti antioksidan dalaman: SOD, GPX dan mengurakan marker stress 
oksidatif MDA. Tambahan pula rawatan dengan PN dan MM menormalkan ekspresi 
gen TGFβ, Collα1, MMP2 dan TIMP1. Konstituen kimia yang diasingkan bagi P. niruri 
adalah (4-O-caffeolquinic acid dan quercetin 3-O-rhamnoside) manakala bagi M. 
malabathricum pula ialah (kaempferol, quercetin dan naringenin). 
Kesimpulannya, keputusan kajian ini menunjukkan ekstrak etanol PN dan MM 
adalah selamat dari segi toksikologi apabila diberi secara oral dan mempunyai kesan 
perlindungan pada hati, antioksidan dan memodulasi sistem imun, hasil daripada 
konstituen kimia yang diasingkan. 
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CHAPTER I 
INTRODUCTION 
1.1 Introduction  
The liver is the largest organ in the human body, it is responsible for the 
metabolism of carbohydrates, proteins and lipids, detoxification and bile secretion, 
regulating blood clotting, converting food nutrients into essential blood components, 
storing vitamins and minerals, and maintaining hormone balances. The liver makes 
factors that help the human immune system and removes bacteria from the blood 
(Nemeth et al., 2009). 
Liver diseases are conditions that involve tissue damage or liver inflammation 
and affects liver function. Liver diseases can be categorized to causes that include 
injuries, infections, exposure to drugs, toxic compounds, alcohol and viruses like the 
hepatitis virus. Exposure to these factors may affect clotting abnormalities, 
inflammation, obstructions, scarring and liver failure. Liver fibrosis and its end-stage 
cirrhosis represent a massive universal healthcare problem, according to the National 
Institutes of Health cirrhosis is the 12th leading cause of death. Liver fibrosis is the last 
pathological way of many chronic liver injuries and cirrhosis is the last step of hepatic 
parenchyma fibrosis, leading in the formation of nodules that alter the hepatic function 
and block the blood flow (Sabir & Rocha, 2008a).  
Cirrhosis affects hundreds of millions of patients worldwide. Due to chronic 
liver disease with fibrosis the overall problem of liver disease continues to expand, as 
does the associated social and economic costs. Cirrhosis had previously been considered 
as being the stage at which fibrotic liver disease became irreversible. However 
nowadays, strong evidences have proven that fibrosis and even cirrhosis is reversible by 
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elimination of the causes of liver diseases in animal models, which provide vital 
evidences to the underlying mechanism (Mosmann, 1983). 
In spite of medical advances, pharmacological drugs lack efficiency, have 
unfavorable side effects and relatively high cost (Stickel & Schuppan, 2007). Therefore, 
alternative drugs are required to prevent and treat these disorders. For thousands of 
years humankind has traditionally used plants as basis from which to formulate new 
remedies for the use as medicines. The utilizing of plants in different traditional 
medicines of various cultures has been comprehensively documented. These plant-based 
systems continue to play an essential role in health care and the World Health 
Organization estimates that 80% of the world‘s inhabitants depend on herbal medicines 
for their health care (Gurib-Fakim, 2006). 
 There is a long history regarding the use of traditional medicine in the treatment 
of liver diseases, starting with the Ayurvedic treatment (the ancient Indian system) and 
extending to the European, Chinese and other systems of traditional medicine. Many 
herbs have been deemed to possess liver protecting qualities. Near 160 phyto-
constituents from 101 herbs have been deemed to have hepatoprotective activity 
(Saleem et al., 2010). 
 In Malaysia, the occurrence of an extraordinary growth in Malaysian herbal 
medicine has led to the development of many efficacious and safe products for human 
consumption. Besideswhich, the advances of many chromatography and spectroscopy 
techniques had a remarkable impact on the analysis of the active constituents of these 
medicinal plants (Jantan, 2004). 
 Silybum marianum (milk thistle) is among the well documented hepatoprotective 
plants, since the silymarin (the seed extract) had been claimed to enclose 
hepatoprotective activities which has been validated in many in vivo and in vitro 
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studies. Also it has been reported to protect the liver from injuries induced by various 
toxins or chemicals, by performing anti-lipid peroxidative, antioxidative, antifibrotic, 
anti-inflammatory, liver regenerating and immunomodulatory activities (Cragg & 
Newman, 2005). 
On another hand, the immunomodulatory profile of the medicinal plants has 
been well defined both in vitro and in vivo. An old tradition exists worldwide to ingest 
phytochemicals for improving the human immune system so as to fight infections (Tan 
& Vanitha, 2004). Classes of medicinal herbs were known to alter the activity of the 
immune function through the dynamic regulation of certain molecules as cytokines, that 
in response to injury stimuli, innate inflammatory responses, cell growth and 
differentiation, angiogenesis, and repair processes (Spelman et al., 2006).  For instance, 
research suggested that in Kampo (Japanese traditional medicine) more than 210 
different herbs have been used in Japan to improve and modulate the immune response 
(Borchers et al., 2000). 
Furthermore, the involvement of reactive oxygen species (ROS) and lipid 
peroxidation products have been clearly reported as the fundamental events of many, if 
not all, diseases affecting liver tissue through an unbalanced increase of reactive oxygen 
species (ROS) with overall anti-oxidant defense mechanisms exerted on the body, such 
as the antioxidant enzymes catalase (CAT), superoxide dismutase (SOD) and 
glutathione peroxidase (GPX) that have been believed to prevent certain degrees of liver 
damage from being caused. Therefore, in recent years medicinal plants have been 
investigated for their antioxidant properties and free radical scavenging activities as a 
natural source of antioxidant with presumed nutritional, safety and therapeutic value to 
replace the synthetic antioxidants that have been restricted due to their health risks and 
undesirable toxicities. Plants natural antioxidants are mainly in the form of phenolic 
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compounds (phenolic acids, flavonoids and tocopherols), ascorbic acid and carotenoids, 
thus the antioxidant supplements derived from plants were thought to quench free 
radicals and prevent human disease (Ali et al., 2008).  
Phyllanthus niruri, a plant from the Euphorbiaceae family commonly known in 
Malaysia as dukung anak, has been used in Malay traditional medicines for various 
purposes and has been investigated extensively worldwide for its medicinal and 
pharmacological properties (Tang et al., 2010; Murugaiyah & Chan, 2009; 
Thippeswamy et al., 2011). It has a long history as the medication of chronic liver 
diseases (Bhattacharjee & Sil, 2006, 2007; Chatterjee et al., 2006; Chatterjee & Sil, 
2006). 
 Melastoma malabathricum, locally known in Malaysia as senduduk, is found in 
most Asian tropical regions. It has been used in Malay traditional medicine as a drug for 
treatment of diarrhoea, cholera, fever, leucorrhoea, dysentery, wounds and skin diseases 
(Sirat et al., 2010). Besideswhich, it has also been reported to exhibit many medicinal 
properties, such as being an anti-bacterial with wound-healing potential, anticoagulant 
properties and anti ulcer activities (Choudhury et al., 2011; Sunilson et al., 2008; 
Manicam et al., 2010; Hussain et al., 2008). 
The underlying mechanism of P. niruri‘s (PN) hepatoprotective effect is still not 
clearly defined. Therefore, we carried out this project in an attempt to characterize the 
hepatoprotective effect of PN by combining a systematic methodology with advanced 
technologies to discover the underlying mechanism involved. Several studies revealed 
certain medicinal properties of Melastoma malabathricum, but to the best of our 
knowledge, there were no reports pertaining to its hepatoprotective activity, so this 
study was carried out to discover more pharmacological properties by investigating the 
basic mechanism of its hepatoprotective action. 
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1.2 Objectives of the study 
1. To evaluate the in vivo hepatoprotective activity of Phyllanthus niruri and 
Melastoma malabathricum crude ethanol extract on thioacetamide-induced liver 
cirrhosis in Sprague Dawley rats. 
2. To investigate the endogenous antioxidant activities of Phyllanthus niruri and 
Melastoma malabathricum. 
3. To monitor the expression of TGFβ, Collα1, MMP2 and TIMP1genes.   
4. To investigate the in vitro free radical scavenging properties and phytochemical 
screening of Phyllanthus niruri and Melastoma malabathricum crude ethanol 
extracts. 
5. To examine the in vitro immunomodulatory role of crude ethanol extract and 
fractions of Phyllanthus niruri and Melastoma malabathricum. 
6. To identify the active constituents of Phyllanthus niruri and Melastoma 
malabathricum from the active fraction by different chromatographic 
techniques.  
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CHAPTER II   
              REVIEW OF LITERATURE 
 
2.1     The liver  
2.1.1 General description 
The liver is the largest gland, constituting about 2.5% of an adult‘s body weight. It is 
located in the upper right side of the abdominal cavity, beneath the diaphragm. The liver 
weighs about 1.6 kilograms and is dark reddish brown in color. It supports most of the 
organs in the body and thus is vital for survival. Due to its multidimensional functions 
and strategic location, the liver is also exposed to many diseases. The liver consists of 
two large sections, the right and the left lobes. The gallbladder lies under the liver, 
along with the pancreas and intestines. The liver and these organs together digest, 
absorb, and process food. Clinical terms referred to the liver mostly start 
in (hepato) or (hepatic) from the Greek word for liver (hepar) (Tortora & Derrickson, 
2008). 
 
2.1.2 Gross and microscopic anatomy of the liver 
The liver has a smooth surface and it is connected to the kidney, adrenal glands, inferior 
vena cava, hepato-duodenal ligament and stomach. As shown in Figure 2.1, it is divided 
into four lobes, thos being right, left, caudate, and quadrate. The right and left lobes are 
the largest, while the caudate and quadrate are smaller and located posteriorly. These 
lobes are further subdivided into small hexagonal lobules (the basic functional units of 
the liver). The liver tissue includes thousands of lobules; each hexagonal lobule includes 
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a plate of hepatocytes and portal triads at each corner of the hexagon, cental vein, liver 
sinusoids, hepatic macrophages (kupffer cells), bile canaliculi and space of disse (Allen, 
2002).   
Blood is passed to the liver by two large blood vessels, the hepatic artery and the portal 
vein. The hepatic artery transfers oxygen-rich blood from the aorta while the portal vein 
transfers blood containing digested food from the small intestine. These blood vessels 
subdivide into very small capillaries. Each capillary leads to a lobule. The two major 
functional types of cells are the hepatocytes, which constitutes 80% of the liver‘s 
volume and performs the majority of liver functions, and the non-parenchyma cells (like 
sinusoidal endothelial cells, kupffer cells and hepatic stellate cells) which occupy only 
6.5% of the total volume, but have been recognized to regulate many hepatocyte 
functions under normal and pathological conditions (Kmiec, 2001). 
 
 
Figure 2.1: Anatomy of the liver: (A) Gross morphology, (B) histology slide 
and (B
*
) histological view of the liver. [adapted from (Gurakar et al., 2012)] 
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2.1.3 Functions of the liver  
The liver carries out a large number of critical functions, it regulates chemical levels in 
the blood and excretes bile that carries out waste products from the liver. The liver 
processes the blood and breaks down its nutrients and drugs. More than 500 vital 
functions have been identified like amino acids synthesis and the metabolism of fats, 
carbohydrates and proteins. In addition, the liver detoxifies chemicals and drugs; and in 
conjunction with the spleen, it is involved in the filtration of blood, through the 
destruction of red blood cells and the retrieval of their constituents. It synthesizes and 
secreets bile proteins important for blood clotting and other functions. (Tso & Mcgill, 
2001). It manages the blood glucose level in several ways including glycogenesis 
(storing glucose as glycogen), glycogenolysis (breaking glycogen to glucose) and 
(gluconeogenesis) the forming of glucose from non-carbohydrate resources such as 
amino acids.  
 
2.1.4 Liver diseases 
The most common diseases of the liver are acute hepatitis (inflammation), chronic (long 
duration) hepatitis, alcohol damage, fatty, cirrhosis (scarring),α1 antitrypsin 
deficiency, progressive familial intrahepatic cholestasis, biliary atresia, alagille 
syndrome, Langerhans cell histiocytosis and cancer. These diseases accelerate liver's 
derangement; however, with its ability to regenerate, it only produces symptoms after 
long-term damage. Liver regeneration is the response to different injuries induced by 
external stimuli, it involves consequent changes in the growth factor production, gene 
expression, and morphologic structure (Michalopoulos & Defrances, 1997). 
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Damage to the liver is mostly accompanied with abnormalities in certain blood 
biomarker tests, for example, alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), and alkaline phosphatase (ALP). In addition, the actual liver 
injury may cause abnormalities in other liver function tests (LFT) such as bilirubin, 
albumin, gamma glutamyl transferase (γGT) and prothrombin time. These tests are 
useful in the evaluation and management of liver dysfunctions in order to detect the 
presence of hepatic injury, distinguish between different types of liver disorders, 
determine the level of known liver damage and track the response to different 
treatments (Giboney, 2005). 
Alanine aminotransferase (ALT), previously known as serum glutamic-pyruvic 
transaminase (SGPT) catalyzes reversible amine group transfer in Krebs cycle and it is 
a specific indicator of Hepato cellular damage. Aspartate aminotransferase (AST), 
previously known as serum glutamic-oxaloacetic transaminase (SGOT), catalyzes the 
conversion of nitrogenous portion of amino acid. It is essential for energy production in 
Krebs cycle. It is most elevated in acute cellular necrosis. Alkaline phosphatase (ALP) 
is often associated with cholestasis and biliary obstruction. Gamma glutamyl transferase 
(γGT) is a liver enzyme involved in the transport of amino acids and peptides into cells, 
as well as glutathione metabolism. γGT is mainly found in liver cells and is extremely 
sensitive to alcohol use. Elevated γGT levels may be found in liver disease, alcoholism, 
obesity, bile-duct obstruction, cholangitis, and drug abuse (Whitfield, 2001).  
Total protein (TP) is a measure of the total proteins of blood.  It reflects liver disease, 
nutritional state, kidney disease and others.  In general, protein consists of albumin and 
globulin.  Globulin is a building block of antibodies, proteins, and clotting factors. 
Globulin is made up of about 60 different important proteins.  A decreased value of 
total protein may indicate liver or kidney disease. Albumin is a very common protein 
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found in the blood with a variety of functions, if its levels are lower than normal it 
could be suggestive of chronic liver disease. Moreover, bilirubin is a byproduct of the 
destruction of red blood cells in the liver released as bile in the feces. Elevation of the 
bilirubin suggests liver dysfunction. (Johnston, 1999; Gopal & Rosen, 2000).  
 
2.2 Cirrhosis of the liver 
The word cirrhosis is derived from the Greek word ―kirrhos‖ that means brownish-
yellow (Behrns, 2008). It is a worldwide health problem and is a complication of 
several liver diseases that are described by abnormal structure and functions of the liver. 
It is the scarring of the liver in response to the development of regenerative nodules 
surrounded by fibrous septa as consequence of long-term liver injury. The scar tissue 
blocks the flow of blood through the liver and slows the production of hormones, 
nutrients, toxins and drugs. It also slows the process of different substances and proteins 
made by the liver. The spleen then becomes congested which sequentially leads 
to splenomegaly and ultimately portal hypertension will be responsible for the majority 
of later complications (Tsukada et al., 2006). 
Liver cirrhosis represents a major medical problem with significant morbidity and 
mortality rates. According to the National Institutes of Health, cirrhosis is the 12th 
leading cause of death and within the top 15 most important causes of death of 1990 to 
2020 as assumed by global burden disease study (Murray & Lopez, 1997). 
Liver cirrhosis historically thought to be irreversible process due to the parenchyma 
collapse and its replacement with collagen, but currently it is considered as a wound-
healing model of response to chronic liver damage. Generally, treatment could delay or 
stop further progression and reduce complications (Mann et al., 2003).  
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2.2.1 Clinical features of liver cirrhosis 
Multi-factorial or single insults to the liver ultimately may lead to cirrhosis. The most 
common causes are viruses, excessive alcohol consumption, drug-related injury, 
inherited disorders and exposure to environmental toxins. However, it can also be 
caused by non-alcoholic steatohepatitis, primary sclerosing cholangitis, hereditary 
hemochromatosis, wilson's disease, alpha 1-antitrypsin deficiency, galactosemia 
glycogen storage disease type IV, cystic fibrosis and lysosomal acid lipase deficiency 
and many other issues. Some patients may have more than one cause of cirrhosis (such 
as alcohol excess and viral hepatitis), while a large number of patients (up to 20%) do 
not have an identifiable cause for cirrhosis, which is known as cryptogenic cirrhosis 
(Schuppan & Afdhal, 2008). In Western countries, chronic hepatitis C and alcohol 
intake are the main causes of liver cirrhosis, whilst in the Asian Pacific region, chronic 
hepatitis B is the most common cause. In Malaysia the etiology of liver cirrhosis had 
peculiar patterns based on the prevalence of hepatitis B and the racial differences in 
alcohol intake (Qua & Goh, 2011). 
Liver cirrhosis is a potentially life-threatening condition that occurs because of scarring-
damage to the liver. This scarring replaces healthy tissue and prevents the liver from 
working normally. Cirrhosis usually develops after years of liver inflammation. Patients 
with cirrhosis often have few symptoms at first, the signs and symptoms are non-
specific or absent at the early stages. As scar tissue replaces healthy tissue and liver 
function worsens, a variety of liver-related symptoms may develop. Some of the more 
common symptoms and signs of cirrhosis include fatigue, itching, weakness, loss of 
appetite, edema (most frequently in the legs) and white nails. The main clinical 
consequences of liver cirrhosis are spontaneous bacterial peritonitis, spider, ascites, 
digestive tract bleeding, jaundice, splenomegaly, mental slowing, excess drowsiness, 
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confusion and slurring of speech, a condition known as hepatic encephalopathy, 
hepatorenal syndrome, hepatopulmonary syndrome, hypersplenism and liver cancer  or 
hepatocellular carcinoma (Kuo et al., 2010). 
The term "cirrhosis" was first introduced in 1826 by Laennec. It derives from the Greek 
term scirrhus and refers to the orange or tawny surface of the liver as seen at autopsy. 
Macroscopically, the liver enlarges its external surface and causes irregularities in the 
appearance of its nodularity. It usually becomes shrunken and yellowish, but in some 
cases became enlarged and yellow such as in alcoholic fatty cirrhosis, or large and green 
in biliary obstruction and rusty in hemochromatosis. A variation in colors, sizes, shapes 
and consistency of the nodules helps in the identification of the etiology. Based on the 
size of the nodules, cirrhosis was classified to micro nodular (nodules ≤ 3 mm), macro 
nodular (nodules >3 mm) and the mixed cirrhosis, which consists of a variety of nodules 
with different sizes (Wanless, 2004). Histological criteria for cirrhosis (Figure 2.2) is 
characterized by vascularised fibrotic bands which link the portal tracts with each other 
and with central veins. The microscopic features include regeneration of hepatocytes 
nodules, deposition of connective tissue between these nodules and destruction of other 
normal tissues of the liver, including the sinusoids, the space of Disse and other 
vascular structures (Schuppan & Afdhal, 2008). 
Cirrhosis was previously considered as being irreversible. Nowadays, several studies 
have demonstrated that progression of liver cirrhosis can be arrested by therapy. That 
said, the complete regression of cirrhosis has not been clearly documented, instead the 
anatomic state of the liver has been proposed to be in a balance between two processes, 
the frequently episodic injury and the slow and continuous repair processes (Wanless et 
al., 2000).  
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Figure 2.2: Histological criteria of chronic hepatic injury. 
 [Adapted from (Moreira, 2007)] 
 
2.2.2 Molecular features of liver cirrhosis 
The normal liver contains hepatocytes (an epithelium), an endothelial lining, Kupffer 
cells (tissue macrophages) and hepatic stellate cell (HSC) (mesenchymal cell, 
previously called lipocyte, Ito cell, peri-sinusoidal cell or fat-storing cell). The cellular 
components of liver are categorized within the sinusoid with the space of disse 
separating hepatocytes from the sinusoidal endothelium. This space consists of a matrix, 
called the extracellular matrix (ECM), that is essential for maintaining the differentiated 
function of all liver cells (Friedman, 2000). The major components of the ECM in 
normal liver are collagens I, III, IV, V, VI and various non-collagenous components like 
laminin, fibronectin, undulin, tenascin, and entactin. In the normal liver, these 
components are remodeled by matrix degrading enzymes, causing controlled deposition 
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of matrix components. The matrix metalloproteinases (MMPs) are the most important 
ECM-degradative enzymes. The activities of these MMPs are regulated through three 
processes: 1) transcription, 2) zymogen activation and 3) through the action of a family 
of inhibitory proteins (the tissue inhibitors of metalloproteinases) (TIMPs) 
(Kossakowska et al., 1998). 
A liver cirrhosis case is a wound-healing process as a response to repeated liver injury, 
associated with alterations in the quantity and composition of ECM, including 
fibronectin, collagens (I, III, and IV), undulin, laminin, elastin, proteoglycans and 
hyaluronans (Friedman, 2003). On the other hand, HSC cells are quiescent cells 
functions in the storing of vitamin A; however, in the response to liver injury these cells 
undergo an"activation" process which is the key issue affecting the main ECM-
producing cells in cases of liver cirrhosis (Reeves & Friedman, 2002).  
After HSCs activation it acquires pro-inflammatory, contractile, and fibrogenic 
properties, accumulating at the sites of tissue repair, secreting large amounts of ECM 
and regulating ECM degradation. A complex interchange takes place among different 
liver cell types during cirrhosis process. Hepatocytes release ROS and fibrogenic 
mediators and induce the white blood cells, then apoptosis of these hepatocytes 
stimulates the activation of HSCs, which in turn secretes collagen, inflammatory 
chemokines and modulates the activation of lymphocytes (Figure 2.3). Kupffer cells 
play‘s a role in the liver inflammation process by releasing ROS and cytokines. 
Therefore, an intense circle is likely to occur (Bataller & Brenner, 2005). 
Nevertheless, many genes have been identified as influencing chronic liver diseases. 
Among these, transforming growth factor beta (TGFβ) is the most potent cytokine that 
promotes patho-physiological significant liver cirrhosis. It induces the activation of 
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hepatic stellate cells (HSCs) in necro-inflammatory tissue regions. Upon activation, 
HSCs differentiate into matrix-producing myofibroblasts producing TGFβ, which in 
turn, initiate and accelerate the deposition of extracellular matrix components that 
distort the liver architecture and impair liver function, causing liver cirrhosis (Wang et 
al., 2008).  
Recently it have been demonstrated that oxidative stress accompanying hepatocytes 
damage was associated with the up-regulation of TGFβ, which enhanced the deposition 
of extracellular matrix proteins by stimulation of fat-storing cells (Flisiak et al., 2000). 
ROS up-regulated expression of these genes have been shown to be through activation 
of a number of critical signal transduction pathways and transcription factors related to 
fibrogenesis (Mormone et al., 2011). 
Moreover, TGFβ has been recognized as a potent inducer of collagen genes. The 
collagen family is a group of extracellular matrix (ECM) proteins that engage in several 
activities, like performing structural support of connective tissue and the basement 
membrane of organs, including the liver. At least 27 different proteins have been 
recognized from this family; however, of these types I, III, and IV are most associated 
with liver fibrosis. Increases in expression and deposition of type I collagen are the 
most-characterized aspect of liver fibrosis.  The level of TGFβ mRNA has been found 
to be correlated with that of collagen α1 mRNA in rat models of cirrhosis induced by 
thioacetamide (Sato et al., 2000). Furthermore, the main feature of liver fibrosis has 
been revealed to be the uncontrolled production of collagen α and the molecular basis of 
its regulation has been shown to be through a complex process involving reactive 
oxygen species (ROS) as the key mediators (Dikshit et al., 2011). 
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In addition, the activated HSCs have been shown to increase the expression of matrix 
metalloproteinases family (MMP) genes, which play an important role in the 
modulation of ECM accumulation and the endogenous inhibitors of metalloproteinases 
activity, the tissue inhibitors of metalloproteinases (TIMPs). The interaction between 
ECM synthesis and its degradation plays a critical role in extracellular homeostasis, and 
disruption of this balance causes alterations in ECM integrity that can result in 
deleterious consequences, including the establishment of hepatic fibrosis (Tsukada et 
al., 2006). TIMP-1 expression has been found to be up-regulated in vitro in the HepG2 
(human hepatoma) cell line under the influence of certain cytokines such as TGF-β and 
IL-6, which suggests the contribution of TIMP-1 in the fibrosis process of the liver 
(Amin et al., 2012). 
           
 
Figure 2.3: Molecular pathogenesis of liver cirrhosis. 
[Adapted from (Gressner et al., 2007)] 
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2.2.3 Experimentally induced cirrhosis 
To achieve a better understanding of liver cirrhosis and other hepatic dysfunctions, 
many models have been established to study the hepatotoxicity of experimental agents, 
which are adequate models of human cirrhosis.  
One of the widely used liver toxicants is carbon tetrachloride (CCL4), which is 
employed in animal models for induction of acute and chronic liver diseases and has 
been reported to induce hepatocellular necrosis, increased lipid peroxidation products 
and decreased levels of antioxidative enzymes (Kuo et al., 2010). The mechanism of its 
action has been proposed to be through activation by cytochromes (CYP2E1, CYP2B1, 
CYP2B2 and CYP3A) to trichloro methyl radical (CCl3), that binds to the cellular 
molecules like nucleic acids, proteins and lipids of the liver thus initiating the damage. 
CCl3
¯ 
reacts with oxygen to form the trichloro methyl peroxy radical CCl3OO¯ that 
initiates the reaction of lipid peroxidation which attacks and destroys polyunsaturated 
fatty acids, resulting in the loss of cellular calcium sequestration and homeostasis, 
which can contribute heavily to subsequent cell damage (Weber et al., 2003). 
Thioacetamide (TAA) is another potent hepatotoxicant that was originally used as a 
fungicide. Studies have shown that its hepatotoxic effects is due to its metabolite 
thioacetamide S-oxide (TASO) and further to thioacetamide-S,S-dioxide (TASO2) 
which is thought to initiate necrosis by covalently binding to liver macromolecules 
(Chilakapati et al., 2005). Moreover, paracetamol has been used experimentally to 
induce acute liver failure (Sawant et al., 2006). The liver injury has been postulated to 
be through mitochondrial oxidant stress and peroxy nitrite formation after its 
metabolism by P450 system to reactive metabolite N-acetyl-p-benzoquinone imine 
(NAPQI) which bind to cellular proteins and initiates liver damage (Knight et al., 
2003).  
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One more hepatotoxic agent is cupric nitrilo-riacetate (Cu-NTA), which has been used 
as a model to induce hepatotoxicity. It has been proven to cause damage to the 
parenchyma cells of the liver when deposited in these cells as an insoluble compound 
(Toyokuni et al., 1989). Also hepatic necrosis was observed in the livers of rats exposed 
to Cu-NTA and the levels of 8-hydroxydeoxyguanosine (8-OHdG) have been 
investigated as being a marker of copper toxicity (Toyokuni & Sagripanti, 
1994). Furthermore, liver fibrogenesis was evidenced after the use of an intragastric 
ethanol infusion model on Wistar rats, in which peri-sinusoidal cells were believed to 
play the key role in fibrogenesis process through increasing DNA synthesis, enhancing 
gene expression of collagen, transforming growth factor-β1 (Tsukamoto, 1993). Other 
studies (Tsukamoto et al., 1995) have demonstrated that dietary iron supplementation to 
intragastric ethanol infusion increased the hepatocyte damage and promoted the 
fibrogenesis by iron catalyzed oxidant stress.  
Nimesulide (NIM) is an analgesic, non-steroidal anti-inflammatory drug (NSAID) that 
has been reported to cause liver damage, due to the way it is metabolized in the liver 
and by generating reactive oxygen species (ROS) which in turn have the potential to 
damage the liver tissues. It has been used in experimental models because it induces 
significant oxidative stress and thus reduces the levels of antioxidant enzymes like 
catalase (CAT), superoxide dismutase (SOD) and non protein thiol (GSH) through 
significant enhancement of lipid peroxidation (LPO) (Chatterjee & Sil, 2006). 
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2.2.3.1 Thioacetamide 
Thioacetamide is a thiono-sulfur compound with the molecular formula of C2H5NS 
(Figure 2.4). Also known as ethane thioamide, it has been used as an organic solvent, 
fungicide, stabilizer of motor oil and accelerator in the vulcanization of rubber. It is a 
white monoclinic crystalline solid, which is soluble in water and serves as a source of 
sulfide ions in the synthesis of organic and inorganic compounds. Thioacetamide was 
first reported as a hepatotoxic agent by Fitzhugh et al. (Fitzhugh & Nelson, 1948). 
Chronic administration of this toxin can lead to liver cirrhosis and hepatocarcinoma in 
vivo and in vitro (Tsukamoto, 1993). 
 
Figure 2.4: Chemical Structure of Thioacetamide. 
 
It undergoes two steps of bioactivation mediated by microsomal CYP2E1 and/or flavin- 
containg monooxygenase (FMO) systems: first to TAA sulfoxide (sulfine), and further 
to TAA-S,S-dioxide (sulfene), which is the reactive metabolite, initiates cellular 
necrosis (Figure 2.5) (Chilakapati et al., 2005). Metabolic activation of TAA then 
directs to the formation of free radicals, derived from thioacetamide-S,S-oxide and by 
reactive oxygen species (ROS) (Tsukamoto et al., 1995).  
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Figure 2.5: Mechanism of TAA induced liver injury. 
 [adapted from (Ramaiah et al., 2001)] 
 
Thioacetamide induced liver cirrhosis has been extensively studied in rats and in other 
animal species using different times, doses and routes of administration. The most 
common types of administration are via drinking water, gastric tube, diet and by 
subcutaneous or intraperitoneal injections. Overall, the thioacetamide induced 
experimental liver disorder showed pathology and biochemical changes similar to 
human liver cirrhosis (Toyokuni & Sagripanti, 1994). Thioacetamide has been revealed 
to cause severe necrosis of the rat's liver by oxidative stress (Kishioka et al., 2007) and 
it caused significant increase in the activity of amino transferases (ALT and AST), 
alkaline phosphatase (ALP), bilirubin and total protein (TP) gamma glutamyl 
transferase (γGT) and other biochemical markers of the liver (Madani et al., 2008; 
Kumar et al., 2004; Galisteo et al., 2006b). Long term administration of thioacetamide 
resulted in distinctive lesions in the rats livers, which resembles the micro nodular 
cirrhosis after treatment over 3 months (Müller et al., 1988). 
Furthermore, thioacetamide has been proven to cause alterations of lipid and 
lipoproteins metabolism in female Wistar rats. It decreased levels of pre-β-lipoproteins, 
increased levels of β-lipoproteins, decreased concentration of serum triglyceride and 
decreased hepatic VLDL-TG output into the serum (Zimmermann et al., 1986). 
Previous studies have described the changes in the collagen deposit after TAA intra 
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peritoneal injection, accompanied by body weight changes with cellular necrosis and 
regeneration, pseudo-lobular hepatic fibrosis and the type of liver nodules vary from 
micro nodular to macro nodular depending on the dosage and the time of TAA exposure 
(Munoz et al., 1991).  
The research of Stankova et al. (Stankova et al., 2010) documented the decrease in 
glutathione (GSH) levels in rat hepatocytes in vitro prior to the increase in endogenous 
ROS production. They suggested that the primary target for TAA metabolites were not 
the mitochondria, which were affected secondarily due to the stimulation of oxidative 
stress. Mice treated with thioacetamide have been proven to experience elevated levels 
of hydroxyl proline and α-smooth muscle actin protein. It also induced increased mRNA 
levels of the genes collagen alpha1 (collα1) and transforming growth factor beta 
1 (TGFβ1) in the liver (Hsieh et al., 2008). TAA treated liver has been found to benefit 
from reduced mRNA levels of TGF-β and pro-collagen α1 genes, which in turn resulted 
in pathological recession of liver fibrosis (Sato et al., 2000). 
 
2.3 Herbal medicine 
Even today, huge numbers of people on this planet still depend on medicinal plants for 
their daily healthcare needs. Natural products derived from plants are the source of most 
active components in modern medications, which in turn play a significant role in the 
treatment and prevention of human illnesses. Fifty percent of the drugs in the clinical 
usage of the world have been derived from natural products. Higher plants represent 
25% of the total, whilst at least a dozen effective medications were found as derivatives 
from flowering plants. According to the World Health Organization‘s (WHO) 
estimation, 70-95% of the population in developing countries (especially Asia, the 
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Middle East, Africa and Latin America) depend on traditional medications to manage 
their primary health care. As a result, tropical plants have been investigated intensively 
during the last few years in order to evaluate the possibility of developing new, 
sustainable, natural and affordable cosmetics and drugs (Gurib-Fakim, 2006; Robinson 
Mm, 2011). 
Recent research conducted by Stickel and Schuppan (Stickel & Schuppan, 2007) on 
medicinal plants signified that new phytochemicals could be developed for many health 
problems, serving as one of the therapeutic challenges of the new millennium. For 
example, the vinca alkaloids (vinblastine, vincristine, and vindesine), derived from 
Vinca rosea, Lochnera rosea and Ammocallis rosea have been utilized for their 
anticancer properties. Thus, many pharmacological uses have been revealed by studying 
medicinal plants, such as antipyretics, sedatives, cardioprotectives, analgesics, antiviral, 
antibacterial, and antiprotozoal (Cragg et al., 2012). Many factors support the rise in 
requests for herbal medicines in the last few decades, such as herbs being considered 
more safe to use because they are ―natural‖ and are therefore perceived as being a 
harmless option, or because no unfavorable side effects exist coupled with easy 
availability and low cost (Stickel & Schuppan, 2007). 
 
2.3.1 Medicinal plants and their role in treating liver disorders 
Medicinal plant extracts play an important role in the management of various liver 
disorders, as evidenced by herbs having been used in the treatment of liver injuries for 
over 2,000 years.  Up to now, more than 160 plant-derived substances, from 101 plant 
families, have been recognized regarding their hepatoprotective activity (Negi et al., 
2008; Saleem et al., 2010). In spite of many experimental limitations, a number of herbs 
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showed promising effects, either practically in cell cultures, in animal studies and even 
in clinical trials (Stickel & Schuppan, 2007). As examples, the hepatoprotective activity 
of Leucas ciliata leaves extract was tested against carbon tetrachloride (CCL4) induced 
hepatotoxicity in rat model, the antihepatotoxic activity of L.ciliata was documented to 
be due to its free radical scavenging activity (Pradhan & Girish, 2006). While the 
aqueous extract of the central stem of Musa sapientum showed a hepatoprotective 
activity against CCL4 hepatotoxicity, comparable to that of silymarin (a well known 
hepatoprotective drug) through pathological, antioxidant and biochemical findings 
(Dikshit et al., 2011).  
Aqueous extracts of Solanum fastigiatum was used to evaluate the hepatoprotective 
activity on mice liver damage induced by paracetamol, by monitoring biochemical and 
antioxidant parameters (Sabir & Rocha, 2008a). Moreover, The results (Galisteo et al., 
2006a) revealed that Rosmarinus tomentosus ethanol extract administered in the diet 
affords protection against thioacetamide (TAA) induced liver cirrhosis, preventing the 
majority of the histological changes and biochemical alterations. 
 
2.3.1.1 Silymarin 
Silymarin (Figure 2.6) is the flavono lignan extracted from the dried seeds of milk 
thistle Silybum marianum. It exsits as four flavono lignan isomers, namely isosilybin, 
silybin, silychristin and silydianin with molecular formula C25H22O10     (Pradhan & 
Girish, 2006). 
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Figure 2.6: Chemical structure of silymarin 
[Adapted from (Katiyar et al., 1997)] 
 
The pharmacological properties of silymarin have been well defined and the 
hepatoprotective profile was reported both in vitro and in vivo. It has been documented 
to prevent the liver from different injuries induced by various toxins or chemicals, by 
performing anti-lipid peroxidative, antioxidative, antifibrotic, membrane stabilizing, 
anti-inflammatory, liver regenerating and immunomodulatory activities. Its mechanisms 
of action have been investigated to be through promoting protein synthesis, controlling 
inflammation, regenerating liver tissue, protecting against glutathione depletion and 
enhancing glucuronidation (Choudhury et al., 2011; Colegate & Molyneux, 1993; Cragg 
& Newman, 2005). Silymarin is reported also to enhance the activity of RNA-
polymerase I, combined to toxic-free iron and blocks the uptake of toxins such as 
Amanitaphalloides toxin (Yadav et al., 2008). Furthermore, promising activities of 
silymarin have been reported in regards its anticancer activity, regulation of apoptosis 
and the inflammation process. It also has potential as a neuroprotective agent due to its 
neurotropic activities, which could be used to prevent and treat cardio-pulmonary 
problems, to treat skin problems and as steroid hormons receptors (Kren & Walterova, 
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2005). Overall, the mechanisms of the hepatoprotective action of silymarin have been 
investigated to be through four actions: 
1- Free radical scavenging activity, increasing of glutathione cellular content and 
lipid peroxidation lowering property. 
2- Membrane permability regulation and increasing the membrane stability against 
damage caused by xenobiotics. 
3- Regulation of nuclear expression through steroid like effects. 
4- Inhibits the formation of myofibroblasts from stellate hepatocytes, which 
releases collagen and subsequently causes cirrhosis of the liver (Pandy Govind, 
2011).  
2.3.2. Immunomodulatory roles of medicinal plants 
The immunomodulator material modulates the responses of the immune system to 
produce antibodies to react with the antigens that initiated their production. Examples of 
immunomodulators are thymosin, corticosteroids, cytotoxic agents, and 
immunoglobulins. Certain immunomodulators naturally exist in the body and some 
would be available by pharmacological preparations. Immunomodulation is a 
therapeutic approach for intervening in auto regulation processes of the defense system; 
it is one of the three homotoxical treatments alongside detoxification and cellular 
activation (Spelman et al., 2006).  Medicinal plants have been studied widely as a 
source of botanical immunomodulators in various in vivo and in vitro studies. Different 
herbs were found to regulate cytokine secretion, immunoglobulin secretion, histamine 
release, cellular co-receptor expression, phagocytosis and lymphocyte expression. These 
herbs might offer an alternative course of therapy to the costly immunotherapeutics 
(Patwardhan & Gautam, 2005). In a recent study by Bin-Hafeez (Bin-Hafeez et al., 
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2003) the immunostimulating effects of  Trigonella foenumgraecum L. was reported at 
doses of 50 and 100 mg/kg. It revealed that this plant has a stimulatory effect on 
immune functions in mice body weight, organ weight, as well as causing a delayed type 
of hypersensitivity response, cellularity of lymphoid organs, phagocytosis, plaque-
forming cell assay, quantitative haemolysis of SRBC assay, haemagglutination titre, and 
lymphoproliferation. While Makare et al (Makare et al., 2001) showed that 
administration of Mangifera indica Linn resulted in a increase in humoral antibodies 
and delayed type hypersensitivity in mice.  
Moreover, results of Yeap et al. (Yeap et al., 2007) revealed the proliferation effect of 
the pre-treatment of peripheral blood mononuclear cells (PBMC) with Rhaphidophora 
korthalsii methanol extract, which stimulated the cytotoxicity toward human 
hepatocellular carcinoma (HepG2). In addition, (Souza-Fagundes et al., 2002) reported 
the role of plant extracts as sources of immunomodulators by screening 313 extracts 
from 136 plant species using the bioassay based on the inhibition of proliferation of 
PBMC stimulation with phytohemaglutinin A (PHA). Furthermore, Acoruscalamus has 
been reported to exhibit an in vitro anti-cellular and immunosuppressive potential, by 
proliferating the mitogen (phyto-haemagglutinin) and the antigen (purified protein 
derivative) that stimulate human peripheral blood mononuclear cells (PBMCs), it also 
inhibits production of interleukin-2 (IL-2) and tumor necrosis factor-α (TNF-α), 
interferon-γ (IFN-γ) (Mehrotra et al., 2003). 
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2.3.3 Free radicals and oxidative stress 
Reactive oxygen species (ROS), such as the free radicals (e.g. hydroxyl, superoxide, 
nitric acid) and certain non-radicals (e.g. lipid peroxide, hydrogen peroxide) lead to 
damage of specific molecules by a process called oxidative stress, which consequently 
leads to the injury of the cells or tissues. High level‘s of ROS results from 
inflammation, viral or fungal infection, ageing, pollution, UV radiation, excessive 
alcohol consumption, cigarette smoking…etc (Mittler, 2002). The ROSs produced in 
vivo in respiratory chains of mitochondria, activated polymorpho-nuclear leukocyte, 
macrophages and peroxisomes. Exogenous sources of these harmful radicals are items 
such as tobacco smoke, pollutants, pesticides, ionizing radiation and organic solvents 
(Kumar, 2011). 
Neutralization of ROS is accomplished by antioxidants, which are chemicals or 
substances that retard the damage caused by these free radicals. Well-known 
antioxidants include enzymes and other substances which are either endogenous (e.g. 
superoxide dismutase, catalase, glutathione) or exogenous (e.g. vitamins A, C, E, α-
tocopherol, selenium, beta carotene, butylated hydroxyl anisole and butylated hydroxyl 
toluene) that are capable of counteracting the destructive effects of oxidation. Food 
products such as vegetable oils and prepared foods are usually supplied with 
antioxidants to prevent or interrupt their rancidity by the action of air (Halliwell, 1994).  
Liver cells, especially hepatocytes, have the excellent ability to metabolize and detoxify 
ROSs, subsequently repairing damage done by antioxidants. Furthermore, the liver 
expresses a multi-layered defense system against these ROSs, as it encloses superoxide 
dismutases (in the cytosol and mitochondria), catalase (in the peroxisomes), glutathione 
peroxidases (in the cytosol and mitochondria), holds glutathione in its cellular 
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compartments besides its cell membranes and carries radical chain-breaking 
antioxidants like vitamin E. Therefore, ROS could cause instability only on cellular 
homeostasis, it would lead to cell death if not effectively counteracted (Jaeschke & 
Ramachandran, 2011). 
Superoxide dismutase (SOD) catalyzes the dismutation of superoxide ion 
into oxygen and hydrogen peroxide (H2O2). Catalase (CAT) catalyzes the 
decomposition of hydrogen peroxide to water and oxygen. Glutathione peroxidase 
(GPX) removes hydrogen peroxide by converting reduced glutathione into oxidized 
glutathione. These enzymes modulate in several diseases, including multiple sclerosis, 
alzheimer disease, diabetes, liver cirrhosis and hepatocellular carcinoma (Szymonik-
Lesiuk et al., 2003). Previous studies documented a significant decrease in the level of 
CAT, SOD and GPX enzymes after consequent increase in oxidative stress and free 
radical levels, resulting in an increase in cellular damage in cirrhotic rats (Abul et al., 
2002).  
The control of ethanol-induced oxidative stress in alcoholic liver diseases (ALD), 
hepatic stellate cells (HSC) and inflammatory cells have been shown to initiate the 
production of hepatocyte growth factor (HGF), which leads to hepatocytes proliferation 
and repair. HGF has been revealed to decrease ROS production, lipid peroxidation and 
protein oxidation damage due to ethanol metabolism, with an increase in cell viability. 
The mechanism involved in the HGF that induced protection against ethanol toxicity 
revealed that HGF induces the expression of antioxidant enzymes such as CAT, SOD, 
and GPX (Gómez-Quiroz et al., 2012).  
Liver cirrhosis has been reported to be accompanied by excessive oxidation of 
polyunsaturated membrane lipids (Poli, 2000). Lipid peroxidation induces over 
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expression of fibrotic cytokines, the key molecules in the fibrosis mechanism, as well as 
increased synthesis of collagen. Thus the hepatic lipid peroxidation has been 
extensively studied in vitro and in vivo experimental models by measuring 
malondialdehyde (MDA), a major end product of lipid peroxidation (Poli & Parola, 
1997).  Lipid peroxidation and subsequently fibrosis have been prevented in the liver of 
animals supplemented with antioxidants like silymarin (Shaker et al., 2010), 
Anoectochilus formosanus (Shih et al., 2005), Nigella sativa (Kanter et al., 2003), 
Rosmarinus officinalis (Gutierrez et al., 2010), Ambrosia maritime (Ahmed & Khater, 
2001) and many other plant extracts. 
 
 
2.3.3.1 Antioxidant properties of medicinal plants 
Many synthetic antioxidants e.g. butylated hydroxyl anisole (BHA), butylated hydroxyl 
toluene (BHT) or tert-butyl hydro quinine (TBHQ) have been restricted against 
includion in foods because of their toxicity, therefore, attention has been directed 
towards the improvement of natural antioxidants from plants materials.  
Natural antioxidants could be either phenolic compounds (phenolic acid, flavonoid, and 
tannin), nitrogen containing compounds (chlorophyll derivative, alkaloid, amino acid, 
amine and peptide,), ascorbic acid, carotenoids or tocopherols and their derivatives. 
Thus interest has raisen amongst food manufacturers, scientists and consumers toward‘s 
antioxidant constituents of botanical sources in the maintenance of health and protection 
from different diseases and cancer (Dimitrios, 2006).  
There have been various in vitro techniques used to determine the effectiveness of plant 
derived natural antioxidants. These techniques are of two types: 
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1) Hydrogen atom transfer reactions, such as total radical trapping antioxidant 
potential (TRAP), oxygen radical absorbance capacity (ORAC) and β- carotene 
bleaching. 
2) Electron transfer reactions such as ferric reducing antioxidant power (FRAP), 
trolox equivalent antioxidant capacity (TEAC), α,α-diphenyl-β-picryl-hydrazyl 
radical scavenging assay (DPPH), hydroxyl radical scavenging assay, 
superoxide anion radical scavenging assay, total phenolic or flavonoids assays 
and nitric oxide radical scavenging assay.  
However, it is important to apply more than one technique to measure the antioxidant 
ability of plant extracts because of the complex structure of phytochemicals (Chanda & 
Dave, 2009).  
Medicinal plants have been screened worldwide for their antioxidant effects. In a study 
by Adewusi and Steenkamp (Adewusi & Steenkamp, 2011) they reported the 
antioxidant activities of 12 plants traditionally use in South Africa to treat neurological 
disorders. Their findings support that the antioxidant activities of plants counteract with 
the ROS and the cholinesterase mechanisms. In vitro radical scavenging activity of 1,1-
diphenyl-2-picrylhydrazyl (DPPH) has been detected with in vivo superoxide dismutase 
(SOD), catalase (CAT) and glutathione peroxidase (GPX) activities enhanced in 
Chinese hamster lung fibroblasts (V79-4) treated with methanol extracts of nine 
medicinal plants traditionally used in Chinese medicine (Lee et al., 2003). 
Moreover, correlations were found between the antioxidant activities of 42 plants used 
traditionally in Thailand and their chemical content such as vitamin C, vitamin E, 
carotenoids, tannin, and totalphenolics (Chanwitheesuk et al., 2005). Also, the 
antioxidant capacity and the total phenols and flavonoid contents of kiwi fruit (Actinidia 
deliciosa) were determined in vitro, by assaying free radical scavenging activities of 
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1,1-diphenyl-2-picryl-hydrazyl (DPPH), 2,2′-azino-bis(3-ethyl benzthiazoline-6-
sulfonic acid) (ABTS), superoxide anion radical and N,N-dimethyl-p-phenyl 
enediamine (DMPD), and reducing power of (FRAP) and (CUPRAC) and the metal 
chelating activities (Bursal & Gulcin, 2011). 
The in vitro inhibition of lipid peroxidation, DPPH radical scavenging activity and 
modulation of mutagenicity in Escherichia coli induced by ter-butyl hydroperoxide 
(TBH) have been screened in 45 medicinal plants in Cuba (Ramos et al., 2003). 
Furthermore, 22 extracts from 14 species of Brazilian medicinal plants were studied for 
their ability to reduce DPPH free radical and to protect the yeast Saccharomyces 
cerevisiae cells against the lethal oxidative stress caused by tert-butyl hydroperoxide 
(TBH) (Silva et al., 2005). 
 
2.3.3.2 Plant-derived polyphenolic compounds 
Plant-derived polyphenolic compounds are organic compounds of plant origin with 
more than one phenol group. Polyphenols are classified by their source of origin, 
chemical structure and biological function into phenolic acids (benzoic acid and 
cinnamic acid derivatives), flavonoids (anthocyanins, flavanols, flavones and 
flavanones) and polyphenolic amides, with some highly polymerised compounds like 
lignans, melanins and hydrolysable tannins (Tsao, 2010). 
Polyphenols are widely involved as the active components in many herbal and 
traditional medicines. More than 5000 plant polyphenols have been identified and are 
known to possess a wide range of pharmacological properties (Ullah & Khan, 2008). In 
recent years, plant-derived polyphenolic compounds were shown to possess a wide 
range of pharmacological properties, such as anti-inflammatory, antioxidant and DNA 
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repair mechanisms (Nichols & Katiyar, 2010).  They are recognized as naturally 
occurring anti-microbial compounds (Taguri et al., 2004) and have been implicated as 
cancer chemopreventive agents (Stoner & Mukhtar, 1995).  
Furthermore, the hepatoprotective effects of different polyphenolic compounds derived 
from plant origins were reported by (Adzet T, 1987 ; De Oliveira E Silva Am, 2012) 
and the mechanisms involved in the hepatoprotective effects have been suggested to be 
related to the inhibition of iron absorption by polyphenol compounds (Mascitelli et al., 
2008).  
 
2.3.4. Modern techniques used for isolation of plants active constituents 
The first research on isolating plants active constituents‘ were scientifically recorded at 
start of the 19
th
 century. Since then, different organic chemistry techniques were 
developed and improved upon. These techniques include extraction, separation and 
identification of the chemical ingredients. Thus, different parameters have been reported 
to affect the extraction yield, such as the used plants parts, solvent type and extraction 
time (Ahmad et al., 2009). Various preparation steps like pre-washing plants, drying or 
freeze drying and grinding are used to gain a homogenous sample. In addition to which, 
extraction methods such as heating under reflux, sonication, soxhlet extraction and 
others are also commonly used (Ong, 2004).  
Sample preparation is the first critical step of the analysis process, since it is important 
to extract the preferred active components from the plant extracts for further separations 
and purifications (Huie, 2002). 
Separations have been reported to be through liquid chromatography with gradient 
elution, by capillary electrophoresis or by using hyphenation procedures. Hyphenated 
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techniques such as high-performance liquid chromatography (HPLC) coupled to UV 
spectroscopy (LC/UV), mass spectrometry (LC/MS), gas chromatography coupled to 
mass spectrometry (GC/MS) and more recently nuclear magnetic resonance (LC/NMR), 
have all been proven to be highly efficient for the chemical screening of crude plant 
extracts (Hostettmann et al., 2001).  
Testing the biological activities subsequent to the plant fractionation has been 
performed continuously in the discovery of new metabolites. (Hostettmann et al., 1998). 
GC/MS have been used mostly for the analysis of volatile and semi-volatile compounds, 
like essential oils and others, while the LC/MS is the method of choice for many 
compounds, ranging from small polar molecules to macromolecules, such as proteins, 
nucleic acids and carbohydrates (Ong, 2004).  
Identification of new compounds could be done by comparing their chromatographic 
retention times and mass-spectral fragmentation outlines to the recognized and expected 
information available in certain databases (Kopka et al., 2004). Additionally direct 
comparison with available authentic materials could confirm the identification, but if the 
authentic compounds were not available, comparison with literature data may suffice for 
the identification (Harborne, 1998). 
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2.4 Phyllanthus niruri Linn 
2.4.1 Botanical classification and characteristics 
Kingdom: Plantae 
Division: Magnoliophyta 
Class: Magnoliopsida 
Order: Euphorbiales 
Family: Euphorbiaceae 
Genus: Phyllanthus 
Species: niruri 
Phyllanthus niruri Linn. Locally known in Malaysia as dukung anak, is found in most 
tropical and subtropical regions (Figure 2.7). It is a small herb, growing up to 60 cm in 
height. Its leaves are small with very short petiole, the flowers vary from white to 
greenish in color (Murugaiyah & Chan, 2009). 
                    
                    Figure 2.7: Phyllanthus niruri Linn. 
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2.4.2 Traditional uses 
Phyllanthus niruri has been used in folk medicine as antipyretic, analgesic, as well as to 
treat inflammations or similar symptoms that might suggest anti-histamine effects. Also, 
the decoction of the whole plant has been used as a drug against diarrhoea and as a bath 
emolient used to treat jaundice. Crushed leaves together with leaves of Eupatorium 
odoratum and lime are applied on boils (Ong & Norzalina, 1999). 
Furthermore, it has been used as an antispasmodic, including treatment of 
stomachaches, abdominal pain, colic, menstrual cramps, dysmenorrhea, relief of 
spasms, childbirth pains, or similar symptoms (Unander et al., 1995). 
 
2.4.3 Medicinal uses 
Previous studies revealed the therapeutic potential of Phyllanthus niruri to treat genito-
urinary infections, venereal diseases, kidney or bladder stones, as well as acting as a 
urinary inhibitor of calcium oxalate crystallization and as effective treatments for 
urolithiasis through its interfere in the growth and aggregation of calcium oxalate  
crystals (Freitas et al., 2002; Boim et al., 2010; Barros et al., 2006). It has also been 
shown that the anti-hyperuricemic action might be due to its uricosuric activity through 
xanthine oxidase inhibitory effect (Murugaiyah & Chan, 2009). 
It has been used to treat diabetes through blood glucose lowering properties such as 
inhibition of glucose absorption and enhancement of glucose storage (Okoli et al., 
2011), with the methanol extract of P. niruri exhibiting significant anti-hyperglycemic 
activity in streptozotocin-induced diabetic rats (Mazunder et al., 2005). 
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In addition, P. niruri aqueous extract had cardio-protective effects on doxorubicin-
induced myocardial toxicity in rats (Thippeswamy et al., 2011), used as antiplasmodial 
to treat malaria and to treat skin or throat infections of bacterial origin (Mustofa & 
Wahyuono, 2007). Khanna et al. (Khanna et al., 2002) studied the lipid lowering 
activity of Phyllanthus niruri. They found that this plant caused lowering in the levels 
of VLDL and LDL when fed to the research animals. In addition, they revealed that this 
activity was mediated through inhibition of hepatic cholesterol biosynthesis, increased 
bile acids excretion, whilst also enhancing plasma lecithin and cholesterol acyl 
transferase activity. Tang et al. (Tang et al., 2010) investigated the cytotoxic effects of 
the aqueous and the methanolic extracts of four Phyllanthus species (P. niruri, P. 
amarus, P. watsonii and P. urinaria) against prostate cancer cells and skin melanoma. 
Their results indicated that Phyllanthus extracts enclosed the ability to induce apoptosis 
with no significant cytotoxicity effects on normal cells. 
Moreover, P. niruri in combination with Nigella sativa has proven to treat viral origin 
acute tonsillo-pharyngitis through anti-inflammatory and immunmodulatory effects 
(Dirjomuljono et al., 2008). 
 
 
 
 
 
 
 
  
37 
 
2.4. 4 Chemical constituents isolated from Phyllanthus niruri 
The most recent research has characterized a wide variety of phytochemicals and their 
pharmacological properties from various parts of P. niruri. The most known active 
phytochemicals that have been isolated were flavonoids, alkaloids, terpenoids, lignans, 
polyphenols, tannins, coumarins and saponins (Bagalkotkar et al., 2006; Murugaiyah & 
Chan, 2009; Markom et al., 2007).  
The aqueous extract of the intact plant provided an acidic arabinogalactan, which was 
characterized chemically, along with its effects on peritoneal macrophage activation 
(Mellinger et al., 2005). Additionally,  Benzenoids, phytallates, lipids, sterols, 
triterpenes have all been identified, and several polyphenolic constituents were isolated 
from tissue cultures of P. niruri, such as gallic acid, catechin, epicatechin, gallocatechin, 
epigallocatechin, epicatchin-3-O-gallate and epigallocatechin-O-gallate (Calixto et al., 
1998). 
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2.5 Melastoma malabathricum Linn 
2.5.1 Botanical classification and characteristics 
 
 Kingdom: Plantae 
 Division: Magnoliophyta 
 Class: Magnoliopsida 
 Order: Myrtales 
 Family: Melastomataceae 
 Genus: Melastoma 
 Species: malabathricum 
Melastoma malabathricum Linn is a plant from the family Melastomaceae with one 
meter of shrub and plenty of branches. It can grow to a height of bween 3 to 6 meters 
(Figure 2.8) and the flowers raise 5 to 10 clusters with 5 petals each (Susanti et al., 
2007). 
 
           Figure 2.8: Melastoma malabathricum Linn.  
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2.5.2 Traditional uses 
Melastoma malabathricum (MM) is a plant found in many regions of tropical Asia, 
where it is known by different local names, such as the Straits Rhododendron 
(Singapore), Malabar melastome (Australia), Indian-rhododendron or Lutki (India) and 
Senduduk (Malaysia). According to the tribes of Manipur it is known as a ―Wonder 
drug‖, since the leaves are medicinally used as an antipyretic drug and commonly 
recommended to lower fever (Ringmichon et al., 2010).  
The Melastomataceae family is used worldwide to treat a range of diseases, such as 
diarrhea, dysentery, wound-healing and post-partum depression. Leaf extracts from M. 
malabathricum have been used in traditional medicine as a drink to cure diarrhea, while 
the fruit juice has been used as a lip polish (Ong & Nordiana, 1999). 
In Malaysia the Malay population use the leaves and shoots of this plant for the 
treatment of wounds, post natal health care and to prevent scars of small pox. The root 
extract‘s have been used to relieve toothaches and the flowers can be used to brew a tea 
to treat stomach ache, flowers cuts were used for washing skin and a root decoction was 
sometimes taken for measles (Rajenderan, 2010). 
 
2.5.3 Medicinal uses 
Prior studies on M. malabathricum leaves showed that the methanol and acetone 
extracts had significant antibacterial and wound-healing potential, possessing potent 
anticoagulant properties compared with heparin (Choudhury et al., 2011; Sunilson et 
al., 2008; Manicam et al., 2010). 
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The study of (Hussain et al., 2008) demonstrated that aqueous extracts from M. 
malabathricum leaves had gastro-protective activities toward ethanol-induced gastric 
ulcers in rats.  The phytochemical investigation of (Susanti et al., 2009) isolated a series 
of flavonoids, triterpenoids and alkaloids by chromatography that scavenged free 
radicals, prevented lipid peroxidation, and reduced inflammation. Moreover, M. 
malabathricum showed  potent antiviral activity against-Herpes simplex virus and 
Poliovirus and showed cytotoxic activity against human and murine cancer lines 
(L1210, 3LL, K562, DU145, U251, MCF-7) (Lohezic-Le Devehat et al., 2002).  The 
natural penta cyclic triterpenes and flavonoids from M. malabathricum could inhibit 
platelet activating factor (PAF) and may act as a natural anti-inflammatory agent and 
may actively scavenge free radicals (Sirat et al., 2010). 
 
2.5.4. Chemical constituents isolated from Melastoma malabathricum 
Kaempferol 3-0-D-galactopyranoside, kaempferol 3-0-(2",6" -di-O-E-p-coumaroyl-D-
galactopyranoside, kaemptero13-O-L-rhamnopyranoside, kaempferol kaempfero13-O-
D-glucopyranoside, quercetin and ellagic acid were isolated from the methanol extract 
of the flowers of Melastoma malabathricum (Susanti et al., 2007). 
The phytochemical research of (Wong et al., 2011) resulted in the recognition of ursolic 
acid, asiatic acid, 2-hydroxyursolic acid, sitosterol 3-O-D-glucopyranoside and the 
glycolipid glycerol 1,2-dilinolenyl-3-O-D-galactopyanoside in the chloroform fraction. 
Kaempferol, kaempferol 3-O-D-glucopyranoside, kaempferol3-O-L-rhamnopyranoside, 
kaempferol 3-O-(2, 6-di-O-Ep-coumaryl)-D-galactopyranoside, kaempferol 3-O--D-
galactopyranoside, ellagic acid and quercetin were found from the ethyl acetate fraction. 
Numerous hydrosable tannins have been identified from this plant likedimers named 
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malabathrins B, C and D oligomers named nobotanin B, monomers named 1,2,4,6-tetra-
O-galloyl-b-D-glucoside, 1, 4, 6-tri-O-galloyl-b-D glucoside, strictinin, pedunculagin, 
casuarictin,  nobotanin D, oligomers nobotanins G, H, and J. and pterocarinin. A further 
research revealed the presence of a-amyrin, b-sitosterol,  sitosterol-3-O-b-D-
glucopyranoside, uvaol, quercitrin, quercetin, and rutin (Sirat et al., 2010).  
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                        CHAPTER III   
                    METHODOLOGY 
3.1 Materials 
Tween 20 and 95% (v/v) ethanol were purchased from (Sigma-Aldrich, UK). Filter 
paper (Whatmann No.1, Fitchburg, WI, USA), R-215 rotating evaporator (Buchi, 
Flawil, Switzerland), freeze-drying machine (LabConco, Kansas City, MO, USA), 
Genie-2 vortex (Scientific Industries Inc., USA). 2,2 Diphenyl-1-picryl dyhydrazyl 
(DPPH) reagent, 2, 2-azinobis 3-ethyl benzothiazoline-6-sulfonic acid (ABTS) reagent, 
Folin-Ciocalteu reagent, ascorbic acid (product no. A4403), potassium persulfate, 
methanol, Folin-Ciocalteu reagent, gallic acid, natrium carbonate (Na2CO3), butylated 
hydroxyl toluene (BHT), aluminium chloride, potassium acetate, quercetin, acetate 
buffer, 2, 4, 6-tripyridyl-s-triazine (TPTZ), HCL, FeCl3.6H2O. were all purchased either 
from (Thermo Fisher scientific ,USA) or (Sigma-Aldrich, UK). Power wave X 340 
ELISA plate reader from (BIO-TEK instruments, Winooski, VT, USA). Trypan blue, 
Histopaque-1077, PBS (phosphate buffer saline), Roswell Park Memorial Institute-1640 
(RPMI-1640) media supplemented with 2 mM glutamine and NaHCO3 purchased from 
(Sigma-Aldrich, Gillingham, UK). 3-(4, 5-dimethylthiazol-2-yl)-2‚5-
diphenyltetrazolium bromide (MTT reagent), FBS (Fetal Bovine Serum), DMSO 
(dimethyl sulphoxide) purchased from (Merck, Darmstadt, Germany). Neubaur 
haemocytometer (Weber, Teddington, UK), IR Jacketed incubator (from NUAIRE 
laboratory equipment supply, Plymouth, MN, USA). Silymarin was purchased from 
International Laboratory (USA), Thioacetamide, xylazine, ketamine, Formalin, 
Hematoxylin & Eosin were obtained from (Sigma-Aldrich, Gillingham, UK). 
Automated tissue processor, Leica Tissue Microtome (Leica, Germany). AM 432 Dino 
Lite microscope eyepiece camera (Dpro Scientific Bhd. Sdn.) Wise Mix
TM
 HG,15A 
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homogenizer (DAIHAN Sci., Seoul, Korea), Jouan C312 centrifuge (Santa Fe Springs, 
CA, USA) and Rotofix 32 refrigerated centrifuge (Hettich Zentrifugen, Germany). 
Commercially available kits from (Cayman Chemical Co., USA) were used to 
determine total antioxidant capacity (TAC) (cat. #709001), Malonialdehyde (MDA) 
(cat. #10009055), Catalase (CAT) (cat. #707002), superoxide dismutase (SOD) (cat. 
#706002) and glutathione peroxidase (GPX) (cat. #703102) activities. RNA-later 
solution (Applied Biosystems, Foster City, CA), Qiamp RNA blood mini kit (Qiagen, 
Germantown, Maryland, USA). RNase- Free DNase set (Qiagen, Germantown, 
Maryland, USA), Nano Drop ND-2000 Spectrophotometer (Thermo Fisher Scientific, 
Wilmington, DE, USA), agarose gels and Tris-Borate-EDTA (10X TBE) (Applied 
Biosystems, USA), Ethidium Bromide (EB) and loading dye (Promega, USA). High 
Capacity RNA-to-cDNA Master Mix, TaqMan Fast Advanced Master Mix, ultrapure 
DNase free water, Transforming growth factor beta (TGFβ1), tissue inhibitors of 
metalloproteinases (TIMP1), matrix metalloproteinase (MMP2), Collagen alpha 
(Collα1).glyceraldehyde 3-phosphate dehydrogenase (GAPDH), beta actin (β-actin), 
hypoxanthine phosphoribosyl transferase 1 (Hprt1) and peptidyl prolylisomerase A 
(Ppia) assay genes were all purchased from (Applied Biosystems, Foster City, CA), 
thermal cycler (PTC-100 thermal controller, MJ Research Inc., Basel, Switzerland), 
Monochrome scientific grade camera and gel documentation system (Vilber Lourmat, 
Thermo Fisher scientific, USA).  Silica gel 60 powder (0.063 - 0.200 mm) and (70 - 230 
mesh), silica gel F254 plates (20 x 20 cm, 0.2 mm), HPLC grade n hexane, HPLC grade 
ethyl acetate, HPLC grade methanol, HPLC grade acetonitrile were purchased from 
(Merck, Germany). (2 x 30 cm) Kontes column with EYEL- 4 pump (Rikakikai, 
Tokyo). Milli-Q academic water purification system (Millipore, USA).  
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3.2 Protocol of the study 
Two plants were selected in this study to evaluate their in vivo hepatoprotective effects; 
based on the ethnobotanical information and literature reports, the previously implicated 
hepatoprotective function of the Phyllanthus niruri was further evaluated and the 
mechanism underlying its hepatoprotective action was investigated using rat model of 
liver cirrhosis induced chemically by thioacetamide (TAA) administration.  
Secondly, the in vitro bioactivities were assessed (including the antioxidant activities and 
the immunomodulatory effects) besides, the isolation of active constituents of both plants 
by different chromatography techniques.  
Then, since no literature was found investigating the activity of Melastoma 
malabathricum as a hepatoprotective agent and the healing properties on liver cirrhosis 
have not been studied before, this study was set out with the aim of assessing the 
importance of M. malabathricum ethanol extract to prevent thioacetamide induced liver 
cirrhosis in Sprague Dawley rats. The obtained results of both plants were compared with 
standard hepatoprotective agent ―silymarin‖. 
All of the processes and procedures that employed in our experiments are shown in the 
Flow Chart of the study in Figure 3.1. 
 
 
 
 
 
 
 
  
45 
 
              Phyllanthus niruri and Melastoma malabathricum 
                  Crude extraction 
 
Antioxidant   Immunomodulatory   Acute toxicity    Isolation of    Hepatoprotective 
Activity                        roles                     test            active constituents            effects   
 
 
DPPH assay             
ABTS assay         Isolation of PBMCs 
FRAP assay     Quantification of PBMCs 
TPC assay                MTT assay 
TFC assay                                           
                                                          Body weight changes 
                                                 Biochemical tests 
                                                   Histopathology 
                 
                                                                             
                                                                           Column Chromatography 
                                                                          Thin Layer Chromatography 
                                                                       UPLC and LC-MS 
 
                                        
                                                                                             Body weight changes                                                                        
                                                                                                         Biochemical tests  
                                                                                             Gross morphology                                   
                                                                                                         Histopathology  
    TAC, MDA, SOD, CAT, GPX                              Endogenous antioxidant activity 
                  TGFβ, TIMP1, MMP2, COLLα                                Gene expression    
 
 
                        Figure 3.1: Protocol of the study 
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3.3 Methods 
3.3.1 Preparation of plants extracts 
Phyllanthus niruri and Melastoma malabathricum whole plant parts were obtained from 
Ethno Resources Sdn Bhd, Selangor Malaysia. For preparation of the ethanol extracts, 
(100 grams) of the fine powders were soaked in (1000 ml) of (95 % ethanol) for 72 
hours. Then the extracts were filtered by filter paper (Whatman No. 1), evaporated 
under low pressure by using rotary evaporator and finally subjected to lyophilization in 
freeze dryer to give the crude-dried extract. The dried extracts were stored at -20°C until 
used.  
 
3.3.2 Antioxidant activity 
3.3.2.1 Diphenylpicrylhydrazyl (DPPH) assay 
DPPH analysis is one of the tests used to prove the ability of the components of the 
plants extracts to act as donors of hydrogen atoms. As the Diphenylpicrylhydrazyl 
(DPPH free radical) molecule has a spare electron over it, gives rise to a deep violet 
colour, characterized by an absorption band in methanol solution centered at about 515 
nm. When a solution of DPPH is mixed with that of a plant extract that can donate a 
hydrogen atom, then this gives rise to the reduced form  diphenylpicrylhydrazine (non 
radical DPPH) with the loss of its violet colour (to a yellow colour) (Molyneux, 2004). 
The scavenging activity of stable 2, 2 Diphenyl-1-picryl dyhydrazyl free radical was 
determined according to the method of (Gorinstein et al., 2005) with slight 
modifications.  (1 mg /1ml) of the plant extracts and the reference standard (ascorbic 
acid) were prepared as stock solutions then a series dilution with five varying 
concentrations were tested. 5µl of samples/standards were loaded, and followed by 195 
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µl of DPPH reagent, the mixtures were then mixed vigorously and incubated in the dark 
at room temperature for 2 hours, and the absorbance was measured 
spectrophotometrically at 515nm. The percentage of DPPH free radical scavenging 
activity was calculated as: 
DPPH (%) = [(Abs of blank-Abs of sample)/absorbance of sample] × 100.  
The results were expressed as (IC50 value) the extract concentration that required to 
reduce 50% of the hydroxyl radical produced.  
 
3.3.2.2 Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) assay 
The total antioxidant capacity assay was carried out using the improved method, as 
described by (Re et al., 1999). The radical cation of 2,2-azinobis-(3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical was generated by oxidation with 
potassium persulfate to a blue/green ABTS chromophore and further reduced in the 
presence of the plants extracts (as the hydrogen-donating sources of antioxidants) 
determined by the decolorization of the ABTS solution and measuring the reduction as 
the percentage inhibition of absorbance at 734 nm. 
 Briefly, ABTS radical cation is generated by reacting 7 mM ABTS and 2.45 mM 
potassium persulfate via incubation at room temperature, in the dark for 12–16 h. The 
ABTS solution was diluted with methanol to an absorbance of (0.700 ± 0.020) at 734 
nm and equilibrated at 30°C while Plant extracts were diluted with distilled water. To 
one milliter of diluted ABTS, 10 µl of each plant extract solution were added and mixed 
thoroughly. The reactive mixture was allowed to stand at room temperature for 15 min 
and the absorbance was recorded immediately at 734 nm. The percentage of ABTS free 
radical scavenging activity was calculated as:  
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ABTS (%) = [(Abs of blank-Abs of sample)/absorbance of sample] × 100.  
The results were expressed as (IC50 value) the extract concentration that required to 
reduce 50% of the free radical produced.  
 
3.3.2.3 Total phenolic content (TPC) assay 
Total phenolic content was determined using Folin-Ciocalteu reagent following the 
method of (Singleton & Rossi Jr, 1965) using gallic acid as a standard. 10µl of extract 
solution (1mg /1ml) was added in a test tube followed by 0.5ml of 1:10 Folin-Ciocalteu 
reagent. The mixture was incubated at room temperature for 5 minutes. After 5 minutes, 
0.35 ml of 115mg /ml natrium carbonate (Na2CO3) was added and mixed thoroughly. 
The mixture was then allowed to stand at room temperature for 2 hours. Absorbance 
readings were taken spectrophotometrically at 765nm and all determinations were done 
in triplicates. The total phenolic content was expressed as miligrams of gallic acid 
equivalent to grams dried plant material and butylated hydroxyl toluene (BHT) was 
used as positive control. 
 
3.3.2.4 Total flavonoid content (TFC) assay 
Total flavonoid content of each sample was determined by aluminium chloride 
colorimetric method by (Chang et al., 2002) and (Harborne & Williams, 2000). Briefly, 
0.5ml of extract solutions (1mg /1ml) were added to a separate test tube and mixed 
with1.5 ml of 95 % ethanol, 0.1ml of 1M of potassium acetate, 0.1 ml of aluminium 
chloride and 2.8 ml of distilled water. After that, the mixtures were incubated for 30 
minutes at room temperature. The absorbance readings were taken 
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spectrophotometrically at 415nm. Total flavonoid content was expressed as milligrams 
of quercetin equivalent to grams of dried plant material. 
 
3.3.2.5 Ferric reducing antioxidant power (FRAP) assay 
Ferric reducing antioxidant power assay is presenting a method of measuring 
antioxidant power by converting ferric tripyridyltriazine complex (Fe III-TPTZ) at low 
pH to a colored ferrous-tripyridyltriazine complex (Fe II).The ferric reducing activity of 
the plant extracts were estimated using the method developed by (Benzie & Strain, 
1996). The reaction mixture contained 300 mmol / L acetate buffer, 10 mmol/ L TPTZ 
(2, 4, 6-tripyridyl-s-triazine) in 40 mmol / L of HCL and 20 mmol /L of FeCl3.6H2O. 
the working FRAP reagent prepared freshly by mixing 25 ml of acetate buffer, 2.5 ml of 
TPTZ solution and 2.5 ml of FeCl3.6H2O. The freshly prepared mixture was incubated 
at 37°C in water bath for five minutes and then a blank reading was taken 
spectrophotometrically at 593 nm. After that, 10 µl of extract or standard and 90 µl of 
distilled water were added to 300 µl of the working FRAP reagent. Absorbance was 
measured (593nm) at 0 minute immediately upon addition of the working FRAP reagent 
after vortexing. Thereafter, absorbance reading was taken after four minutes. All results 
were expressed as mmol ferric reducing activity of the extract per gram of dried weight 
based on three experiments and butylated hydroxyl toluene (BHT) was used as the 
positive control. 
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3.3.3 Immunomodulatory effects 
3.3.3.1 Isolation of peripheral blood mononuclear cells (PBMC) 
To achieve the immunomodulatory effects of the plant extracts the peripheral blood 
mononuclear cell (PBMC) proliferation activity was investigated (Boyum, 1968). 
Ten milliliters of whole blood was drawn from a healthy donor and diluted with the 
same volume of Histopaque-1077 (sigma Aldrich). The mixed solution was centrifuged 
under at 1,000 rpm for 30 min. The mononuclear layer was carefully transferred out and 
washed, then pelleted down with 30 ml PBS (phosphate buffer saline) and centrifuged 
at 1,000 rpm for 10 min for thrice and re-suspended with Roswell Park Memorial 
Institute-1640 (RPMI-1640) media supplemented with 2 mM glutamine and NaHCO3 
(Sigma-Aldrich, Gillingham, UK) with addition of 10% FBS (Fetal Bovine Serum).  
 
3.3.3.2 Quantification of peripheral blood mononuclear cell (PBMC)  
Haemocytometer grid system was used to determine the concentrations of PMBCs. First 
of all, 10 μL of the isolated PBMC was mixed with 10 μL of trypan blue (0.4%) and 
mixed eventually and 10 μL of this suspension was loaded into Neubaur 
haemocytometer (Weber, Teddington, UK) to find out the PBMC cell number. The 
PBMCs were visualized under 40X microscope and the numbers were counted 
following the formula: 
PBMC concentration (cells/ml) = Average cell count * dilution factor *10
4 
Consequently, the cells were mixed with RPMI-1640 media to the required 
concentration. 
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3.3.3.3 MTT assay 
3-(4, 5-dimethylthiazol-2-yl)-2‚5-diphenyltetrazolium bromide (MTT) assay was used 
to study the effect of the extract on PBMC cells viability (Mosmann, 1983). Briefly, 100 
μL of cells suspended in RPMI media (with 10% of FBS) was added into the 96 well 
plate and incubated at IR Jacketed incubator (from NUAIRE laboratory equipment 
supply, Plymouth, MN, USA) for 24 h at 37 °C. Then, 10 μL of the extracts (20 mg/ml) 
were added and further incubated for 24 h.  
After the corresponding period 10 µl of MTT reagent (Merck, Darmstadt, Germany) (5 
mg/ml PBS) was added into each well and further incubated for 4 h. 100 µl of DMSO 
were added and shake for 20 min to solubilize and extract the formazan crystal. At the 
last, the plate was read at 595 nm by using Power wave X 340 ELISA plate reader 
(from BIO-TEK instruments, Winooski, VT, USA). All extract samples and controls 
were tested in triplicates in four independent experiments. The percentage of cell 
viability was calculated by the formula:  
% Cell viability = (abs of extract sample – abs of control/abs of control) × 100 
 
 
 
 
 
 
 
  
52 
 
3.3.4 Acute oral toxicity test 
To determine the safety of the plants extracts when administered orally, the acute 
toxicity test was performed following OECD-423 guidelines (Oecd, 1998). The 
experiment design is given in Figure 3.2. which in brief, forty healthy Sprague Dawley 
rats (20 males and 20 females) were randomly assigned equally into 5 groups labeled as 
vehicle 10% Tween 20 and two large doses 2 g/kg and 5 g/kg for each of P. niruri and 
M. malabathricum ethanol extract, respectively.  Each rat was made to fast (no food but 
water) overnight prior to dosing. Food was withheld for another 3 to 4 hours after the 
dosing.  The rats were closely observed for 30 minutes and at 2, 4, 24 and 48 hours after 
the dosing to detect if there were any acute signs of clinical toxicity, morbidity and 
mortality twice daily. Comparisons were verified between the individual animals and 
their respective vehicle treated animals. Detailed behavioral observations include: 
respiration (dyspenea), salivation, skin piloerection, exopthalmus, convulsion and 
locomotion changes.  After keeping alive for 14 days, on day 15, the rats were sacrificed 
to measure serum biochemical and (liver and kidney) histological parameters following 
the standard methods (Abdulla et al., 2010).  
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P. niruri and M. malabathricum's ethanol extracts 
                           (Sprague Dawley rats, 20 males and 20 females) 
 
 
Vehicle group              PN/LD                   PN/HD              MM/LD             MM/HD 
10 % Tween 20           (2g/kg)                   (5g/kg)              (2g/kg)                 (5g/kg) 
 
                                             Two weeks observation 
                             
                                              Overnight fasting 
 
                                   Sacrificed on 15
th
 day 
 
                       Collection of blood                         Histopathological examinations 
            for Biochemical tests                            of livers and kidneys  
 
Figure 3.2: Experimental design of acute toxicity test: PN/LD: P. niruri low dose 
group, PN/HD: P. niruri high dose group MM/LD: M. malabathricum low dose group, 
MM/HD: M. malabathricum high dose group. 
 
 
 
 
 
 
  
54 
 
3.3.5 Hepatoprotective activity 
3.3.5.1 Animals and ethical considerations 
This study was approved by the institutional Ethics Committee, University of Malaya, 
Malaysia with protocol number PM/28/08/2010/MAA.  Throughout the experiments, 
we provided human care to the animals according to the criteria outlined in the ―Guide 
for the Care and Use of laboratory Animals‖ prepared by the National Academy of 
Sciences and published by the National Institutes of Health.   
Adult healthy Sprague Dawley rats weighing between 190 -260 grams were obtained 
from the Laboratory Animal Centre of the Faculty of Medicine, University of Malaya. 
The rats were placed individually in a separate cage and maintained on standard pellet 
diet and water ad libitum.   
 
3.3.5.2 Experimental protocol and samples collection 
Fifty-six healthy male Sprague Dawley rats weighing 190-260 gm were divided into 7 
groups randomly, each of eight rats. The plant extract and silymarin were dissolved in 
10% Tween 20 and distilled water respectively and (5 ml/kg body weight) whereas 
thioacetamide was dissolved in distilled water (2 ml/kg body weight) and injected intra-
peritoneally to the rats. The plants extracts were administered orally by oral gavages 
three days prior to TAA injection following the methods of (Bruck et al., 2007; Dorğru-
Abbasoğlu et al., 2001) in which  the administration of the tested substance together 
with TAA injection, have shown to diminish the severity of the liver injury. The sample 
concentrations, durations and the complete experimental design are shown in Table 3.1.  
Group 1 (vehicle control group) rats were administered orally with 10% Tween 20 (5 
ml/kg) daily and injected ip with sterile distilled water (1 ml/kg) thrice weekly for 8 
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weeks. Group 2 (hepatotoxic group) rats were administered orally with 10% Tween 20 
(5 ml/kg) and injected intraperitoneally (ip) with Thioacetamide (TAA) (200 mg/kg) 
thrice weekly for 8 weeks. The injection protocol above was according to the 
recommendation of Alshawsh et al. (Alshawsh et al., 2011) Group 3 (hepatoprotective 
group) rats were administered orally with silymarin (50 mg/kg) daily and injected ip 
with TAA (200 mg/kg) thrice weekly for 8 weeks. Group 4 and 5 (PN treatment 
groups) rats were administered orally with the PN extract (100 mg/kg and 200 mg/kg) 
daily and injected ip with TAA (200 mg/kg) thrice weekly for 8 weeks. Group 6 and 7 
(MM treatment groups) rats were administered orally with the MM extract (100 mg/kg 
and 200 mg/kg) daily and injected ip with TAA (200 mg/kg) thrice weekly for 8 weeks. 
The body weights of the animals were taken every week. 
After 8 weeks, each rat was made to fast for 24 hours after the last treatment and then 
perfused under Ketamine and Xylazine (1:10 v/v) anesthesia and quickly sacrificed by 
exsanguination of jugular vein for blood sample collection. Gross morphology 
examinations were performed and the absolute weights of livers and spleens were 
documented.  
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Table 3.1: P. niruri and M.malabathricum's hepatoprotective experimental protocol. 
Group 
number 
     Group name 
Oral feeding (Daily) 
Injection of TAA 
(Thrice weekly) 
5 ml/kg BW 2 ml/kg BW 
1 Vehicle control group 10 % Tween 20 D.W. 
2 TAA (hepatotoxic) group 10 % Tween 20 200 mg / kg BW 
3 Silymarin (hepatoprotective) group 50 mg / kg BW 200 mg / kg BW 
4 PN/ LD group 100 mg / kg BW 200 mg / kg BW 
5 PN /HD group 200 mg / kg BW 200 mg / kg BW 
6 MM/ LD group 100 mg / kg BW 200 mg / kg BW 
7 MM /HD group 200 mg / kg BW 200 mg / kg BW 
TAA: thioacetamide, PN: Phyllanthus niruri MM: Melastoma malabathricum, HD: 
high dose, LD: low dose, D.W.: Distilled Water and BW: body weight. 
 
 
3.3.5.3 Biochemical tests 
The blood was withdrawn and immediately centrifuged at 4000 rpm for 10 minutes 
(Jouan C312 centrifuge). The serum was separated and subjected to the subsequent 
biochemical tests at Clinical Diagnostic Laboratory (CDL) division of University of 
Malaya Medical Center (UMMC) to determine the liver function enzymes such as 
alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline 
phosphatase (ALP), Bilirubin, albumin, total protein (TP) and gamma glutamyl 
transferase (γGT). 
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3.3.5.4 Gross morphology and histopathology 
Gross morphology was observed and photographs were taken immediately. 
Subsequently, the livers and the spleens were carefully collected, weighed, trimmed and 
kept in 10 % fresh Formalin for 48 hours then, processed by automated tissue processor 
(Leica, Germany). Molds were prepared by embedding in Paraffin Wax and 5 µm thick 
sections were sliced by Leica Tissue Microtome. Finally, the slides were kept in oven at 
55 °C then stained with Hematoxylin& Eosin.  
Histo-pathological observations were documented using Olympus microscope and 
photographs were captured using (AM 432 Dino Lite) microscope eyepiece camera.  
 
3.3.5.5 Endogenous antioxidant activities 
One gram of the livers were kept in 10 ml (10% w/v) PBS (phosphate buffer solution 
pH 7.4), then homogenized using Wise Mix
TM
 HG 15A homogenizer (DAIHAN Sci., 
Seoul, Korea) and centrifuged at 4000 rpm for 10 minutes in -4°C using refrigerated 
centrifuge Rotofix 32 (Hettich Zentrifugen, Germany). The supernatant was separated and 
kept in -80°C freezer until the assays was performed according to the instruction manual 
from the manufacturer. Commercially available kits from (Cayman Chemical Co., 
USA) were used to determine total antioxidant capacity (TAC), Malondialdehyde 
(MDA), Catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase 
(GPX). 
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3.3.5.6 Gene expression profile 
A small portion of the livers were kept immediately in RNA-later solution (Applied 
Biosystems, Foster City, CA) for gene expression assay and kept in -80 ºC until the 
purification experiment was performed. The gene expression assay was done following 
the Taqman gene expression workflow starting from (RNA isolation and purification), 
(transcription of RNA to cDNA) and (amplification of cDNA and target genes by Real 
Time PCR). The assay genes that chosen for this study were: transforming growth 
factor beta (TGFβ1) assay number (Rn00572010-m1), tissue inhibitors of 
metalloproteinases (TIMP1) assay number (Rn00587558-m1), matrix metalloproteinase 
(MMP2) assay number (Rn01538167-m1), Collagen alpha (Collα1) assay number 
(Rn01463848-m1). While glycer aldehyde 3-phosphate dehydrogenase (GAPDH) assay 
number (Rn0177563-g1), beta actin (β-actin) assay number (Rn00667869-m1), 
hypoxanthine phosphor ribosyl transferase 1(Hprt1) assay number (Rn01527840-m1) 
and peptidyl prolylisomerase A (Ppia) assay number (Rn00690933-m1) were used as 
housekeeping genes. 
 
3.3.5.6.1 RNA isolation and purification 
First, total RNA was extracted from the frozen liver using Qiamp RNA blood mini kit 
following the manufacturer‘s protocol (Qiagen, Germantown, Maryland, USA). Briefly, 
30 mg of frozen RNAlater stabilized liver tissue was weighed immediately (without 
allowing the tissue to thaw), then disrupted and grinded by using a mortar and pestle. 
The QIA-shredder spin columns were used for homogenization and separation of tissue 
lysates. Further on column digestion of DNA was performed during RNA purification 
using RNase- Free DNase set (Qiagen, Germantown, Maryland, USA) as recommended 
by the manufacturer.  Finally, the total RNA was stored at -70 ºC until further use.  
  
59 
 
RNA purity was quantified using ND-2000 Nano Drop Spectrophotometer (Thermo 
Fisher Scientific, Wilmington, DE, USA). The absorbance was measured at 230, 260, 
280, 320, and 260/280, 260/320 ratios were documented.  
While RNA integrity was measured by agarose gels electrophoresis. Electrophoresis 
buffer Tris-Borate-EDTA (10X TBA) was prepared (Applied Biosystems, USA) to fill 
the electrophoresis tank and to cast the gel. A 0.5% (w/v) solution of agarose in 
electrophoresis buffer was prepared and Ethidium Bromide (EB) was added to the 
molten gel to a final concentration (0.5 μg/ ml) then mixed thoroughly by gentle 
swirling. A small toothed comb (allows 1μL sample / well) positioned on the plate so a 
complete well was formed. The 60 ºC warm agarose solution was poured into the mold, 
and then allowed to set at RT for 30-45 minutes. The gel mounted in the tank and the 
electrophoresis buffer was added to cover the gel at depth of 1 mm. 
1μL of RNA samples were loaded after mixing with the loading dye (Promega, USA). 
Then the RNAs allowed migrating toward the positive anode. The gel ran for 30 
minutes at 95V until the migrated distance is 75% through the gel. The gels were 
examined under UV light to observe the discrete 18S and 28 S ribosomal RNA and 
photographs were taken using a Monochrome scientific grade camera in a gel 
documentation system (Vilber Lourmat, from Fisher Scientific, USA) 
 
3.3.5.6.2 Reverse Transcription of RNA to cDNA 
cDNA was synthesized using High Capacity RNA-to-cDNA Master Mix (Applied 
Biosystems, Foster City, CA) by loading the reaction plates into thermal cycler (PTC-
100 thermal controller, MJ Research Inc., Basel, Switzerland) following the reaction 
condition of the manufacturer. 
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3.3.5.6.3 Amplification of cDNA by Real Time PCR 
Real Time Polymerase Chain Reaction (Real-time PCR) was performed using 
StepOnePlus system and TaqMan Fast Advanced Master Mix (Applied Biosystems, 
Foster City, CA). The total reaction volume was 10 μL: 1μL cDNA (20 ng), 5 Μl 
Taqman Fast Advanced Master Mix, 0.5 μL of each Taqman Gene Expression Assays, 
and 3.5 μL ultrapure DNase free water. Cycle parameters were as follows: UNG 
incubation at 50 ºC for 2 min., polymerase activation at 95 ºC for 20 sec., denaturation 
at 95 ºC for 1 sec. and then annealing and extension at 60 ºC for 20 sec.  
 
3.3.5.6.4 Real Time PCR data normalization  
The real-time PCR reaction was performed in triplicate for each sample and the 
averages of the obtained threshold cycle (Ct) values were processed for further 
calculations according to the comparative Ct method described in the ABI manual 
(http://www.appliedbiosystems.com). Two endogenous control genes, hypoxanthine 
phosphor ribosyl transferase1 (Hprt1) and peptidyl prolylisomerase A (Ppia), were used 
for the normalization. The comparative CT method was used to calculate relative 
quantification of gene expression. The following formula was used to calculate the 
relative amount of the transcripts in all groups and were normalized to the endogenous 
controls. The final value then was normalized to the housekeeping gene and relative to 
the control sample values of the studied genes.  
 
 ∆∆CT = ∆ CT (sample) - ∆ CT (control). 
 Where ∆CT: is the difference in CT between the target gene and endogenous controls 
by subtracting the average CT of controls. The fold-change for each treated sample 
relative to the control sample = 2
-∆∆CT
. 
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3.3.6 Isolation of the plants active constituents 
3.3.6.1 Sample preparation  
One gram of each plant fraction was dissolved in 5 ml of methanol then filtered through 
a 0.45 μm filter and kept in fridge at 4° C until the tests were performed. 
 
3.3.6.2 Flash column chromatography (FCC) 
Plants fractionations were done following the method of Fraga et. Al. (Fraga et al., 
1987). Flash column chromatography was performed on silica gel 60 (0.063 - 0.200 
mm) and (70 - 230 mesh) from (Merck, Germany) using a (2 x 30 cm) Kontes column 
with EYEL- 4 pump (Rikakikai, Tokyo). Elution to plant extract (1gm / 5 ml methanol) 
starts with the most non-polar solvent (n hexane) then continuous gradient elution with 
n hexane - ethyl acetate - methanol - acetonitrile and ended with the most polar solvent 
(dH2O) which was purified by a Milli-Q academic water purification system (Millipore, 
USA).  
 
3.3.6.3 Thin layer chromatography (TLC) 
 The obtained fractions were dissolved in methanol at 10 mg/ml to perform thin layer 
chromatography (TLC) with silica gel F254 (20 x 20 cm, 0.2 mm) plates. The analyses 
have been achieved in (n hexane - ethyl acetate), (ethyl acetate - methanol), (methanol - 
acetonitrile), (acetonitrile - water). 
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3.3.6.4 UPLC and LC-MS 
Waters Synapt HDMS system was used with TOF-mode to provide Ultra Performance 
Liquid Chromatography (UPLC) and HDMS- mode to provide mass spectrometry, 
equipped with ACQUITY PDA Detector and an ACQUITY UPLC BEH C18, 1.7 µm, 
2.1 x 50 mm Column. The flow rate was (0.5 ml /min) and the injection volume was (3 
μL). The analyses were carried out using binary gradients of Milli-Q water (with 0.1 % 
Formic Acid) (solvent A) and HPLC grade acetonitrile (with 0.1 % Formic Acid) 
(solvent B). with the following elution profile: from 0 min: 0% (B) in (A); 7 min: 100% 
(B) in (A); 10 min: 100% (B) in (A); 11 min: 0% (B) in (A).  
 
3.3.6.5 Identification of the isolated components 
The identification of the isolated components from the active fractions of P. niruri and M. 
malabathricum were performed by comparing ultraviolet (UV) and mass spectrometry 
(MS) as described by (Halket et al., 2005). The method development and optimization were 
done at the Cancer Research Initiatives Foundation (CARIF) laboratory. Moreover, special 
software, namely ―The Dictionary of Natural Products on DVD‖ was used for 
processing and interpretation of mass spectra by comparison with the data from the 
commercial library and the available literatures review. 
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3.4 Data management and statistical analysis 
Data obtained from the in vitro antioxidant assay were analyzed using Statistical 
Program for Social Scientists (SPSS program for windows version 19, SPSS Inc. 
Chicago, IL, USA) using one-way ANOVA followed by Post-Hoc multiple 
comparisons, Duncan‘s test.  Results presented as (Mean ± S.E.M.) of triplicates for 
three different experiments. Pearson correlation used to study the correlation between 
the assays. For the hepatoprotective and immunomodulatory studies, statistical 
significance differences between the groups were assessed using one-way ANOVA 
using Bonferroni‘s test / Post-Hoc multiple comparisons.  A value of P ≤ 0.05 was 
considered significant as compared to the respective control group. 
All graphs were illustrated using Graph Pad Prism program version 5.04 for Windows, 
(Graph Pad Software, San Diego California USA, www.graphpad.com). 
The NormFinder and geNorm algorithm software (MultiD Analyses AB, Göteborg, 
Sweden) were used to evaluate and calculate the expression stability of four endogenous 
reference genes: HPRT-1, Ppia, GAPDH and β-actin for normalization in the rat liver 
samples.  Real-time RT-PCR data exported from ―StepOnePlus‖ software to Ms. Excel 
where all results arranged in one study and finally analyzed by using GenEx program 
version 5.4. (GenEx software, www.multid.se ), fold changes were calculated and T-test 
was used to examine the differences between groups for all genes and P ≤ 0.05 was 
considered as the level of significance.  
―The Dictionary of Natural Products on DVD‖ software Version 20:2 (2011) (CRC 
Press, Taylor and Francis Group, www.netbeans.org) was used to analyze the obtained 
data from chromatography profiling of the plants active fractions. 
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                                CHAPTER IV 
                                 RESULTS 
 
4.1 Extraction yield 
As shown in Table 4.1, the percentage yields for the crude ethanol extraction of 
Phyllanthus niruri and Melastoma malabathricum were 4.84 % and 10.68 % (w/w) 
respectively. 
 
4.2 Antioxidant Activity of P. niruri and M. malabathricum 
4.2.1 Scavenging effects on DPPH free radicals 
As displayed in Figure 4.1, both plant extracts showed signiﬁcant eﬀects in inhibiting 
DPPH, at a comparable extents. The DPPH scavenging activities were observed to be 
dose dependent and increased gradually with high concentrations.  
The ethanol extract of P. niruri showed DPPH free radical scavenging activity reaching 
up to (86.53 %) at concentration 25 µg/ml with IC50 value (11.07 ± 1.37 µg/L). while 
M. malabathricum showed DPPH inhibiting activity (80.09 %) at concentration 25 
µg/ml and IC50 value (11.599 ± 0.84 µg/L) and had a regression coeﬃcients of R
2
 = 
0.991 as shown in appendix A1.  As the lower IC50 value indicates a higher free radical 
quenching activity, so P. niruri and M. malabathricum shown to be significantly less 
active than the synthetic reference antioxidant ascorbic acid (Vit. C IC50 = 3.346 ± 1.20 
µg/L) and significantly better than the synthetic reference antioxidant butylated 
hydroxytoluene (BHT IC50 = 21.1 ± 0.01 µg/L) and no significant differences were 
found between P. niruri and M. malabathricum (Table 4.1).  
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Table 4.1: In vitro antioxidant activity of P. niruri and M. malabathricum. 
  Vitamin C BHT PN/E MM/E 
Extraction Yield % 
(w/w) 
  
4.84 10.68 
DPPH (IC50 µg/mL) 3.35±1.20
a
 21.30 ± 0.01
c
 11.07 ± 1.37
b
 11.60 ± 0.84
b
 
ABTS (IC50 µg/mL) 21.37±0.12
a
 65.7±0.41
d
 53.34 ± 1.97
b
 62.66 ± 0.78
c
 
TPC (mg GAE/g) … … 270.00 ± 0.03 384.33 ± 0.01 
TFC (mg QE/g) … … 123.9 ± 0.02 85.8 ± 0.01 
FRAP (mmol FeІІ/g) 101600±0.01d 57300 ± 0.01c 7755 ± 0.02a 33590 ± 0.04b 
The data represented as the Mean ± SEM of triplicates; means followed by the same letters are not 
significantly different at * P < 0.05. 
 
 
 
 
Figure 4.1: DPPH free radical scavenging activities of P. niruri and M. malabathricum.  
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4.2.2 Scavenging effects on ABTS free radicals 
As shown in Table 4.1 and Figure 4.2, both extracts displayed antioxidant capacities as 
they were able to scavenge ABTS radical cations in dose dependent manner. The 
ethanol extract of P. niruri showed higher activity to scavenge ABTS free radicals than 
the ethanol extract of M. malabathricum with less IC50 values (53.34 ± 1.97µg/mL) and 
(62.66 ± 0.78 µg/mL)  respectively with regression coeﬃcients of R2 = 0.998 as shown 
in appendix A2.  
The extracts of the present study were shown to exhibit significantly lower antioxidant 
capacity than the synthetic reference antioxidant ascorbic acid (Vit C IC50 = 
21.37±0.12µg/mL) but significantly better than the synthetic reference antioxidant 
butylated hydroxyl toluene (BHT IC50 = 65.70 ± 0.41µg/mL) and significant differences 
were found between P. niruri and M. malabathricum‘s ABTS radical scavenging 
activities.  
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Figure 4.2: ABTS free radical scavenging activities of P. niruri and M. malabathricum.  
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4.2.3 Total phenolic and total flavonoids contents (TPC & TFC)  
Figure 4.3 and Table 4.1, show that both investigated extracts had appreciable amounts 
of phenolic compounds as the ethanol extract of P. niruri had phenolic and flavonoids 
contents values (270 ± 0.003 mg GAE/ g extract) and (123.9 ± 0.002mg  QE / g extract) 
respectively, with TFC/TPC ratio of (0.45). While the phenolic and flavonoids contents 
of the ethanol extract of M. malabathricum were (384.33 ± 0.005mg GAE / g extract) 
and (85.8 ± 0.009 mg QE / g extract) respectively and the ratio TFC/TPC was (0.22).  
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Figure 4.3: Total phenolic (TPC) and flavonoids (TFC) contents of P. niruri 
and M. malabathricum. 
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4.2.4 Ferric reducing antioxidant power (FRAP) 
Figure 4.4 shows that M. malabathricum had a stronger reducing power as it attained 
significantly (P < 0.05) higher FRAP value (33590 ± 0.038 mmol Fe ІІ/g) as compared 
to P. niruri (7755 ± 0.015 mmol Fe ІІ/g). Furthermore, the FRAP value for the synthetic 
reference antioxidants ascorbic acid (Vit C) and butylated hydroxyl toluene (BHT) were 
reported to be (57300 ± 0.01 mmol Fe ІІ/g) and (101600 ± 0.01 mmol Fe ІІ/g) 
respectively with regression coeﬃcient of R2 = 0.982 as shown in appendix A3. 
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 Figure 4.4: FRAP activities of P. niruri and M. malabathricum. Data expressed as 
Mean ± SEM, different superscripts indicates significant differences between groups at 
(P ≤ 0.05). 
 
Finally, Pearson‘s correlation coefficient results for both plants showed that the highest 
positive correlation was between TPC and FRAP (r = 0.908) as shown in appendix B. 
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4.3 Immunomodulatory effects of P. niruri and M. malabathricum on human 
peripheral blood mononuclear cells (PBMC) viability 
The effects of the ethanol extracts of P. niruri and M. malabathricum on human 
peripheral blood mononuclear cells (PBMC) viability show evidence that both 
investigated plant extracts significantly stimulated the proliferation of PBMCs in vitro 
in a dose-dependent manner, as shown in Figure 4.5 and 4.6.   
Results showed that the PBMCs cell viability increased significantly after treatment, 
which means that the extract was not toxic to the immune cells and it modulated the 
cellular immune response.
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Figure 4.5: Percentage of (PBMC) cell viability after treatment with P. niruri and M. 
malabathricum; CTRL= dH2O; PN= P. niruri and MM= M. malabathricum. Data 
expressed as Mean ± SEM, (*) indicates significant differences between groups at (P ≤ 
0.05). 
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Figure 4.6: Photographs of PBMC cells: (A) normal cells without treatment, (B) cells 
treated with 200 µg/ml PN, (C) cells treated with 200 µg/ml MM (magnification 10x).
A 
B 
C 
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4.4 Acute oral toxicity test  
The acute toxicity study at doses of 2 g / kg and 5 g / kg for both plants extracts did not 
result in any mortality in the treated rats and no toxic effects were observed throughout 
the 14 days study period. Physical observations indicated no signs of changes in rats‘ 
skin and fur, eyes and mucus membrane, behavior patterns, tremors, salivation, diarrhea 
and sleep. The body weight, clinical observations and biochemical measurements 
reflected normal status of the kidney and liver functions, and histopathological 
evaluations of these organs all together revealed that there were no significant 
differences between the control and the test groups, as shown by the quantitative data in 
Tables 4.2, 4.3, 4.4, and qualitative data in Figures 4.7 and 4.8. The findings from the 
applications of the P. niruri and M. malabathricum extracts to the control rats provided 
sufficient evidence to conclude that the orally administered extract was safe and 
presented no extract-related toxicity even at the highest dose of 5 g / kg. 
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Table 4.2: Effects of 2 g/kg and 5 g/kg of P. niruri and M. malabathricum extracts on 
rats body weights.  
Groups 
 
BW (At Day 0) BW (At Day 14) 
Tween 20 (10%) 
 
202.69  ± 2.86 206.63  ± 3.06 
PN extract (2g/kg) 
 
205.00 ± 2.20 207.88  ± 3.78 
PN extract (5g/kg) 
 
210.63  ± 3.96 213.88  ± 3.01 
MM extract (2g/kg) 
 
209.25 ± 4.12 205.50  ± 3.62 
MM extract (5g/kg) 
 
207.63  ± 2.71 201.44 ± 1.92 
 
Values expressed as mean ± S.E.M. There are no statistically significant differences 
between the measurements in different groups. The significant value was set at P < 
0.05. 
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Table 4.3: Effects of 2 g/kg and 5 g/kg of P. niruri and M. malabathricum extracts on biochemical parameters. 
Groups  
Sodium 
(mmol/L) 
Potassium 
(mmol/L) 
Chloride 
(mmol/L) 
CO2 
(mmol/L) 
Anion Gap 
(mmol/L) 
Urea 
(mmol/L) 
Creatinine 
(µmol/L) 
Tween 20 (10%) 141.33 ± 1.59 4.33 ± 0.27 102.83 ± 1.05 26.83 ± 1.72 14.33 ± 1.75 4.60 ± 0.70 37.33 ± 0.18 
PN (2 g/kg) 140.00 ± 1.77 4.37 ± 0.30 103.17 ± 1.45 26.33 ± 1.59 13.00 ± 1.44 4.57 ± 0.70 37.60 ± 0.19 
PN (5 g/kg) 137.17 ± 1.14 4.42 ± 2.39 102.67 ± 0.99 22.17 ± 0.60 17.83 ± 1.45 4.73 ± 0.67 37.52 ± 0.11 
MM (2 g/kg) 140.33 ± 1.20 4.54 ± 0.23 105.33 ± 2.08 27.33 ± 1.50 12.80 ± 1.33 4.62 ± 0.65 37.48 ± 0.16 
MM (5 g/kg) 136.33 ± 1.50 4.28 ± 2.25 104.60 ± 1.54 25.50 ± 1.15 19.00 ± 0.52 4.56 ± 0.56 36.58 ± 0.82 
Values expressed as mean ± S.E.M. There are no statistically significant differences between the measurements in different groups.  
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Table 4.4: Effects of 2 g/kg and 5 g/kg of P. niruri and M. malabathricum extracts on biochemical parameters. 
Groups ALT (IU/L) AST (IU/L) ALP (IU/L) Total 
Protein (g/L) 
Albumin 
(g/L) 
Bilirubin 
(µmol/L) 
γGT (IU/L) 
Tween 20 (10%) 45.00 ± 5.32 27.00 ± 4.16 97.67 ± 13.86 73.00 ± 2.96 44.17 ± 2.59 10.17 ± 2.26 58.17 ± 9.90 
PN (2 g/kg) 49.67 ± 4.60 26.33 ± 3.22 92.67 ± 9.76 74.50 ± 2.31 42.83 ± 1.97 8.00 ± 1.06 37.67 ± 6.82 
PN (5 g/kg) 45.17 ± 5.30 28.00 ± 3.65 78.33 ± 6.81 74.33 ± 2.72 42.50 ± 2.93 9.50 ± 1.69 55.00 ± 8.83 
MM (2 g/kg) 46.50 ± 4.21 26.83 ± 3.84 92.83 ± 11.97 72.67 ± 2.09 45.67 ± 6.73 6.67 ± 1.41 55.00± 10.58 
MM (5 g/kg) 44.33 ± 5.94 28.00 ± 3.84 88.17 ± 6.58 74.33 ± 4.62 44.17 ± 4.05 9.50 ± 1.65 58.83 ± 7.15 
Values expressed as mean ± S.E.M. There are no statistically significant differences between the measurements in different groups.  
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Figure 4.7: Histological sections of livers from the acute toxicity test. 
(a) Control treated with 5 ml/kg vehicle (10% Tween20); (b and c) PN and MM 
extracts (5 g/kg) respectively. No structural differences were seen between the 
plants treated groups and the control group. (H & E stain; 20x magnification). 
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Figure 4.8: Histological sections of kidneys from the acute toxicity test. 
(a) Control treated with 5 ml/kg vehicle (10% Tween20); (b and c) PN and MM 
extracts (5 g/kg) respectively. No structural differences were seen between the 
plants treated groups and the control group. (H & E stain; 20x magnification). 
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4.5 Hepatoprotective effects of P. niruri and M. malabathricum 
4.5.1 Body, liver and spleen weights 
The measurements of the body, liver and spleen weights of the rats by the end of the study 
in all groups were listed in Table 4.5.  Through out the eight weeks of study (Figure 4.9), 
the hepatotoxic rats weighted significantly less, but their livers and spleens weighted 
significantly more compared with the control rats. The rats subjected to the treatment with 
either silymarin or PN or MM extracts exhibited gains in the body weight and no increase 
in the liver and spleen masses were observed. 
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                        Table 4.5: Body, Liver and Spleen weight changes of the rats in the different treatment groups. 
Groups BW (gm) LW (gm) LW/BW (%) SW (gm) SW/BW (%) 
Normal 237.00 ± 17.24 6.20 ± 0.49 2.63 ± 0.13 0.36± 0.02 0.16 ± 0.02 
TAA 195.40 ± 18.35 9.40 ± 0.98 4.81 ± 0.23
a
 0.51 ± 0.10 0.25 ± 0.04
a
 
S 222.00 ± 12.00 9.20 ± 0.97 4.10 ± 0.22
a
 0.53 ± 0.04 0.24 ± 0.01 
PN/LD (100mg/kg)  258.60 ± 14.02 8.20 ± 1.02 3.22 ± 0.41
c
 0.46 ± 0.04 0.18 ± 0.02 
PN/HD (200mg/kg) 253.40 ± 16.41 7.80 ± 0.58 3.18 ± 0.24
c
 0.40 ± 0.04 0.16 ± 0.01
b
 
MM/LD (100mg/kg) 249.40 ± 14.70 10.80  ± 0.58
a
 4.35  ± 0.15
a
 0.46 ± 0.02 0.19  ± 0.01 
MM/HD (200mg/kg) 231.20 ± 13.85 9.20 ± 0.37 4.05 ± 0.34
a
 0.41 ± 0.01 0.18 ± 0.01 
             The data were stated as mean ± S.E.M.; the mean difference is significant at 
a
 P <0.01 against Normal group,
 b
 P <0.05 against TAA  
           group and at 
c 
P < 0.01 against TAA group. BW: Body Weight, LW: Liver Weight, SW: Spleen Weight. 
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Figure 4.9: Changes of rats body weights in different experimental groups throughout the eight weeks of the study. The data were stated as Mean ± 
S.E.M.; the mean difference is significant from initial weight at 
a
 P <0.05 and 
b
 P <0.01. 
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4.5.2 Gross morphology 
As depicted in Figure 4.10, the control rats had livers with smooth surfaces.  In the 
hepatotoxic group, exposure to TAA made the liver attain irregular shape and at the same 
time be occupied with uniform formations of micro nodules and macro nodules (whitish 
granules), some of which were localized close to the surface.  The nodular transformation 
in liver parenchyma is also a typical characteristic of human cirrhosis.  The treatment with 
either silymarin or the PN and MM extracts (Figures 4.11 and 4.12) prevented the 
development of the macro- and micro nodules and made the liver preserve its nearly normal 
anatomical shape and appearance in rats.  Although based on visual evaluations, these 
results clearly demonstrated that the PN and MM extracts effectively prevented the 
development of the nodules and hence protected the liver from further deterioration of its 
structure and function. 
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Figure 4.10: Images showing the macroscopic appearances of livers from N, TAA 
and Sily groups.  (N) control group rats liver with regular smooth surface.  (TAA) 
thioacetamide rats liver showing iirregular whitish micro- and macronodules and a large 
area of ductular cholangiocellular proliferation embedded within fibrosis.  (Sily) silymarin 
treated rats liver with smooth surface.  
N 
Sily. 
TAA 
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Figure 4.11: Images showing the macroscopic appearances of livers from P. nirui 
treated groups.  (PN/LD 100 mg/kg) P. niruri’s low dose treatment group showing slight 
micrnodules on the liver surface. (PN/HD 200 mg/kg) P. niruri s high dose treatment group 
showing nearly smooth surface. 
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Figure 4.12: Images showing the macroscopic appearances of livers from M. 
malabathricum treated groups.  (MM/LD 100 mg/kg) M. malabathricum’s low dose 
treatment group showing slight micrnodules on the liver surface. (MM/HD 200 mg/kg) M. 
malabathricum’s high dose treatment group showing nearly smooth surface. 
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4.5.3 Histopathology of the liver  
Histological examination of Haematoxylin and Eosin-stained sections was performed to 
determine the extent of liver injury and fibrosis for each section. Example slides obtained 
from the histopathological examinations under the light microscope were given in Figure 
4.13, 4.14 and 4.15.  In the control rats, there were no pathological abnormalities, the liver 
sections looked normal with regular cellular architecture and were clear of any pathology.  
Polygonal hepatic cells had intact cytoplasm, sinusoidal spaces, prominent nucleus, 
nucleolus, and central vein. In the hepatotoxic rats, the histology confirmed liver damage as 
evidenced by the presence of inflammation and necrosis in the respective liver sections.  
Histological examination showed loss of normal architecture of the liver parenchyma with 
fibrous septa forming collagen bridges between hepatic triads delineating small and large 
regenerative nodules of hepatocytes or necrosis.  The nodules were surrounded by thick 
fibrous septa, which divided the liver into pseudo lobules.  The histology also delineated 
cytoplasmic vacuolization, megalocytosis, bile duct proliferation, hepatocyte degeneration, 
necrosis, infiltration of inflammatory cells, and centrilobular necrosis with portal triaditis, 
expanded portal tracts and collagen deposition.  Proliferation of spindle cells and the 
hepatic cells surrounding the central vein showed various degenerative changes like cloudy 
swelling, hydropic degeneration, loss of nucleus and nucleolus and necrosis (Cassiman et 
al., 2002).  The rats in silymarin treated group exhibited significantly lesser pathology as 
compared to the extensive liver damage found in the hepatotoxic group.  Silymarin 
administration prevented the incidences of liver lesions including hepatic cells cloudy 
swelling, lymphocytes infiltration, hepatic necrosis, and fibrous connective tissue 
proliferation induced by TAA.  Consequently, the liver tissue preserved its nearly normal 
hepatic lobular architecture with central veins and radiating hepatic cords.  These results 
  
85 
 
reconfirmed the preventive and protective functions of silymarin against the TAA-induced 
liver damage. The histopathological examination of the liver sections from the rats treated 
with the PN and MM extracts revealed reduced degree of fibrosis induced by TAA, but 
small size necrotic zones with nodules and centrolobular veins still occupied the 
parenchyma. The slides showed appreciable level of normal parenchymal architecture with 
thinner fibrous septa.  The livers of the treated rats experienced lesser amount of 
cytoplasmic vacuolization, megalocytosis, bile duct proliferation, and nuclei injury.  These 
results provided microscopic evidence again demonstrating the significant 
hepatopreservation and hepatoprotection functions of the PN and MM extract to counter 
balance the negative effects of TAA in the liver tissue. 
Masson's trichrome staining of liver sections was used to determine the extent of hepatic 
fibrosis induced by TAA treatment in the presence and absence of PN and MM (Figures 
4.16, 4.17 and 4.18). No fibrosis was detected in the liver sections of the untreated control 
animals. In contrast, extensive fibrosis was observed in the liver sections from TAA-treated 
animals (Figure 4.16). Sections from the PN (Figure 4.17) or MM (Figure 4.18) treated 
animals showed mild fibrosis; however, the degree of fibrosis was substantially less than 
the cirrhosis control animals. Thus, TAA treatment for 8-week induced hepatic fibrosis 
(blue color), but treatment with PN or MM reduced collagen accumulation in the liver. 
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Figure 4.13:  Histopathological changes of livers from N, TAA and Sily groups. 
(N) control rats liver section shows normal histological structure and architecture.  (TAA) 
Severe structural damage, formation of pseudolobules with thick fibrotic septa and necrotic 
areas were present in the liver of the hepatotoxic rat.  (Sily) Mild inflammation but no 
fibrotic septa was depicted in the liver of the rats treated with silymarin. . (H & E stain 
Original magnification 20x). 
N 
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Figure 4.14:  Histopathological changes of livers from P. niruri treated groups: 
(PN/LD 100 mg/kg) and (PN/HD 200 mg/kg ). Preserved hepatocyte and architecture with 
small areas of mild necrosis were observed in the liver of the rat treated with 200 mg/kg of 
the PN. (H & E stain Original magnification 20x). 
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Figure 4.15:  Histopathological changes of livers from M. malabathricum treated 
groups: (MM/LD 100mg/kg) and (MM/HD 200 mg/kg). Preserved hepatocyte and 
architecture with small areas of mild necrosis were observed in the liver of the rat treated 
with 200 mg/kg of the MM extract.  (H & E stain Original magnification 20x). 
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Figure 4.16:  Histological section of N, TAA and Sily. Groups liver parenchyma 
stained with Masson‘s trichrome stain. N: normal rat‘s liver section showing normal liver 
architecture. TAA: Extensive hepatic fibrosis (blue color) with proliferating bile ducts was 
observed in TAA-treated liver sections. Sily.: silymarin treated rats showed mild hepatic 
fibrosis (blue color) in liver section. 
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Figure 4.17:  Effects of P. niruri on TAA-induced liver cirrhosis in rats. (PN/LD 
100 mg/kg): P. niruri low dose treated rats showed mild hepatic fibrosis (blue color) in 
liver section. (PN/HD 200 mg/kg): P. niruri high dose treated rats showed less hepatic 
fibrosis (blue color) in liver section. (Masson‘s trichrome stain, Original magnification 
20x). 
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Figure 4.18:  Effects of M. malabathricum on TAA-induced liver cirrhosis in rats. 
(MM/LD 100 mg/kg):  M. malabathricum low dose treated rats showed mild hepatic 
fibrosis (blue color) in liver section. (MM/HD 200 mg/kg): M. malabathricum high dose 
treated rats showed less hepatic fibrosis (blue color) in liver section. (Masson‘s trichrome 
stain, Original magnification 20x). 
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4.5.4 Hepatic biochemical parameters 
At the end of the experimental duration and as compared to normal group rats, TAA rats 
had elevated serum activities of liver function enzymes: ALT, AST and ALP. Similarly, 
there were elevated levels of Bilirubin and γGT and subsequently reduced levels of 
albumin. The raised parameters monitored in TAA group were reduced markedly by 
feeding with (100 and 200 mg) PN and MM extracts per kg body weight of rats, as shown 
in Figure 4.19 and Figure 4.20. 
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Figure 4.19: Effect of Experimental samples on Alanine Amino Transferase (ALT), 
Aspartate Amino Transferase (AST), Alkaline Phosphatase (ALP) and Total Protein levels. 
Data expressed as Mean ± SEM, (a) indicates significance versus normal group at P ≤ 0.01; 
(b) indicates significance versus thioacetamide group at P ≤ 0.05 and; (c) indicates 
significance versus thioacetamide group at P ≤ 0.01   
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Figure 4.20: Effect of Experimental samples on Bilirubin, Albumin and Gamma Glutamyl 
transferase (γGT) levels. Data expressed as Mean ± SEM, (a) indicates significance versus 
normal group at P ≤ 0.01; (b) indicates significance versus thioacetamide group at P ≤ 0.05 
and; (c) indicates significance versus thioacetamide group at P ≤ 0.01    
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4.5.5 Endogenous antioxidant activities  
Figure 4.21 shows in vivo activities of oxidative enzymes involved in the hepatic 
antioxidant defense system. SOD and GPX enzyme levels were decreased significantly in 
TAA groups when compared with the normal control group and similarly their levels were 
lower in the low dose plant group when compared with the high dose group. However, the 
decrease was non-significant for CAT levels. Furthermore, under the reaction conditions 
used, the capacity of the total antioxidants in both plants to prevent ABTS oxidation was 
proportional to their concentration in the livers of the animals where the values were 
substantially increased in the treatment groups in comparison to their HD and LD groups. 
However, Figure 4.21 indicates that treatment with MM or PN or Silyamrin significantly 
decreased the MDA values as compared to TAA group.  
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Figure 4.21: P. niruri and M. malabathricum's in vivo antioxidant activities. Data 
expressed as Mean ± SEM, (a) indicates significant differences at P < 0.01 versus Normal 
control group, (b) at
 
P < 0.05 versus TAA group and (c) at P < 0.01 versus TAA group. 
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4.5.6 Gene expression profile 
4.5.6.1 Integrity of RNA 
Total RNA was extracted from the liver tissues and quantity of RNA was determined by 
reading the absorbance at 260nm spectrophotometrically with ND-2000 Nano Drop 
Spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA). The ratio of 
absorbance reading at 260nm and 280 nm was used to indicate the quality of the RNA. The 
260/280 ratio for our RNA preparation ranged from 1.6-2.1 in most cases  (Table 4.6), 
which suggested good quality RNA.  
The integrity of RNA was checked by agarose gel electrophoresis. Discrete 28S and 18S 
ribosomal RNA bands were obtained in each case, with the 28S band about twice the 18S 
band, indicating that the RNA extracted was intact and could be applied for RT-PCR. 
(Figure 4.22) shows a typical ethidium bromide stained-agarose RNA gel.  
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Table 4.6: The quality of the RNA as measured by Nano Drop spectrophotometer at 230, 
260, 280, 320, 260/280 and 260/320 nm absorbances. 
Sample 
name 
Concentration 
ng/µl 
260/280 260/230 230nm 260nm 280nm 320nm 
 
N1 603 1.993 1.813 1.283 1.959 1.208 0.452 
N2 496 2.091 2.191 0.372 1.046 0.339 0.194 
N3 625 2.08 1.818 0.668 1.371 0.56 0.191 
N4 600 2.059 2.062 0.529 1.301 0.53 0.198 
N5 764 1.833 1.99 1.335 2 1.417 0.375 
 
TAA1 145 2.017 1.276 0.8 0.95 0.825 0.584 
TAA2 567 2.052 2.026 0.7 0.414 0.691 0.004 
TAA3 272 2.072 1.616 0.443 0.717 0.346 0 
TAA4 416 1.964 1.512 1.093 1.445 0.935 0.406 
TAA5 690 1.977 2.029 1.077 1.952 1.116 0.227 
 
PN1 243 2.082 1.906 0.32 0.609 0.293 0.001 
    PN2 224 2.102 0.809 0.63 0.562 0.269 0.003 
PN3 105 1.13 0.25 1.13 0.251 0.113 0.011 
PN4 494 2.057 1.836 1.726 1.288 0.654 0.054 
PN5 308 2.059 2.059 0.38 0.776 0.38 0.006 
 
MM1 130 2 1.5 0.23 0.33 0.168 0.011 
MM2 102 2.1 1.81 0.2 0.35 0.21 0.098 
MM3 417 2 2 0.5 1.05 0.5 0.01 
MM4 262 2 2 1.01 1.35 1.018 0.69 
MM5 385 2 1.9 0.5 0.96 0.47 0.007 
N: normal control group, TAA: thioacetamide treated group, PN: P. niruri treated group 
and MM: M. malabathricum treated group. 
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                                                     (A) 
 
                                          (B) 
Figure 4.22: A typical ethidium bromide-stained agarose gel showing the integrity 
of the extracted RNA; (A) visualized under Vilber Lourmat gel documentation system (B) 
visualized under UV light. 
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3.5.6.2 Real Time PCR analysis 
Between the four endogenous reference genes used, the lowest variabilities have been 
shown by HPRT-1 and Ppia in comparison to GAPDH and β-actin, according to the 
analysis of NormFinder and geNorm algorithm softwares (Figure 4.23). Therefore, HPRT-1 
and Ppia were chosen for further analyses and normalization of the target genes in animal 
liver tissue samples. 
 
 
Figure 4.23:  The best genes with less variabilities were Ppia and HPRT-1  among 
the four endogenous genes used (Analyzed by geNorm software). 
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Prior to running the quantitative Real Time PCR, standardization processes have been done 
for all investigated target and endogenous genes as shown in Table 4.7. All obtained data 
were within the reference range to perform the Real Time PCR. 
 
Table 4.7: The standard curve properties of all investigated genes 
 
Genes 
 
 
Efficiency 
(%) 
 
Slope 
 
Y-intercept 
 
R
2
 value 
 
HPRT1 97.78 -3.376 28.026 0.995 
 
Ppia 92.679 -3.511 27.154 0.998 
 
TGFβ1 98.056 -3.369 28.85 0.993 
 
Coll α 95.351 -3.439 32.567 0.990 
 
MMP2 108.376 -3.136 31.042 0.991 
 
TIMP1 
 
99.408 -3.336 34.01 0.989 
 
Reference Range 
 
(90-110) (-3.1)-(-3.5) …. (≥ 0.98) 
 
Ct values of Real Time PCR data were calculated by GenEX software and normalized to 
the reference genes HPRT-1 and Ppia. The analysis showed significant differences in 
mRNA levels of investigated genes expression between controls, TAA, PN and MM treated 
rats.  
In the control rats the mRNA levels of transforming growth factor β (TGFβ) gene, collagen 
α type I (collα1) gene, metalloproteinase- 2 (MMP2) gene or tissue inhibitor of 
metalloproteinase-1 (TIMP1) gene did not change suggesting that the hepatic satellite cells 
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(HSCs) were in their quiescent state (Figure 4.24). When treated with thioacetamide (200 
mg/kg b.w), the livers expressed up-regulations of all investigated genes. The up-regulation 
was significant at (P < 0.01) in TAA group in comparison to N group for the genes TGFβ 
(1.677 ± 0.120 fold increase), Coll α1 (47.062 ± 7.716 fold increase) and MMP2 (14.500 
3.528 fold increase). However, the difference was non-significant for TIMP1 gene (1.738 ± 
0.486 fold increase).  
Oral administration of PN and MM (200 mg/kg b.w.) before cirrhosis induction prevented 
and resolved the activation of HSCs and the remaining cells expressed decreased levels of 
TGFβ, Collα1 and MMP2 in comparison to TAA group as shown in Figure 4.24 and Table 
4.8. For TGFβ1 gene; PN treated group did not show significant difference with TAA 
group (1.644 ± 0.158 fold increase) while in contrast, MM group showed significant 
difference at (P < 0.05) (1.113 ± 0.180 fold increase).  
For Collα1 and MMP2 genes; in comparison to TAA group, mRNA expression decreased 
significantly in PN and MM groups than TAA group at (P < 0.01) (9.948 ± 8.021 and 
8.555 ± 7.762 fold increases) for Collα1 gene and at (P < 0.05) (4.167 ± 3.557 and 3.436 ± 
3.601 fold increases) for MMP2 gene respectively. 
The mRNA expression of TIMP1 gene in the TAA treated group showed decreased levels 
than PN and MM treated groups (2.706 ± 0.703 and 1.912 ± 0.441 fold changes) 
respectively as shown in Figure 4.24 and Table 4.8.    
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Figure 4.24: Real Time PCR analysis showing relative fold changes of 
transforming growth factor beta (TGFb), matrix metalloproteinase 2 (MMP2),tissue 
inhibitors of metalloproteinases 1 (TIMP1) and collagen alpha (Coll) genes between all 
experimental groups. Values expressed as Mean ± S.E.M. with different superscripts are 
significantly different. (a) Indicates significance versus Normal group at P ≤ 0.05; (b) 
indicates significance versus TAA group at P ≤ 0.05 and (c) indicates significance versus 
TAA group at P ≤ 0.01.  
  
Table 4.8:  TAA, PN and MM effects on mRNA expressions of investigated genes. 
Group TGFβ1 TIMP1 MMP2 Collα1 
N 1 1 1 1 
TAA 1.677 ± 0.120 
a
 1.738 ± 0.486 14.500 ± 3.528 
a
 47.062 ± 7.716 
a
 
PN (200 mg/kg) 1.644 ± 0.158 2.706 ± 0.703 4.167 ± 3.557 
b
 9.948 ± 8.021 
c
 
MM (200 mg/kg) 1.113 ± 0.180 
b
 1.912 ± 0.441 3.436 ± 3.601 
b
 8.55482 ± 7.762 
c
 
Values expressed as Mean ± S.E.M. with different superscripts are significantly different. 
(a) Indicates significance versus Normal group at P ≤ 0.05; (b) indicates significance versus 
TAA group at P ≤ 0.05 and (c) indicates significance versus TAA group at P ≤ 0.01.  
 
β 
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3.6 Chromatography profile  
After crude extraction of P. niruri and M. malabathricum, the ethanol extracts were 
objected to flash column chromatography to separate the constituents of the extracts 
according to molecular size, molecular mass and polarity.  Thus, (12) fractions were 
obtained from P. niruri and (9) fractions were obtained from M. malabathricum; and by 
performing thin layer chromatography the subsequent fractions with the same Rf (retention 
factor) and the spot colors after visualizing under UV light at 240 nm and 360 nm, were 
combined to give five fractions for P. niruri (PNF1, PNF2, PNF3, PNF4 and PNF5) and 
four fractions for M. malabathricum (MMF1, MMF2, MMF3 and MMF4). The best 
resolutions of plates were given by acetonitrile- water.  
Subsequently the immunomodulatory activity for all fractions was tested to examine their 
abilities to proliferate human peripheral mononuclear cells (PBMC). As shown in Figures 
4.25 and 4.26, both plants fractions showed high activities to proliferate PMBCs 
percentages of viability but best fractions were fraction number one for P. niruri (PNF1) 
and M. malabathricum (MMF1). 
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Figure 4.25: The effects of P. niruri fractions on human peripheral mononuclear cells 
(PBMC) proliferation. Data expressed as Mean ± SEM for triplicates; (*) indicates 
significance versus control group (CTRL= dH2O) at P ≤ 0.05 
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Figure 4.26: The effects of M. malabathricum fractions on human peripheral 
mononuclear cells (PBMC) proliferation. Data expressed as Mean ± SEM for triplicates; 
(*) indicates significance versus control group (CTRL= dH2O) at P ≤ 0.05. 
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LC-MS was performed to the fractions (PNF1 and MMF1) that showed higher activities to 
proliferate the PBMC cells. The concept of the combination of LC partition with UV 
spectrophotometric detection and MS enables the recognition of identified compounds in 
the extract by comparing their LC retention time and UV and MS spectra with those 
obtained from authentic compounds. Afterward, In LC-MS/MS by using the positive 
ionization mode four peaks were observed from PNF1 (Figures 4.27, 4.28, 4.29 and Table 
4.9). However, only peaks number 2 and 4 were identified. the peak number 2 at (RT= 
4.454 min, λ=221 and 280 nm, MW=355) (Figure 4.27) had [M + H] + at m/z 356 identified 
as Caffeolquinic acid (an isomer of chlorogenic acid) with fragments at m/z 340 (loss of 
CH3) and the predominant fragments at m/z 191,165,151 and 147 respectively (Tang et al., 
2010). The peak number 4 (Figure 4.28) at (RT= 7.96 min , λ= 225 nm, MW= 448) had  [M 
+ H-H2O]
+ 
at  m/z 430 identified as Quercetin 3-O-rhamnoside with loss of H2O  and with 
loss the rhamnoside the ion appeared  at m/z 303 identified as quercetin with other 
fragments  219, 205 and 165, respectively (Bravo et al., 2007; Seeram et al., 2006). 
At the same time, four peaks were recognized from MMF1, (Figure 4.30). Among them, 
only the first peak was not identified. The second peak at (RT= 2.31 min, λ= 210,263 and 
313 nm, MW= 286) as shown in Figure 4.31 was identified as kaempferol with MS/MS 
fragmention at 147, 241 and 317. The third peak appeared at (RT 2.61 min, λ= 203, 254 
and 368 nm, MW= 302) at m/z 303 identified as quercetin (Figure 4.32) with the 
predominant fragments at m/z 121, 153, 165, 245 and 257 respectively. The forth peak at 
m/z 273 (RT= 3.27 min, λ= 219,267 and 312 nm, MW= 272) with daughter peaks at 119, 
147 and 181, identified as naringenin as shown in Figure 4.33. All the chemical and 
molecular informations of the identified chemicals were given in Table 4.9. 
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Figure 4.27: HPLC-TOF/MS and UV diode array chromatograms of P. niruri  fraction 1 (PNF1); (A) Diode array detection UV spectra at 280 nm (B) 
Diode array detection UV spectra at range between 190 and 800 nm (C) TOF MS peaks in positive mode ionization
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Figure 4.28: UV max spectra and Mass Spectrum (TOF MS ES+) of peak no. 2 in P. niruri 
F1 (identified as 4-O-Caffeolquinic acid). 
 
 
        
Figure 4.29: Mass Spectrum (TOF MS ES+) and UV max spectra of peak no. 4 in P. niruri 
F1 (identified as Quercetin 3-O-rhamnoside).  
 
 
  
108 
 
 
 
Figure 4.30: HPLC-TOF/MS and UV diode array chromatograms of M. malabathricum fraction 1 (MMF1); (A) Diode array detection UV spectra at 
280 nm (B) Diode array detection UV spectra at range between 190 and 800 nm (C) TOF MS peaks in positive mode ionization.
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Figure 4.31: Mass Spectrum (TOF MS ES+) and UV max spectra of peak no. 2 in M. 
malabathricum F1 (identified as Kaempferol).  
 
 
 
Figure 4.32: UV max spectra and Mass Spectrum (TOF MS ES+) of peak no. 3 in M. 
malabathricum F1 (identified as Quercetin).  
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Figure 4.33: UV max spectra and Mass Spectrum (TOF MS ES+) of peak no. 4 in M. 
malabathricum F1 (identified as Naringenin).  
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                Table 4.9: Putative identification of main components of P. niruri fraction (PNF1) and Melastoma malabathricum fraction (MMF1).  
Plant 
Fraction 
Rt.Time 
(min) 
λ (nm) 
Molecular 
Weight 
[M+H] 
m/z 
MS/MS  
Fragmentation 
Tentative identification 
Molecular 
Formula 
PNF1 
 
4.437 221, 280 355 356 340, 191, 165 , 151, 147 4-O-Caffeolquinic acid C16H18O9 
7.92 225 448 430 303, 219, 205, 165 Quercetin3-O-rhamnoside C21H20O11 
MMF1 
2.31 210, 263, 313 286 287 147, 241, 317 Kaempferol C15H10O6 
2.61 203, 254, 368 302 303 121, 153, 165, 245, 257 Quercetin C15H10O7 
3.27 219, 267, 312 272 273 119, 147, 181 Naringenin C15H12O5 
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CHAPTER V 
DISCUSSION AND CONCLUSION 
 
5.1 Discussion 
5.1.1 Antioxidant Activities of P. niruri and M. malabathricum 
Reactive oxygen species (ROS) are prospective carcinogenic substances due to generating 
free radicals including hydroxyl, superoxide, peroxyl, hydroperoxyl and alkoxyl radicals, 
which participate in tumor promotion, mutagenesis and progression. If there is no effective 
regulation, the excess ROS would damage proteins, lipids or DNA and in turn inhibit the 
normal function and modulation of gene expression, cell cycle, cell metabolism, cell 
adhesion and cell death (Ha et al., 2010).  
Medicinal plants have been presumed to be rich resources of natural antioxidants that 
counterbalance these ROSs, remove the free radicals and minimize the damage to the 
tissues. In this investigation, we have tested the crude ethanol extract of Phyllanthus niruri 
and Melastoma malabathricum for their radical scavenging potentials.  
The data of the present study demonstrated that DPPH and ABTS free radicals were 
reduced in the presence of the plant extracts following the trend Vit C > P. niruri > M. 
malabathricum > BHT. In addition, both plants showed a high ability for reducing the 
ferric ions. The antioxidant activities of Phyllanthus niruri and Melastoma malabathricum 
ethanol extracts may be attributed to their  phenolic and flavonoid contents, which are 
powerful in vitro antioxidant molecules (Rice-Evans, 2001) and predictable free radical 
scavengers due to their reducing properties as hydrogen or electron-donating agents (Rice-
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Evans, 1995). The mechanism of these plant derived polyphenolic compounds may be 
through free radical scavenging, complexion of pro-oxidant metals and quenching of the 
formation of singlet oxygen (Pratt, 1992). 
These findings seems to be in agreement with the recent study of  Mollataghi et al. and 
Arya et al. (Mollataghi et al., 2012; Arya et al., 2012), who determined the DPPH 
scavenging activity of ascorbic acid and found the IC50  to be less than 4 µg / mL.  
Poh-Hwa et al. (Poh-Hwa, 2011) proposed that over 95% of the antioxidant capacity in the 
Phyllanthus species was due to the involvement of polyphenolic compounds. In addition, it 
is encouraging to compare such findings with those found by Harish et al.  (Harish & 
Shivanandappa, 2006), who discovered that methanol and aqueous extracts of the leaves 
and fruits of P. niruri showed scavenging of 1,1-diphenyl-2picrylhydrazyl (DPPH) radical 
and inhibition of reactive oxygen species (ROS) in vitro.  
Furthermore, many recent studies reported the in vitro antioxidant and free radical 
potentials of M. malabathricum‘s methanol and aqueous extracts, suggesting that the high 
phenol component explains the high antioxidant activity (Faravani, 2009).  
 
5.1.2 Immunomodulatory Roles of P. niruri and M. malabathricum 
The immune system is one of the body‘s means for detecting different pathogens, by 
producing immediate responses through the activation of immune cells, chemokines, 
cytokines and the release of inflammatory mediators, which in turn modulate and adapt the 
immune system (Singh Virendra Kumar, 2011).   
Extracts of many medicinal plants have been shown to possess significant roles as 
immunomodulators and antitumor agents (Wong et al., 1994). The naturally derived 
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immunomodulators have great prospectives for future development of new pharmaceutical 
products, serving as the initial point from which we may discover modern medicines 
(Ganju et al., 2003) .  
The ethanol extracts of P. niruri and M. malabathricum have shown to stimulate the 
PBMCs proliferation to more than double or triple the amount of the initial PBMCs control 
quantity, which may be of value in combination with other therapies in the treatment of 
immunodeficiency, cancer, infections and even autoimmune disorders. 
Several attempts have been made to report on the immunomodulatory roles of Phyllanthus 
species, as the aqueous and the aceton extracts of Phyllanthus tenellus stimulates the 
macrophages activation through nitric oxide production (Ignácio et al., 2001) and 
Phyllanthus emblica was named as ― an immunomodulator‖ that enhanced natural killer 
cells activities and antibody dependent cellular cytotoxicity in BALB/c mice when 
administered orally (Suresh & Vasudevan, 1994).  
Moreover, the study of Nworu et al. (Nworu et al., 2010) suggested that P. niruri‘s 
stimulation of the immune system was through an expression of surface activation maker 
(CD69) and proliferation of B and T lymphocytes. These activities were proposed to be 
achieved by lysosomal enzymes activity, phagocytosis and TNF-α release.  
Additionally, the Melastomaceae family has been reported to include a wide variety of  
immune modulator species, such as Osbeckia aspera that has proven to induce in vitro 
phagocytosis by peripheral blood mononuclear cells (PBMC) and enclosed inhibitory 
patterns on mitogen/antigen stimulation with PBMC from patients with chronic hepatitis C 
viral infections (Nicholl et al., 2001). In fact the anticancer activity of several isolated 
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compounds from M. malabathricum was reported by Susanti et al. (Susanti et al., 2009) to 
involve cell proliferation and changes in the cell morphology.  
Perhaps, the immunomodulatory potentials of P. niruri and M. malabathricum are due to 
their high antioxidant and free radical scavenging activities, which have been identified to 
innate pro-inflammatory immune responses and acts as therapeutic pathways for controlling 
inflammatory-mediated diseases (Tse et al., 2004). 
 
5.1.3 Acute Oral Toxicity Tests of P. niruri and M. malabathricum 
Many clinical and toxicological studies have been carried out on medicinal plant extracts to 
ensure the secure and safe use and of such plants. In the ‗Global Harmonized System of 
Classification and Labeling of Chemicals‘ and the Environmental Protection Agency  
‗Health Effects Test Guidelines‘, an LD50 value higher than 5000 mg/kg shown by plant 
extracts are considered to be practically safe (Ghs, 2005). 
Therefore, the investigated plant extracts are toxicologically safe by oral administration, 
since they did not show any signs of body weight loss, no behavioral abnormalities were 
observed and no significant differences were found in the PN and MM treated groups in 
comparison to the control group regarding liver and renal function tests. Thus, our findings 
supports the logical usage of these plants in Malaysian folk medicine. 
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5.1.4 Hepatoprotective Activities of P. niruri and M. malabathricum 
The experimental model of liver cirrhosis induced by thioacetamide in rats has been shown 
to reveal many alterations similar to human cirrhosis (Fontana et al., 1996). The present 
study aimed to evaluate the protective role of P. niruri and M. malabathricum against 
thioacetamide induced liver cirrhosis on Sprague Dawley rats. The livers of rats that were 
administered TAA showed anatomical macroscopic and microscopic symptoms of 
cirrhosis, alteration of hepatic biochemical markers, significant loss of rat‘s body weights 
accompanied with significant increase in the liver and spleen masses.  
On the contrary, the administration of the plant extracts prior to TAA injection has been 
proven to reduce the incidence of cirrhosis process and to decrease the necrosis, calcium 
levels and leakage of enzymes (Bruck et al., 2007; Balkan et al., 2001). Thus, the 
administration of crude ethanol extracts of P. niruri and M. malabathricum revealed 
significant hepatoprotective activity comparable to silymarin, based on normal body weight 
gaining, normal liver and spleen masses, preservation of the liver‘s normal morphologic 
shape and appearance, normal microscopic liver architecture and regular levels of hepatic 
biochemical tests.  
These results support earlier studies by Bhattacharjee & Sil (Bhattacharjee & Sil, 2006, 
2007) who mentioned that  P. niruri exhibited hepatoprotective effects due to its 
antioxidant contents, which could protect liver from oxidative stress induced by different 
chemicals in vivo  (Chatterjee et al., 2006; Chatterjee & Sil, 2006) and in vitro (Erra 
Rajeshwar et al., 2008; Sarkar & Sil, 2007). 
Much literature can be found to verify the protective activity of Phyllanthus niruri against 
different drug and toxin induced hepatic disorders. Earlier studies  (Harish & 
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Shivanandappa, 2006) have shown that the aqueous and methanol extracts of P. niruri 
demonstrated hepatoprotective action against carbon tetrachloride (CCL4) induced 
formation of lipid perioxidation in the livers of rats, judged by the raised serum enzymes 
levels. While (Manjrekar et al., 2008) studied the effects of the aqueous extracts of P. 
niruri against carbon tetrachloride (CCL4) induced liver, kidney and testes injuries, and 
they conducted that the hepatoprotective and the antioxidant activity of this plant was 
associated with a deleterious effects on kidney and testes. In the study of (Bhattacharjee & 
Sil, 2007) the hepatoprotective potential of the protein isolated from P. niruri against 
carbon tetrachloride (CCL4) induced liver damage was investigated. The results suggested 
that this protein protected the liver against oxidative stress and stimulated liver repair 
mechanisms.  
A study was conducted by Chatterjee et al. (Chatterjee et al., 2006; Chatterjee & Sil, 2006) 
that evaluated the preventive and curative effects of a protein fraction of P. niruri against 
nimesulide-induced oxidative stress in vivo, using a murine model through promotion of 
antioxidant defense. Moreover, the aqueous extracts of leaves of P. niruri exhibited 
distinctive antioxidant and hepatoprotective effects against paracetamol-induced liver 
injury in mice, which might be due to the high free radical scavenging activity, lipid 
peroxidation and inhibition of reactive oxygen species (Sabir & Rocha, 2008b) and pre-
treatment by n-hexane extract of P. niruri  all of which may have improved paracetamol-
induced injury of the rat liver (Iqbal et al., 2008). 
Phyllanthin, known as "the principle active constituent" of P. niruri, has been demonstrated 
as being a hepatoprotective agent against ethanol-induced oxidative stress in rat liver cells 
(Chirdchupunseree & Pramyothin, 2010). On the other hand, in the in vitro study of Sarkar  
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and Sil (Sarkar & Sil, 2007) the hepatoprotective effect of the protein isolate of P. niruri 
was evaluated against thioacetamide (TAA) induced cytotoxicity in mice hepatocytes. 
Their data suggested that the protein isolate protected mice hepatocytes by its radical 
scavenging and antioxidative properties. 
However, to the best of our knowledge, this is the first time that Melastoma malabathricum 
has been evaluated for hepatoprotective activity. Thus, we suggest a strong association 
between the in vitro free radical scavenging activities and in vivo hepatoprotective effects 
of Melastoma malabathricum crude ethanol extract, since thioacetamide induced 
hepatotoxicity is through its bioactivation to thioacetamide-S-oxide, which covalently binds 
to the macromolecules and induces oxidative stress (Pallottini et al., 2006).  
The hepatoprotective effects of the investigated plants are not only due to in vitro 
antioxidant activities. Previous studies have proved that plant extracts possess protective 
effects against toxic chemical caused liver injury through the endogenous oxidative enzyme 
systems involved in the hepatic defense system, like catalase (CAT), superoxide dismutase 
(SOD) and glutathione perioxidase (GPX), which counter balance the oxidative stress 
induced by thioacetamide (Kuo et al., 2010; Huang et al., 2011).  
TAA injection has been reported to produce ROSs that followed lipid peroxidation (Sun et 
al., 2000), glutathione depletion and reduction in the SH-thiol groups (Zaragoza et al., 
2000). The present study‘s finding demonstrated that TAA administration caused severe 
damage to rats endogenous antioxidant system, represented by down- regulation of the total 
antioxidant capacity (TAC) of the rats, alongside lipid peroxidation that was characterized 
by up-regulation in MDA levels and disturbance of oxidative stress enzymes (CAT, SOD 
and GPX) activities which led to a decrease in their levels. These results are in agreement 
with the previous research of  Balkan et al. (Balkan et al., 2001), who reported that 
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treatment of experimental rats with thioacetamide caused an increase in the MDA levels 
and decrease in the GPX levels. Moreover, Yogalakshmi et al. (Yogalakshmi et al., 2010) 
displayed that TAA administration to rats resulted in significant decrease in the activities of 
SOD, CAT, GPX.   
P. niruri and M. malabathricum crude ethanol extracts enhanced the levels of oxidative 
stress enzymes: SOD, GPX and reduced the lipid peroxidation (MDA) levels back to their 
normal levels after damage induced by thioacetamide. 
Nevertheless, peripheral blood mononuclear cells (PBMCs) are critical cells of the immune 
system that fight different types of infections. PBMCs comprise the circulating 
mononuclear cells, including monocytes, T-cells, B-cells, and natural killer (NK) cells. 
These cells have been verified recently as specific markers of several diseases including 
inflammatory (e.g. rheumatoid arthritis, preeclampsia and chronic pancreatitis) and 
malignant (renal cell carcinoma and chronic lymphocytic leukemia) diseases (Baine et al., 
2011). Strong relations found between plants immunomodulatroy activities and 
hepatoprotective roles since the PBMCs have high expression of the gene encoding TGF-β 
(Navikas et al., 1994; Reinhold & Ansorge, 2007; Turner et al., 1990)  which is an essential 
regulator of chronic liver disease including initial liver injury, inflammation, fibrosis, 
cirrhosis and hepatocellular carcinoma (Dooley & Ten Dijke, 2012). On the other hand, as 
mentioned earlier (section 2.2.2) liver cirrhosis activates the hepatic satellite cells (HSC), 
which in turn increases the extracellular matrix (ECM) synthesis and causes a relative 
imbalance between production and degradation of matrix metalloproteins. In addition, the 
activated HSCs constitute various collagenases and tissue inhibitors of metalloproteinases 
to remodel the ECM (Bruck et al., 2001).  
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In the present study results, the mRNA levels of transforming growth factor β (TGF-β1), 
collagen αI (Coll-α1), metalloproteinase-2 (MMP-2) and tissue inhibitor of 
metalloproteinase-1 (TIMP-1) genes did not change in the control group. This supports the 
idea that the hepatic satellite cells (HSCs) were still in their quiescent state. However, those 
HSCs activated by the presence of TAA led to the high production of ECM and 
consequently high expressions of TGFβ, Collα1, MMP2 and the TIMP1 gene. PN and MM 
treatment successfully prevented the high synthesis of ECM and reduced the mRNA 
expression of TGFβ, Collα1, MMP2 genes in comparison to TAA group.  
Most studies of human liver diseases and animal models of progressive fibrosis have 
showed that TIMP-1 mRNA expression was up-regulated  at early stages of fibrosis (Arthur 
et al., 2006) since the TIMP-1 functions not only in reduction of the MMP activity 
(Tsukada et al., 2006), but also acts on suppression of the apoptosis process of HSCs 
(Yoshiji et al., 2002). So in our findings, hepatic reduction in TIMP-1 mRNA expression in 
the TAA group can be explained as a consequence of the increased HSC apoptosis. (Arthur, 
2000). 
Figure 5.1 shows the putative mechanism of alteration of mRNA levels of the investigated 
genes in TAA treated rats. First of all TAA converted to the free radical thioacetameide-S-
oxide and other ROSs (Chilakapati et al., 2005) causes lipid peroxidation (elevation levels 
of MDA), alters the antioxidant defense system of (CAT, SOD and GPX) (Yogalakshmi et 
al., 2010) and activates the HSCs, which in turn, releases more ECM and subsequently 
increase the TGFβ gene expression that affects the release of collagen α gene, MMP1 gene 
and the TIMP1 gene. Thus, scar tissue develops and the liver loses its normal functions, 
anatomical shape and architecture (Wang et al., 2008; Mormone et al., 2011).  
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Treatment with PN and MM significantly reduced the impact of thioacetamide toxicity. 
Firstly through removing the causative stimuli of TAA, neutralizing the ROSs by their high 
antioxidant content and attenuation of endogenous antioxidant enzymes to their normal 
levels. Secondly, by maintaining the HSCs in their quiescent state. Thirdly, through 
increasing the TIMP1 release to counter balance the MMP2 and complete remodeling of 
the hepatocyte cellular system that preserves or sustains the normal liver function, shape 
and appearance. 
These findings confirm the previous findings of Wills & Asha (Wills & Asha, 2007), who 
suggested the hepatoprotective role of Lygodium flexuosum plant extract is to reduce the 
mRNA levels of growth factors, pro inflammatory cytokines and other signaling molecules, 
which are involved in hepatic fibrosis including TGF-β1, procollagen-I, and TIMP-1. Also 
Chen et al. (Chen et al., 2012) demonstrated the hepatoprotective effects of silymarin 
against TAA-induced liver damage to be due to down-regulation of hepatic MMP-2, TIMP-
1,TGF-β1, COL-α1 and other genes in the mouse model of chronic liver fibrosis. While the 
antifibrotic and hepatoprotective properties of silybin–phosphatidylcholine- Vitamin E 
complex in the rat model of hepatic fibrosis induced by bile duct ligation and 
dimethylnitrosamine administration was postulated to attribute reduced mRNA levels of 
procollagen type I, TGFβ1, TIMP-1 and MMP2 genes expression. Furthermore, the 
administration of the complex has been reported to reduce hepatic stellate cell activation 
and proliferation with collagen deposition. (A.Di Sario, 2005). 
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Figure 5.1: Putative mechanism of Phyllanthus niruri and Melastoma 
malabathricum‘s  hepatoprotective effects as a respond to TAA induced hepatotoxicty.   
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5.1.5 Active constituents of P. niruri and M. malabathricum 
The identified chemical constituents included in P. niruri (4-O-caffeolquinic acid and 
quercetin 3-O-rhamnoside) and M. malabathricum (kaempferol, quercetin and naringenin) 
can further interpret the above-mentioned medicinal activities. 
4-O-caffeolquinic acid classified as tannin has been isolated previously from P. niruri 
(Tang et al., 2010) and proven to posses antioxidant, immunomodulatory and 
hepatoprotective effects in several in vivo and in vitro assays (Chun et al., 2003) (Silva et 
al., 2004; Adzet et al., 1987; Kapil et al., 1995). Additionally, all of quercetin 3-O-
rhamnoside, kaempferol, quercetin and naringenin belong to flavonoid groups of 
compounds that are considered as having a wide range of pharmacological benefits 
including: antimicrobial, antiviral, antioxidant, gastroprotective, hepatoprotective, anti-
infalmmatory and chemopreventive effects (Kähkönen et al., 1999; Zayachkivska et al., 
2005; Ozcelik et al., 2006; Oh et al., 2004). Furthermore, a potentially valuable working 
mechanism of flavonoids during injuries and tissue damage has been suggested to occur 
through interfere with ≥3 different free radical producing systems, whilst also increasing 
the functions of the endogenous antioxidants CAT, SOD and GPX (Nijveldt et al., 2001). 
The findings of the present study seem to confirm the findings of Joffry et al. (Joffry et al., 
2012) who reviewed the chemical constituents of Melastoma malabathricum and 
demonstrated the presence of kaempferol, quercetin and naringenin in this plant. Otherwise, 
quercetin 3-O-rhamnoside was confirmed to be present in Phyllanthus species and other 
species of Euphorbiaceae family (Zhang et al., 2002; Calixto et al., 1998; Kuti & Konuru, 
2004). 
Finally, all isolated chemical compounds from P. nrirui and Melastoma malabathircum 
(tannins and flavonoids) are classified as ―polyphenols‖, which are one of the most frequent 
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groups of plant metabolites and has an important role in human and animal diets (Bravo, 
1998). Recent studies have shown that plant-derived polyphenols are promising 
nutraceuticals for the control of various disorders such as cardiovascular, neurological and 
neoplastic diseases (Ullah & Khan, 2008). In addition, the use of plant derived 
polyphenolic compounds were explored for use as hepatoprotective agents against different 
types of liver damage inducers like CCL4 (Shimoda et al., 2008), paracetamol (Chen et al., 
2009) and thioacetamide (Madani et al., 2008), which explains the high interest of many 
researchers interested in studying the biological activity and bioavailabilities of the 
polyphenolic compounds. 
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5.2 Conclusion 
1. Phyllanthus niruri and Melastoma malabathricum have significant amounts of 
phenolic and flavonoid contents and exhibited potent antioxidant activity in vitro by 
virtue of DPPH, ABTS radical scavenging activities and ferric ion reducing power. 
2. P. niruri and M. malabathricum possessed significant in vitro immunomodulatory 
roles on human peripheral mononuclear cells (PBMC). 
3. P. niruri and M. malabathricum ethanol extracts were toxicologically safe in vivo 
by oral administration. 
4. 200 mg/kg of P. niruri and M. malabathricum extracts were significantly effective in 
vivo to prevent liver cirrhosis induced by thioacetamide based on biochemical 
parameters, gross morphology and histopathology and accordingly they might have 
promising hepatoprotective activities. The mechanism underlied the 
hepatoprotective effects of Phyllanthus niruri and Melastoma malabathricum were 
suggested to be through maintaining the endogenous antioxidant system of the liver 
and monitoring the expression of TGFβ, Collα1, MMP2 and TIMP1genes.   
5. The antioxidant, immunmodulatory and hepatoprotective activities were probably 
due to the identified chemical compounds (4-O-caffeolquinic acid, quercetin 3-O-
rhamnoside) and (kaempferol, quercetin and naringenin) of Phyllanthus niruri and 
Melastoma malabathricum respectively. 
6. From this study promising potential has been identified that can be harnessed 
towards the development of new therapies, which must focus on gene expression for 
the treatment of liver cirrhosis. 
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5.3 Future Work  
1. Purification, identification and structure elucidation using 1D- and 2D-NMR 
spectroscopic processes should be done for the unidentified chemical components.   
2. Future studies should focus on how to effectively transition herbal remedies from 
the in vivo animal models, to the in vitro cell line models which can establish the 
hepatoprotective efficiency of the plants. 
3. The fractionations of the plant extracts might be repeated several times so as to 
isolate sufficient quantities of the active fractions in order to test their bioactivities 
in the experimental animals.  
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                                 APPENDICES 
Appendix A: Analytical techniques and preparations 
A1. DPPH free radical scavenging assay   
Reagents  
2, 2-diphenyl-1-picrylehydrazyl (C18H12N5O0) solution 
Ascorbic acid (Vit. C)  
Preparation of reagent 
0.001761 g/ml Vit. C was prepared as a standard. 
The DPPH solution was prepared by dissolving 0.001972 g of DPPH in 50 ml of   
absolute ethanol then stirred until the DPPH was completely dissolved. 
   
 
Figure A.1: DPPH Standard curve 
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A2. ABTS free radical scavenging assay   
Reagents  
2.5 mM Trolox (Co-hydroxy-2,5,7,8-tetramethyl chroman-2- carboxylic acid) (Standard) 
7 mM ABTS (C18H24N6O6S4) 
2.45 mM potassium persulfate (K2S2O8) 
Preparation of reagent 
1- The trolox standard was prepared by dissolving 0.00625g of trolox in 10 ml of 
absolute methanol. It was then stirred until completely dissolved. 
2-         To prepare the ABTS solution, 0.0384 g was dissolved in 10 ml dH2O and 0.033 
g of potassium persulfate dissolved in 5 ml dH2O then both were mixed and incubated for 
(12-16 hrs) in a dark place at room temperature. Then the prepared ABTS stock was 
diluted with methanol to an absorbance of (0.700 ± 0.020) at 734 nm.   
 
Figure A.2:  ABTS Standard curve 
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A3. Total Phenolic Content (TPC)    
Reagents 
Commercial Folin-Ciocalteu solution 
Sodium carbonate 
Gallic acid 
Preparation of reagent 
1- A ratio of (1:10) of Folin-Ciocalteu solution was prepared by diluting 10 ml of it with 90 
ml dH2O in a dark place. 
2- 5.75 g of sodium carbonate was dissolved in 50 ml of dH2O to give a final concentration 
of 0.115 mg/ml. 
3- 0.2 mg/ml of gallic acid solution was prepared and used as the standard solution. 
 
 
Figure A.3:  Gallic acid calibration plot 
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A4. Total flavonoid content (TFC)      
Reagents 
Aluminium trichloride (Al Cl3) 
Quercetin (Standard) 
Potassium acetate (CH3COOK) 
Preparation of reagents 
One gram of Al Cl3 was dissolved in 10 ml dH2O. 
0.9815 g of potassium acetate was dissolved in 10 ml dH2O. 
And 0.02g of quercetin was dissolved in 4 ml (95%) methanol. 
 
 
Figure A.4:  Quercetin calibration plot 
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A5. Ferric reducing antioxidant power (FRAP) assay    
Reagents 
Iron (II) sulfate hepatohydrate (FeSO4. 7H2O) 
Sodium acetate trihydrate buffer (C2H3O2N9. 3H2O) 
2,4,6-tris(2-pyridyl)-s-triazine (TPTZ) 98% 
FeCl3. 6H2O 
 
Preparation of reagents 
 
0.0278 g of FeSO4.7H2O was dissolved in 100 ml dH2O. 
0.0775 g of acetate buffer was dissolved in 25 ml dH2O mixed previously with 0.4 ml 
glacial acetic acid. 
0.00781 g of TPTZ was dissolved in 2.5 ml dH2O mixed previously with 0.1 ml (1M HCL). 
0.0135g FeCl3. 6H2O was dissolved in 2.5 ml dH2O. 
The freshly prepared: acetate buffer, TPTZ and FeCl3. 6H2O solutions were mixed and 
vortexed to obtain the ready to use FRAP reagent. 
 
Figure A.5: FeSO4.7H2O calibration plot 
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A6. (MTT) assay    
Reagents 
3-(4, 5-Dimethyl-2-thiazolyl)-2,3-diphenyl-2H-tetrazolium bromide (MTT) reagent  
RPMI media  
Preparation of reagents 
1- 5 mg / ml MTT reagent prepared in PBS and filtered through sterilized filter 0.22 µm. 
2- RPMI media reconstitute with 10% (v/v) Fetal bovine serum (FBS).  
 
A7. Total Antioxidant Capacity (TAC) assay    Catalog no.709001 
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Figure A.6: Trolox standard curve 
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A8.Catalase (CAT) assay    Catalog no.707002 
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Figure A.7: Formaldehyde standard curve 
 
A9. Superoxide Dismutase (SOD) assay    Catalog no.70600
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Figure A.8: Superoxide Dismutase standard curve 
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A10. TBARS assay    Catalog no.10009055 
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Figure A.9: MDA standard curve 
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A11. Glutathione peroxidase (GPX) assay    Catalog no.703102
 
  
164 
 
 
  
165 
 
 
   
Figure A.10: Activity of GPX in TAA treated rat liver. 
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A12. Histopathology Techniques 
 
1) Routine slide preparation 
a- Tissue trimming and fixation 
The tissue processing started with trimming and excising the tissues into small pieces of 
about 1 cm in size and then put in cassettes containing fresh 10% buffered formalin of 
10:1 ratio of fixative to tissue for 48 hr. The purpose of fixation is to preserve tissues 
permanently in life - like state as possible after removal of the tissues.  
 
b- Processing 
The technique of getting fixed tissue into paraffin is called tissue processing. This process 
have been done by using automatic tissue processor. The main steps in this process were: 
dehydration, clearing and infiltration in a programmed sequence. 
 
c- Embedding 
After the above processes, the tissues were manually transferred from the cassettes and 
put into the blocks with molten paraffin over them, with proper orientation of tissue in the 
block of paraffin. 
d- Sectioning 
Once the melted paraffin was cooled and hardened, the blocks were trimmed into an 
appropriately sized block and put into freezer under -4°C for 1 hr before sectioning. Each 
block was then mounted in a specially designed slicing machine, a microtome. They were 
cut with steel knife into sections of 5 µm thickness. These sections were floated in a 40°C 
warm water bath to avoid wrinkling, then they were picked up on a labeled glass 
microscopic slides. All these slides were then dried less than 50°C temperature. 
e- Staining 
Before staining, all the slides were deparaffinized by running them through xylenes I, II 
for 5 min each, in order to remove the paraffin wax out of the tissues and allow water 
soluble dyes to penetrate the sections. The stains which were used in our experiment were 
H and E stains. Thick paraffin sections (5 µm) of liver were de-waxed in xylene, 
dehydrated in series of alcohol to water then immersed in hematoxylin for 15 min. 
Sections were then differentiated with 1% acid alcohol and washed in tap water, followed 
by staining with eosin for 5 min.  
f- Mounting 
Finally, to protect the stained sections from damage, the stained sections were dehydrated 
in series of alcohol, cleared in xylene and mounted with the mounting media DPX and the 
use of coverslip in 45º angle then bubbles were removed carefully and left to dry 
overnight at room temperature. 
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2) Haematoxylin and Eosin (H&E) stain 
Reagents required: 
 
1- Harris haematoxylin working solution 
2- Eosin working solution 
3- 0.5 % acid alcohol 
4- 2 %  soidium acetate 
5- 80 % alcohol 
6- 95 % alcohol 
7- Absolute alcohol 
 
 
Procedure: 
 
1- Bring section to water 
2- Stain in Harris haematoxylin                      10 min. 
3- Wash in running water until excess blue color goes off 
4- Differentiation: Dip 2 to 3X in 0.5% acid alcohol and wash in running tab water 
5- Wash well in running tab water                  2-3 min. 
6- Blue section with 2% sodium acetate         2 sec. 
7- Wash again in running tab water                2-3 min. 
8- Rinse in 80% alcohol 
9- Stain in eosin solution                                5 min. 
10- Dehydration: 95 % alcohol I                      5 sec 
                       95 % alcohol II                    2 min. 
Absolute alcohol I                                      2 min. 
Absolute alcohol II                                     2 min. 
11- Clear in xyline                                             2 min. x3 
12- Mount with DPX 
13- Wipe slide to remove excess xyline 
14- Label slide appropriately. 
 
 
Results: 
Nuclei            blue 
Cytoplasm      various shades of pink and red. 
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3) Masson’s trichrome stain 
 
Reagents required: 
 
1- Bouin‘s fixative 
2- Celestine blue stain 
3- Harris haemtoxylin 
4- 0.5 % acid alcohol 
5- BSAF stain (Biebrich scarlet acid fuchsin) 
6- 5 % aqueous phosphotungstic acid 
7- Light green stain (2 % light green in 1 % acetic acid) 
 
 
Procedure: 
 
1- Bring section to water                       
2- Stain in Celestine blue                            6 min. 
3- Brief rinse in water       
4- Stain in Harris haematoxylin                   6 min 
5- Wash in running tap water until excess blue color goes off 
6- Differentiate with acid alcohol until background is colorless 
7- Wash well in running water 
8- Stain with BSAF                                      5 min. 
9- Brief rinse in water 
10- Differentiate in phosphotungstic acid     10 min.  
11- Brief rinse in water 
12- Stain in light green solution                     10 min. 
13- Drain off excess light green then dehydrate quickly 
14- Clear and mount 
 
 
Results: 
Nuclei          black 
Cytoplasm     red 
Collagen       blue 
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A13. Gene expression techniques: 
1-  RNA Purification by QIAamp® RNA Blood Mini kit catalog no. 52304 
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2- Transcription of RNA to cDNA by High Capacity RNA-to-cDNA Master Mix 
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3- Gene Expression by Real time PCR 
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4- Genes efficiencies and Standard curves 
  
Figure: Hprt1 standard curve 
 
 
Figure: Ppia standard curve 
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Figure: TGFβ standard curve 
 
 
Figure: TIMP1 standard curve 
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Figure: MMP2 standard curve 
 
 
Figure: Collα standard curve 
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Appendix B: Data analysis and statistics 
 
B1: In vitro antioxidant analysis 
1- DPPH analysis 
DPPH 
Duncan test 
GROUPS N 
Subset for alpha = 0.05 
A b C 
VITC 3 3.3587   
PN 3  11.0233  
MM 3  11.2000  
BHT 3   21.1000 
Sig.  1.000 .775 1.000 
Means for groups in homogeneous subsets are 
displayed. 
 
2-  ABTS analysis 
ABTS 
Duncan test 
GROUPS N 
Subset for alpha = 0.05 
A b c d 
VITC 3 21.3227    
PN 3  53.1133   
MM 3   62.2200  
BHT 3    65.2333 
Sig.  1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are displayed. 
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3- FRAP analysis 
FRAP 
Duncan test 
GROUPS N 
Subset for alpha = 0.05 
A b C d 
PN 3 7755.0000    
MM 3  33589.6667   
BHT 3   57303.3333  
VITC 3    101603.3333 
Sig.  1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are displayed. 
  
4-  Correlation between in vitro antioxidant tests 
  ABTS FRAP TPC TFC 
DPPH Pearson Correlation .631
*
 .383 -.355- .276 
Sig. (2-tailed) .012 .158 .257 .385 
N 15 15 12 12 
ABTS Pearson Correlation  .404 -.173- .174 
Sig. (2-tailed)  .135 .591 .589 
N  15 12 12 
FRAP Pearson Correlation   .908
**
 -.805-
**
 
Sig. (2-tailed)   .000 .002 
N   12 12 
TPC Pearson Correlation    -.766-
**
 
Sig. (2-tailed)    .004 
N    12 
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B2: Hepatoprotective Test Statistics 
1- Body, Liver and Spleen weights 
Multiple Comparisons 
BW 
Bonferroni 
(I) 
GROUP
S 
(J) 
GROUP
S 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
N TAA 41.60000 21.72411 1.000 -30.9672- 114.1672 
S 15.00000 21.72411 1.000 -57.5672- 87.5672 
PN/LD -21.60000- 21.72411 1.000 -94.1672- 50.9672 
PN/HD -16.40000- 21.72411 1.000 -88.9672- 56.1672 
MM/LD -12.40000- 21.72411 1.000 -84.9672- 60.1672 
MM/H
D 
5.80000 21.72411 1.000 -66.7672- 78.3672 
TAA N -41.60000- 21.72411 1.000 -114.1672- 30.9672 
S -26.60000- 21.72411 1.000 -99.1672- 45.9672 
PN/LD -63.20000- 21.72411 .147 -135.7672- 9.3672 
PN/HD -58.00000- 21.72411 .262 -130.5672- 14.5672 
MM/LD -54.00000- 21.72411 .403 -126.5672- 18.5672 
MM/H
D 
-35.80000- 21.72411 1.000 -108.3672- 36.7672 
S N -15.00000- 21.72411 1.000 -87.5672- 57.5672 
TAA 26.60000 21.72411 1.000 -45.9672- 99.1672 
PN/LD -36.60000- 21.72411 1.000 -109.1672- 35.9672 
PN/HD -31.40000- 21.72411 1.000 -103.9672- 41.1672 
MM/LD -27.40000- 21.72411 1.000 -99.9672- 45.1672 
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MM/H
D 
-9.20000- 21.72411 1.000 -81.7672- 63.3672 
PN/LD N 21.60000 21.72411 1.000 -50.9672- 94.1672 
TAA 63.20000 21.72411 .147 -9.3672- 135.7672 
S 36.60000 21.72411 1.000 -35.9672- 109.1672 
PN/HD 5.20000 21.72411 1.000 -67.3672- 77.7672 
MM/LD 9.20000 21.72411 1.000 -63.3672- 81.7672 
MM/H
D 
27.40000 21.72411 1.000 -45.1672- 99.9672 
PN/HD N 16.40000 21.72411 1.000 -56.1672- 88.9672 
TAA 58.00000 21.72411 .262 -14.5672- 130.5672 
S 31.40000 21.72411 1.000 -41.1672- 103.9672 
PN/LD -5.20000- 21.72411 1.000 -77.7672- 67.3672 
MM/LD 4.00000 21.72411 1.000 -68.5672- 76.5672 
MM/H
D 
22.20000 21.72411 1.000 -50.3672- 94.7672 
MM/LD N 12.40000 21.72411 1.000 -60.1672- 84.9672 
TAA 54.00000 21.72411 .403 -18.5672- 126.5672 
S 27.40000 21.72411 1.000 -45.1672- 99.9672 
PN/LD -9.20000- 21.72411 1.000 -81.7672- 63.3672 
PN/HD -4.00000- 21.72411 1.000 -76.5672- 68.5672 
MM/H
D 
18.20000 21.72411 1.000 -54.3672- 90.7672 
MM/H
D 
N -5.80000- 21.72411 1.000 -78.3672- 66.7672 
TAA 35.80000 21.72411 1.000 -36.7672- 108.3672 
S 9.20000 21.72411 1.000 -63.3672- 81.7672 
PN/LD -27.40000- 21.72411 1.000 -99.9672- 45.1672 
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PN/HD -22.20000- 21.72411 1.000 -94.7672- 50.3672 
MM/LD -18.20000- 21.72411 1.000 -90.7672- 54.3672 
 
Multiple Comparisons 
LW 
Bonferroni 
(I) 
GROUP
S 
(J) 
GROUP
S 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
N TAA -3.20000- 1.06904 .120 -6.7710- .3710 
S -3.00000- 1.06904 .189 -6.5710- .5710 
PN/LD -2.00000- 1.06904 1.000 -5.5710- 1.5710 
PN/HD -1.60000- 1.06904 1.000 -5.1710- 1.9710 
MM/LD -4.60000-
*
 1.06904 .004 -8.1710- -1.0290- 
MM/H
D 
-3.00000- 1.06904 .189 -6.5710- .5710 
TAA N 3.20000 1.06904 .120 -.3710- 6.7710 
S .20000 1.06904 1.000 -3.3710- 3.7710 
PN/LD 1.20000 1.06904 1.000 -2.3710- 4.7710 
PN/HD 1.60000 1.06904 1.000 -1.9710- 5.1710 
MM/LD -1.40000- 1.06904 1.000 -4.9710- 2.1710 
MM/H
D 
.20000 1.06904 1.000 -3.3710- 3.7710 
S N 3.00000 1.06904 .189 -.5710- 6.5710 
TAA -.20000- 1.06904 1.000 -3.7710- 3.3710 
PN/LD 1.00000 1.06904 1.000 -2.5710- 4.5710 
PN/HD 1.40000 1.06904 1.000 -2.1710- 4.9710 
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MM/LD -1.60000- 1.06904 1.000 -5.1710- 1.9710 
MM/H
D 
.00000 1.06904 1.000 -3.5710- 3.5710 
PN/LD N 2.00000 1.06904 1.000 -1.5710- 5.5710 
TAA -1.20000- 1.06904 1.000 -4.7710- 2.3710 
S -1.00000- 1.06904 1.000 -4.5710- 2.5710 
PN/HD .40000 1.06904 1.000 -3.1710- 3.9710 
MM/LD -2.60000- 1.06904 .455 -6.1710- .9710 
MM/H
D 
-1.00000- 1.06904 1.000 -4.5710- 2.5710 
PN/HD N 1.60000 1.06904 1.000 -1.9710- 5.1710 
TAA -1.60000- 1.06904 1.000 -5.1710- 1.9710 
S -1.40000- 1.06904 1.000 -4.9710- 2.1710 
PN/LD -.40000- 1.06904 1.000 -3.9710- 3.1710 
MM/LD -3.00000- 1.06904 .189 -6.5710- .5710 
MM/H
D 
-1.40000- 1.06904 1.000 -4.9710- 2.1710 
MM/LD N 4.60000
*
 1.06904 .004 1.0290 8.1710 
TAA 1.40000 1.06904 1.000 -2.1710- 4.9710 
S 1.60000 1.06904 1.000 -1.9710- 5.1710 
PN/LD 2.60000 1.06904 .455 -.9710- 6.1710 
PN/HD 3.00000 1.06904 .189 -.5710- 6.5710 
MM/H
D 
1.60000 1.06904 1.000 -1.9710- 5.1710 
MM/H
D 
N 3.00000 1.06904 .189 -.5710- 6.5710 
TAA -.20000- 1.06904 1.000 -3.7710- 3.3710 
S .00000 1.06904 1.000 -3.5710- 3.5710 
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PN/LD 1.00000 1.06904 1.000 -2.5710- 4.5710 
PN/HD 1.40000 1.06904 1.000 -2.1710- 4.9710 
MM/LD -1.60000- 1.06904 1.000 -5.1710- 1.9710 
*. The mean difference is significant at the 0.05 level. 
 
Multiple Comparisons 
SW 
Bonferroni 
(I) 
GROUP
S 
(J) 
GROUP
S 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
N TAA -.14800- .06599 .693 -.3684- .0724 
S -.16600- .06599 .376 -.3864- .0544 
PN/LD -.10000- .06599 1.000 -.3204- .1204 
PN/HD -.04000- .06599 1.000 -.2604- .1804 
MM/LD -.09800- .06599 1.000 -.3184- .1224 
MM/H
D 
-.04200- .06599 1.000 -.2624- .1784 
TAA N .14800 .06599 .693 -.0724- .3684 
S -.01800- .06599 1.000 -.2384- .2024 
PN/LD .04800 .06599 1.000 -.1724- .2684 
PN/HD .10800 .06599 1.000 -.1124- .3284 
MM/LD .05000 .06599 1.000 -.1704- .2704 
MM/H
D 
.10600 .06599 1.000 -.1144- .3264 
S N .16600 .06599 .376 -.0544- .3864 
TAA .01800 .06599 1.000 -.2024- .2384 
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PN/LD .06600 .06599 1.000 -.1544- .2864 
PN/HD .12600 .06599 1.000 -.0944- .3464 
MM/LD .06800 .06599 1.000 -.1524- .2884 
MM/H
D 
.12400 .06599 1.000 -.0964- .3444 
PN/LD N .10000 .06599 1.000 -.1204- .3204 
TAA -.04800- .06599 1.000 -.2684- .1724 
S -.06600- .06599 1.000 -.2864- .1544 
PN/HD .06000 .06599 1.000 -.1604- .2804 
MM/LD .00200 .06599 1.000 -.2184- .2224 
MM/H
D 
.05800 .06599 1.000 -.1624- .2784 
PN/HD N .04000 .06599 1.000 -.1804- .2604 
TAA -.10800- .06599 1.000 -.3284- .1124 
S -.12600- .06599 1.000 -.3464- .0944 
PN/LD -.06000- .06599 1.000 -.2804- .1604 
MM/LD -.05800- .06599 1.000 -.2784- .1624 
MM/H
D 
-.00200- .06599 1.000 -.2224- .2184 
MM/LD N .09800 .06599 1.000 -.1224- .3184 
TAA -.05000- .06599 1.000 -.2704- .1704 
S -.06800- .06599 1.000 -.2884- .1524 
PN/LD -.00200- .06599 1.000 -.2224- .2184 
PN/HD .05800 .06599 1.000 -.1624- .2784 
MM/H
D 
.05600 .06599 1.000 -.1644- .2764 
MM/H N .04200 .06599 1.000 -.1784- .2624 
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D 
TAA -.10600- .06599 1.000 -.3264- .1144 
S -.12400- .06599 1.000 -.3444- .0964 
PN/LD -.05800- .06599 1.000 -.2784- .1624 
PN/HD .00200 .06599 1.000 -.2184- .2224 
MM/LD -.05600- .06599 1.000 -.2764- .1644 
 
Multiple Comparisons 
LWBW 
Bonferroni 
(I) 
GROUP
S 
(J) 
GROUP
S 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
N TAA -2.18340-
*
 .37298 .000 -3.4293- -.9375- 
S -1.47520-
*
 .37298 .010 -2.7211- -.2293- 
PN/LD -.59120- .37298 1.000 -1.8371- .6547 
PN/HD -.48920- .37298 1.000 -1.7351- .7567 
MM/LD -1.72100-
*
 .37298 .002 -2.9669- -.4751- 
MM/H
D 
-1.42540-
*
 .37298 .014 -2.6713- -.1795- 
TAA N 2.18340
*
 .37298 .000 .9375 3.4293 
S .70820 .37298 1.000 -.5377- 1.9541 
PN/LD 1.59220
*
 .37298 .004 .3463 2.8381 
PN/HD 1.69420
*
 .37298 .002 .4483 2.9401 
MM/LD .46240 .37298 1.000 -.7835- 1.7083 
MM/H
D 
.75800 .37298 1.000 -.4879- 2.0039 
S N 1.47520
*
 .37298 .010 .2293 2.7211 
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TAA -.70820- .37298 1.000 -1.9541- .5377 
PN/LD .88400 .37298 .523 -.3619- 2.1299 
PN/HD .98600 .37298 .279 -.2599- 2.2319 
MM/LD -.24580- .37298 1.000 -1.4917- 1.0001 
MM/H
D 
.04980 .37298 1.000 -1.1961- 1.2957 
PN/LD N .59120 .37298 1.000 -.6547- 1.8371 
TAA -1.59220-
*
 .37298 .004 -2.8381- -.3463- 
S -.88400- .37298 .523 -2.1299- .3619 
PN/HD .10200 .37298 1.000 -1.1439- 1.3479 
MM/LD -1.12980- .37298 .110 -2.3757- .1161 
MM/H
D 
-.83420- .37298 .703 -2.0801- .4117 
PN/HD N .48920 .37298 1.000 -.7567- 1.7351 
TAA -1.69420-
*
 .37298 .002 -2.9401- -.4483- 
S -.98600- .37298 .279 -2.2319- .2599 
PN/LD -.10200- .37298 1.000 -1.3479- 1.1439 
MM/LD -1.23180- .37298 .055 -2.4777- .0141 
MM/H
D 
-.93620- .37298 .381 -2.1821- .3097 
MM/LD N 1.72100
*
 .37298 .002 .4751 2.9669 
TAA -.46240- .37298 1.000 -1.7083- .7835 
S .24580 .37298 1.000 -1.0001- 1.4917 
PN/LD 1.12980 .37298 .110 -.1161- 2.3757 
PN/HD 1.23180 .37298 .055 -.0141- 2.4777 
MM/H
D 
.29560 .37298 1.000 -.9503- 1.5415 
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MM/H
D 
N 1.42540
*
 .37298 .014 .1795 2.6713 
TAA -.75800- .37298 1.000 -2.0039- .4879 
S -.04980- .37298 1.000 -1.2957- 1.1961 
PN/LD .83420 .37298 .703 -.4117- 2.0801 
PN/HD .93620 .37298 .381 -.3097- 2.1821 
MM/LD -.29560- .37298 1.000 -1.5415- .9503 
*. The mean difference is significant at the 0.05 level. 
 
Multiple Comparisons 
SWBW 
Bonferroni 
(I) 
GROUP
S 
(J) 
GROUP
S 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
N TAA -.09700-
*
 .02623 .020 -.1846- -.0094- 
S -.08120- .02623 .093 -.1688- .0064 
PN/LD -.02520- .02623 1.000 -.1128- .0624 
PN/HD -.00320- .02623 1.000 -.0908- .0844 
MM/LD -.03000- .02623 1.000 -.1176- .0576 
MM/H
D 
-.02140- .02623 1.000 -.1090- .0662 
TAA N .09700
*
 .02623 .020 .0094 .1846 
S .01580 .02623 1.000 -.0718- .1034 
PN/LD .07180 .02623 .223 -.0158- .1594 
PN/HD .09380
*
 .02623 .027 .0062 .1814 
MM/LD .06700 .02623 .344 -.0206- .1546 
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MM/H
D 
.07560 .02623 .158 -.0120- .1632 
S N .08120 .02623 .093 -.0064- .1688 
TAA -.01580- .02623 1.000 -.1034- .0718 
PN/LD .05600 .02623 .875 -.0316- .1436 
PN/HD .07800 .02623 .126 -.0096- .1656 
MM/LD .05120 .02623 1.000 -.0364- .1388 
MM/H
D 
.05980 .02623 .639 -.0278- .1474 
PN/LD N .02520 .02623 1.000 -.0624- .1128 
TAA -.07180- .02623 .223 -.1594- .0158 
S -.05600- .02623 .875 -.1436- .0316 
PN/HD .02200 .02623 1.000 -.0656- .1096 
MM/LD -.00480- .02623 1.000 -.0924- .0828 
MM/H
D 
.00380 .02623 1.000 -.0838- .0914 
PN/HD N .00320 .02623 1.000 -.0844- .0908 
TAA -.09380-
*
 .02623 .027 -.1814- -.0062- 
S -.07800- .02623 .126 -.1656- .0096 
PN/LD -.02200- .02623 1.000 -.1096- .0656 
MM/LD -.02680- .02623 1.000 -.1144- .0608 
MM/H
D 
-.01820- .02623 1.000 -.1058- .0694 
MM/LD N .03000 .02623 1.000 -.0576- .1176 
TAA -.06700- .02623 .344 -.1546- .0206 
S -.05120- .02623 1.000 -.1388- .0364 
PN/LD .00480 .02623 1.000 -.0828- .0924 
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PN/HD .02680 .02623 1.000 -.0608- .1144 
MM/H
D 
.00860 .02623 1.000 -.0790- .0962 
MM/H
D 
N .02140 .02623 1.000 -.0662- .1090 
TAA -.07560- .02623 .158 -.1632- .0120 
S -.05980- .02623 .639 -.1474- .0278 
PN/LD -.00380- .02623 1.000 -.0914- .0838 
PN/HD .01820 .02623 1.000 -.0694- .1058 
MM/LD -.00860- .02623 1.000 -.0962- .0790 
*. The mean difference is significant at the 0.05 level. 
 
2-  Hepatic Biochemical parameters 
Multiple Comparisons 
ALT 
Bonferroni 
(I) 
GROUP
S 
(J) 
GROUP
S 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
N TAA -99.60000-
*
 13.54841 .000 -144.8571- -54.3429- 
S -41.25000- 13.54841 .106 -86.5071- 4.0071 
PN/LD -16.60000- 13.54841 1.000 -61.8571- 28.6571 
PN/HD -12.20000- 13.54841 1.000 -57.4571- 33.0571 
MM/LD -30.60000- 13.54841 .670 -75.8571- 14.6571 
MM/H
D 
-28.00000- 13.54841 1.000 -73.2571- 17.2571 
TAA N 99.60000
*
 13.54841 .000 54.3429 144.8571 
S 58.35000
*
 13.54841 .004 13.0929 103.6071 
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PN/LD 83.00000
*
 13.54841 .000 37.7429 128.2571 
PN/HD 87.40000
*
 13.54841 .000 42.1429 132.6571 
MM/LD 69.00000
*
 13.54841 .000 23.7429 114.2571 
MM/H
D 
71.60000
*
 13.54841 .000 26.3429 116.8571 
S N 41.25000 13.54841 .106 -4.0071- 86.5071 
TAA -58.35000-
*
 13.54841 .004 -103.6071- -13.0929- 
PN/LD 24.65000 13.54841 1.000 -20.6071- 69.9071 
PN/HD 29.05000 13.54841 .858 -16.2071- 74.3071 
MM/LD 10.65000 13.54841 1.000 -34.6071- 55.9071 
MM/H
D 
13.25000 13.54841 1.000 -32.0071- 58.5071 
PN/LD N 16.60000 13.54841 1.000 -28.6571- 61.8571 
TAA -83.00000-
*
 13.54841 .000 -128.2571- -37.7429- 
S -24.65000- 13.54841 1.000 -69.9071- 20.6071 
PN/HD 4.40000 13.54841 1.000 -40.8571- 49.6571 
MM/LD -14.00000- 13.54841 1.000 -59.2571- 31.2571 
MM/H
D 
-11.40000- 13.54841 1.000 -56.6571- 33.8571 
PN/HD N 12.20000 13.54841 1.000 -33.0571- 57.4571 
TAA -87.40000-
*
 13.54841 .000 -132.6571- -42.1429- 
S -29.05000- 13.54841 .858 -74.3071- 16.2071 
PN/LD -4.40000- 13.54841 1.000 -49.6571- 40.8571 
MM/LD -18.40000- 13.54841 1.000 -63.6571- 26.8571 
MM/H
D 
-15.80000- 13.54841 1.000 -61.0571- 29.4571 
MM/LD N 30.60000 13.54841 .670 -14.6571- 75.8571 
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TAA -69.00000-
*
 13.54841 .000 -114.2571- -23.7429- 
S -10.65000- 13.54841 1.000 -55.9071- 34.6071 
PN/LD 14.00000 13.54841 1.000 -31.2571- 59.2571 
PN/HD 18.40000 13.54841 1.000 -26.8571- 63.6571 
MM/H
D 
2.60000 13.54841 1.000 -42.6571- 47.8571 
MM/H
D 
N 28.00000 13.54841 1.000 -17.2571- 73.2571 
TAA -71.60000-
*
 13.54841 .000 -116.8571- -26.3429- 
S -13.25000- 13.54841 1.000 -58.5071- 32.0071 
PN/LD 11.40000 13.54841 1.000 -33.8571- 56.6571 
PN/HD 15.80000 13.54841 1.000 -29.4571- 61.0571 
MM/LD -2.60000- 13.54841 1.000 -47.8571- 42.6571 
*. The mean difference is significant at the 0.05 level. 
 
Multiple Comparisons 
AST 
Bonferroni 
(I) 
GROUP
S 
(J) 
GROUP
S 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
N TAA -322.20000-
*
 61.97843 .000 -529.2327- -115.1673- 
S -56.40000- 61.97843 1.000 -263.4327- 150.6327 
PN/LD -39.60000- 61.97843 1.000 -246.6327- 167.4327 
PN/HD -28.00000- 61.97843 1.000 -235.0327- 179.0327 
MM/LD -51.20000- 61.97843 1.000 -258.2327- 155.8327 
MM/H
D 
-55.40000- 61.97843 1.000 -262.4327- 151.6327 
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TAA N 322.20000
*
 61.97843 .000 115.1673 529.2327 
S 265.80000
*
 61.97843 .004 58.7673 472.8327 
PN/LD 282.60000
*
 61.97843 .002 75.5673 489.6327 
PN/HD 294.20000
*
 61.97843 .001 87.1673 501.2327 
MM/LD 271.00000
*
 61.97843 .003 63.9673 478.0327 
MM/H
D 
266.80000
*
 61.97843 .004 59.7673 473.8327 
S N 56.40000 61.97843 1.000 -150.6327- 263.4327 
TAA -265.80000-
*
 61.97843 .004 -472.8327- -58.7673- 
PN/LD 16.80000 61.97843 1.000 -190.2327- 223.8327 
PN/HD 28.40000 61.97843 1.000 -178.6327- 235.4327 
MM/LD 5.20000 61.97843 1.000 -201.8327- 212.2327 
MM/H
D 
1.00000 61.97843 1.000 -206.0327- 208.0327 
PN/LD N 39.60000 61.97843 1.000 -167.4327- 246.6327 
TAA -282.60000-
*
 61.97843 .002 -489.6327- -75.5673- 
S -16.80000- 61.97843 1.000 -223.8327- 190.2327 
PN/HD 11.60000 61.97843 1.000 -195.4327- 218.6327 
MM/LD -11.60000- 61.97843 1.000 -218.6327- 195.4327 
MM/H
D 
-15.80000- 61.97843 1.000 -222.8327- 191.2327 
PN/HD N 28.00000 61.97843 1.000 -179.0327- 235.0327 
TAA -294.20000-
*
 61.97843 .001 -501.2327- -87.1673- 
S -28.40000- 61.97843 1.000 -235.4327- 178.6327 
PN/LD -11.60000- 61.97843 1.000 -218.6327- 195.4327 
MM/LD -23.20000- 61.97843 1.000 -230.2327- 183.8327 
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MM/H
D 
-27.40000- 61.97843 1.000 -234.4327- 179.6327 
MM/LD N 51.20000 61.97843 1.000 -155.8327- 258.2327 
TAA -271.00000-
*
 61.97843 .003 -478.0327- -63.9673- 
S -5.20000- 61.97843 1.000 -212.2327- 201.8327 
PN/LD 11.60000 61.97843 1.000 -195.4327- 218.6327 
PN/HD 23.20000 61.97843 1.000 -183.8327- 230.2327 
MM/H
D 
-4.20000- 61.97843 1.000 -211.2327- 202.8327 
MM/H
D 
N 55.40000 61.97843 1.000 -151.6327- 262.4327 
TAA -266.80000-
*
 61.97843 .004 -473.8327- -59.7673- 
S -1.00000- 61.97843 1.000 -208.0327- 206.0327 
PN/LD 15.80000 61.97843 1.000 -191.2327- 222.8327 
PN/HD 27.40000 61.97843 1.000 -179.6327- 234.4327 
MM/LD 4.20000 61.97843 1.000 -202.8327- 211.2327 
*. The mean difference is significant at the 0.05 level. 
 
Multiple Comparisons 
ALP 
Bonferroni 
(I) 
GROUP
S 
(J) 
GROUP
S 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
N TAA -321.40000-
*
 53.08026 .000 -498.7093- -144.0907- 
S -333.95000-
*
 53.08026 .000 -511.2593- -156.6407- 
PN/LD -103.60000- 53.08026 1.000 -280.9093- 73.7093 
PN/HD -96.40000- 53.08026 1.000 -273.7093- 80.9093 
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MM/LD -96.00000- 53.08026 1.000 -273.3093- 81.3093 
MM/H
D 
-135.40000- 53.08026 .346 -312.7093- 41.9093 
TAA N 321.40000
*
 53.08026 .000 144.0907 498.7093 
S -12.55000- 53.08026 1.000 -189.8593- 164.7593 
PN/LD 217.80000
*
 53.08026 .007 40.4907 395.1093 
PN/HD 225.00000
*
 53.08026 .005 47.6907 402.3093 
MM/LD 225.40000
*
 53.08026 .005 48.0907 402.7093 
MM/H
D 
186.00000
*
 53.08026 .033 8.6907 363.3093 
S N 333.95000
*
 53.08026 .000 156.6407 511.2593 
TAA 12.55000 53.08026 1.000 -164.7593- 189.8593 
PN/LD 230.35000
*
 53.08026 .004 53.0407 407.6593 
PN/HD 237.55000
*
 53.08026 .002 60.2407 414.8593 
MM/LD 237.95000
*
 53.08026 .002 60.6407 415.2593 
MM/H
D 
198.55000
*
 53.08026 .018 21.2407 375.8593 
PN/LD N 103.60000 53.08026 1.000 -73.7093- 280.9093 
TAA -217.80000-
*
 53.08026 .007 -395.1093- -40.4907- 
S -230.35000-
*
 53.08026 .004 -407.6593- -53.0407- 
PN/HD 7.20000 53.08026 1.000 -170.1093- 184.5093 
MM/LD 7.60000 53.08026 1.000 -169.7093- 184.9093 
MM/H
D 
-31.80000- 53.08026 1.000 -209.1093- 145.5093 
PN/HD N 96.40000 53.08026 1.000 -80.9093- 273.7093 
TAA -225.00000-
*
 53.08026 .005 -402.3093- -47.6907- 
S -237.55000-
*
 53.08026 .002 -414.8593- -60.2407- 
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PN/LD -7.20000- 53.08026 1.000 -184.5093- 170.1093 
MM/LD .40000 53.08026 1.000 -176.9093- 177.7093 
MM/H
D 
-39.00000- 53.08026 1.000 -216.3093- 138.3093 
MM/LD N 96.00000 53.08026 1.000 -81.3093- 273.3093 
TAA -225.40000-
*
 53.08026 .005 -402.7093- -48.0907- 
S -237.95000-
*
 53.08026 .002 -415.2593- -60.6407- 
PN/LD -7.60000- 53.08026 1.000 -184.9093- 169.7093 
PN/HD -.40000- 53.08026 1.000 -177.7093- 176.9093 
MM/H
D 
-39.40000- 53.08026 1.000 -216.7093- 137.9093 
MM/H
D 
N 135.40000 53.08026 .346 -41.9093- 312.7093 
TAA -186.00000-
*
 53.08026 .033 -363.3093- -8.6907- 
S -198.55000-
*
 53.08026 .018 -375.8593- -21.2407- 
PN/LD 31.80000 53.08026 1.000 -145.5093- 209.1093 
PN/HD 39.00000 53.08026 1.000 -138.3093- 216.3093 
MM/LD 39.40000 53.08026 1.000 -137.9093- 216.7093 
*. The mean difference is significant at the 0.05 level. 
 
Multiple Comparisons 
TPROTEIN 
Bonferroni 
(I) 
GROUP
S 
(J) 
GROUP
S 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
N TAA 13.40000
*
 2.54320 .000 4.9047 21.8953 
S 5.00000 2.54320 1.000 -3.4953- 13.4953 
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PN/LD 2.20000 2.54320 1.000 -6.2953- 10.6953 
PN/HD .95000 2.54320 1.000 -7.5453- 9.4453 
MM/LD 4.40000 2.54320 1.000 -4.0953- 12.8953 
MM/H
D 
5.00000 2.54320 1.000 -3.4953- 13.4953 
TAA N -13.40000-
*
 2.54320 .000 -21.8953- -4.9047- 
S -8.40000- 2.54320 .055 -16.8953- .0953 
PN/LD -11.20000-
*
 2.54320 .003 -19.6953- -2.7047- 
PN/HD -12.45000-
*
 2.54320 .001 -20.9453- -3.9547- 
MM/LD -9.00000-
*
 2.54320 .030 -17.4953- -.5047- 
MM/H
D 
-8.40000- 2.54320 .055 -16.8953- .0953 
S N -5.00000- 2.54320 1.000 -13.4953- 3.4953 
TAA 8.40000 2.54320 .055 -.0953- 16.8953 
PN/LD -2.80000- 2.54320 1.000 -11.2953- 5.6953 
PN/HD -4.05000- 2.54320 1.000 -12.5453- 4.4453 
MM/LD -.60000- 2.54320 1.000 -9.0953- 7.8953 
MM/H
D 
.00000 2.54320 1.000 -8.4953- 8.4953 
PN/LD N -2.20000- 2.54320 1.000 -10.6953- 6.2953 
TAA 11.20000
*
 2.54320 .003 2.7047 19.6953 
S 2.80000 2.54320 1.000 -5.6953- 11.2953 
PN/HD -1.25000- 2.54320 1.000 -9.7453- 7.2453 
MM/LD 2.20000 2.54320 1.000 -6.2953- 10.6953 
MM/H
D 
2.80000 2.54320 1.000 -5.6953- 11.2953 
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PN/HD N -.95000- 2.54320 1.000 -9.4453- 7.5453 
TAA 12.45000
*
 2.54320 .001 3.9547 20.9453 
S 4.05000 2.54320 1.000 -4.4453- 12.5453 
PN/LD 1.25000 2.54320 1.000 -7.2453- 9.7453 
MM/LD 3.45000 2.54320 1.000 -5.0453- 11.9453 
MM/H
D 
4.05000 2.54320 1.000 -4.4453- 12.5453 
MM/LD N -4.40000- 2.54320 1.000 -12.8953- 4.0953 
TAA 9.00000
*
 2.54320 .030 .5047 17.4953 
S .60000 2.54320 1.000 -7.8953- 9.0953 
PN/LD -2.20000- 2.54320 1.000 -10.6953- 6.2953 
PN/HD -3.45000- 2.54320 1.000 -11.9453- 5.0453 
MM/H
D 
.60000 2.54320 1.000 -7.8953- 9.0953 
MM/H
D 
N -5.00000- 2.54320 1.000 -13.4953- 3.4953 
TAA 8.40000 2.54320 .055 -.0953- 16.8953 
S .00000 2.54320 1.000 -8.4953- 8.4953 
PN/LD -2.80000- 2.54320 1.000 -11.2953- 5.6953 
PN/HD -4.05000- 2.54320 1.000 -12.5453- 4.4453 
MM/LD -.60000- 2.54320 1.000 -9.0953- 7.8953 
*. The mean difference is significant at the 0.05 level. 
 
Multiple Comparisons 
BILIRUBIN 
Bonferroni 
(I) (J) Mean Std. Error Sig. 95% Confidence Interval 
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GROUP
S 
GROUP
S 
Difference (I-
J) Lower Bound Upper Bound 
N TAA -5.40000-
*
 .94718 .000 -8.5639- -2.2361- 
S -1.00000- .94718 1.000 -4.1639- 2.1639 
PN/LD -4.80000-
*
 .94718 .000 -7.9639- -1.6361- 
PN/HD -1.80000- .94718 1.000 -4.9639- 1.3639 
MM/LD -3.00000- .94718 .078 -6.1639- .1639 
MM/H
D 
-3.00000- .94718 .078 -6.1639- .1639 
TAA N 5.40000
*
 .94718 .000 2.2361 8.5639 
S 4.40000
*
 .94718 .002 1.2361 7.5639 
PN/LD .60000 .94718 1.000 -2.5639- 3.7639 
PN/HD 3.60000
*
 .94718 .015 .4361 6.7639 
MM/LD 2.40000 .94718 .360 -.7639- 5.5639 
MM/H
D 
2.40000 .94718 .360 -.7639- 5.5639 
S N 1.00000 .94718 1.000 -2.1639- 4.1639 
TAA -4.40000-
*
 .94718 .002 -7.5639- -1.2361- 
PN/LD -3.80000-
*
 .94718 .009 -6.9639- -.6361- 
PN/HD -.80000- .94718 1.000 -3.9639- 2.3639 
MM/LD -2.00000- .94718 .919 -5.1639- 1.1639 
MM/H
D 
-2.00000- .94718 .919 -5.1639- 1.1639 
PN/LD N 4.80000
*
 .94718 .000 1.6361 7.9639 
TAA -.60000- .94718 1.000 -3.7639- 2.5639 
S 3.80000
*
 .94718 .009 .6361 6.9639 
PN/HD 3.00000 .94718 .078 -.1639- 6.1639 
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MM/LD 1.80000 .94718 1.000 -1.3639- 4.9639 
MM/H
D 
1.80000 .94718 1.000 -1.3639- 4.9639 
PN/HD N 1.80000 .94718 1.000 -1.3639- 4.9639 
TAA -3.60000-
*
 .94718 .015 -6.7639- -.4361- 
S .80000 .94718 1.000 -2.3639- 3.9639 
PN/LD -3.00000- .94718 .078 -6.1639- .1639 
MM/LD -1.20000- .94718 1.000 -4.3639- 1.9639 
MM/H
D 
-1.20000- .94718 1.000 -4.3639- 1.9639 
MM/LD N 3.00000 .94718 .078 -.1639- 6.1639 
TAA -2.40000- .94718 .360 -5.5639- .7639 
S 2.00000 .94718 .919 -1.1639- 5.1639 
PN/LD -1.80000- .94718 1.000 -4.9639- 1.3639 
PN/HD 1.20000 .94718 1.000 -1.9639- 4.3639 
MM/H
D 
.00000 .94718 1.000 -3.1639- 3.1639 
MM/H
D 
N 3.00000 .94718 .078 -.1639- 6.1639 
TAA -2.40000- .94718 .360 -5.5639- .7639 
S 2.00000 .94718 .919 -1.1639- 5.1639 
PN/LD -1.80000- .94718 1.000 -4.9639- 1.3639 
PN/HD 1.20000 .94718 1.000 -1.9639- 4.3639 
MM/LD .00000 .94718 1.000 -3.1639- 3.1639 
*. The mean difference is significant at the 0.05 level. 
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Multiple Comparisons 
ALBUMIN 
Bonferroni 
(I) 
GROUP
S 
(J) 
GROUP
S 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
N TAA 2.58000
*
 .67140 .013 .3373 4.8227 
S .25000 .67140 1.000 -1.9927- 2.4927 
PN/LD .58000 .67140 1.000 -1.6627- 2.8227 
PN/HD .28000 .67140 1.000 -1.9627- 2.5227 
MM/LD -.40000- .67140 1.000 -2.6427- 1.8427 
MM/H
D 
-.60000- .67140 1.000 -2.8427- 1.6427 
TAA N -2.58000-
*
 .67140 .013 -4.8227- -.3373- 
S -2.33000-
*
 .67140 .036 -4.5727- -.0873- 
PN/LD -2.00000- .67140 .124 -4.2427- .2427 
PN/HD -2.30000-
*
 .67140 .040 -4.5427- -.0573- 
MM/LD -2.98000-
*
 .67140 .003 -5.2227- -.7373- 
MM/H
D 
-3.18000-
*
 .67140 .001 -5.4227- -.9373- 
S N -.25000- .67140 1.000 -2.4927- 1.9927 
TAA 2.33000
*
 .67140 .036 .0873 4.5727 
PN/LD .33000 .67140 1.000 -1.9127- 2.5727 
PN/HD .03000 .67140 1.000 -2.2127- 2.2727 
MM/LD -.65000- .67140 1.000 -2.8927- 1.5927 
MM/H
D 
-.85000- .67140 1.000 -3.0927- 1.3927 
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PN/LD N -.58000- .67140 1.000 -2.8227- 1.6627 
TAA 2.00000 .67140 .124 -.2427- 4.2427 
S -.33000- .67140 1.000 -2.5727- 1.9127 
PN/HD -.30000- .67140 1.000 -2.5427- 1.9427 
MM/LD -.98000- .67140 1.000 -3.2227- 1.2627 
MM/H
D 
-1.18000- .67140 1.000 -3.4227- 1.0627 
PN/HD N -.28000- .67140 1.000 -2.5227- 1.9627 
TAA 2.30000
*
 .67140 .040 .0573 4.5427 
S -.03000- .67140 1.000 -2.2727- 2.2127 
PN/LD .30000 .67140 1.000 -1.9427- 2.5427 
MM/LD -.68000- .67140 1.000 -2.9227- 1.5627 
MM/H
D 
-.88000- .67140 1.000 -3.1227- 1.3627 
MM/LD N .40000 .67140 1.000 -1.8427- 2.6427 
TAA 2.98000
*
 .67140 .003 .7373 5.2227 
S .65000 .67140 1.000 -1.5927- 2.8927 
PN/LD .98000 .67140 1.000 -1.2627- 3.2227 
PN/HD .68000 .67140 1.000 -1.5627- 2.9227 
MM/H
D 
-.20000- .67140 1.000 -2.4427- 2.0427 
MM/H
D 
N .60000 .67140 1.000 -1.6427- 2.8427 
TAA 3.18000
*
 .67140 .001 .9373 5.4227 
S .85000 .67140 1.000 -1.3927- 3.0927 
PN/LD 1.18000 .67140 1.000 -1.0627- 3.4227 
PN/HD .88000 .67140 1.000 -1.3627- 3.1227 
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MM/LD .20000 .67140 1.000 -2.0427- 2.4427 
*. The mean difference is significant at the 0.05 level. 
 
Multiple Comparisons 
GGT 
Bonferroni 
(I) 
GROUP
S 
(J) 
GROUP
S 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
N TAA -10.00000-
*
 2.58664 .013 -18.6404- -1.3596- 
S -4.85000- 2.58664 1.000 -13.4904- 3.7904 
PN/LD -7.20000- 2.58664 .200 -15.8404- 1.4404 
PN/HD -2.60000- 2.58664 1.000 -11.2404- 6.0404 
MM/LD -1.00000- 2.58664 1.000 -9.6404- 7.6404 
MM/H
D 
-1.80000- 2.58664 1.000 -10.4404- 6.8404 
TAA N 10.00000
*
 2.58664 .013 1.3596 18.6404 
S 5.15000 2.58664 1.000 -3.4904- 13.7904 
PN/LD 2.80000 2.58664 1.000 -5.8404- 11.4404 
PN/HD 7.40000 2.58664 .166 -1.2404- 16.0404 
MM/LD 9.00000
*
 2.58664 .035 .3596 17.6404 
MM/H
D 
8.20000 2.58664 .077 -.4404- 16.8404 
S N 4.85000 2.58664 1.000 -3.7904- 13.4904 
TAA -5.15000- 2.58664 1.000 -13.7904- 3.4904 
PN/LD -2.35000- 2.58664 1.000 -10.9904- 6.2904 
PN/HD 2.25000 2.58664 1.000 -6.3904- 10.8904 
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MM/LD 3.85000 2.58664 1.000 -4.7904- 12.4904 
MM/H
D 
3.05000 2.58664 1.000 -5.5904- 11.6904 
PN/LD N 7.20000 2.58664 .200 -1.4404- 15.8404 
TAA -2.80000- 2.58664 1.000 -11.4404- 5.8404 
S 2.35000 2.58664 1.000 -6.2904- 10.9904 
PN/HD 4.60000 2.58664 1.000 -4.0404- 13.2404 
MM/LD 6.20000 2.58664 .492 -2.4404- 14.8404 
MM/H
D 
5.40000 2.58664 .967 -3.2404- 14.0404 
PN/HD N 2.60000 2.58664 1.000 -6.0404- 11.2404 
TAA -7.40000- 2.58664 .166 -16.0404- 1.2404 
S -2.25000- 2.58664 1.000 -10.8904- 6.3904 
PN/LD -4.60000- 2.58664 1.000 -13.2404- 4.0404 
MM/LD 1.60000 2.58664 1.000 -7.0404- 10.2404 
MM/H
D 
.80000 2.58664 1.000 -7.8404- 9.4404 
MM/LD N 1.00000 2.58664 1.000 -7.6404- 9.6404 
TAA -9.00000-
*
 2.58664 .035 -17.6404- -.3596- 
S -3.85000- 2.58664 1.000 -12.4904- 4.7904 
PN/LD -6.20000- 2.58664 .492 -14.8404- 2.4404 
PN/HD -1.60000- 2.58664 1.000 -10.2404- 7.0404 
MM/H
D 
-.80000- 2.58664 1.000 -9.4404- 7.8404 
MM/H
D 
N 1.80000 2.58664 1.000 -6.8404- 10.4404 
TAA -8.20000- 2.58664 .077 -16.8404- .4404 
S -3.05000- 2.58664 1.000 -11.6904- 5.5904 
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PN/LD -5.40000- 2.58664 .967 -14.0404- 3.2404 
PN/HD -.80000- 2.58664 1.000 -9.4404- 7.8404 
MM/LD .80000 2.58664 1.000 -7.8404- 9.4404 
*. The mean difference is significant at the 0.05 level. 
 
3- Endogenous antioxidant analysis 
Multiple Comparisons 
Bonferroni  
Depende
nt 
Variable 
(I) 
GROU
PS 
(J) 
GROU
PS 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
TAC N TAA 3.35567
*
 .80428 .020 .3804 6.3309 
SILY -.53467 .80428 1.000 -3.5099 2.4406 
PNLD 1.10033 .80428 1.000 -1.8749 4.0756 
PNHD 1.11133 .80428 1.000 -1.8639 4.0866 
MMLD 2.10700 .80428 .424 -.8682 5.0822 
MMHD 1.50500 .80428 1.000 -1.4702 4.4802 
TAA N -3.35567
*
 .80428 .020 -6.3309 -.3804 
SILY -3.89033
*
 .80428 .006 -6.8656 -.9151 
PNLD -2.25533 .80428 .295 -5.2306 .7199 
PNHD -2.24433 .80428 .303 -5.2196 .7309 
MMLD -1.24867 .80428 1.000 -4.2239 1.7266 
MMHD -1.85067 .80428 .783 -4.8259 1.1246 
SILY N .53467 .80428 1.000 -2.4406 3.5099 
TAA 3.89033
*
 .80428 .006 .9151 6.8656 
PNLD 1.63500 .80428 1.000 -1.3402 4.6102 
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PNHD 1.64600 .80428 1.000 -1.3292 4.6212 
MMLD 2.64167 .80428 .114 -.3336 5.6169 
MMHD 2.03967 .80428 .499 -.9356 5.0149 
PNLD N -1.10033 .80428 1.000 -4.0756 1.8749 
TAA 2.25533 .80428 .295 -.7199 5.2306 
SILY -1.63500 .80428 1.000 -4.6102 1.3402 
PNHD .01100 .80428 1.000 -2.9642 2.9862 
MMLD 1.00667 .80428 1.000 -1.9686 3.9819 
MMHD .40467 .80428 1.000 -2.5706 3.3799 
PNHD N -1.11133 .80428 1.000 -4.0866 1.8639 
TAA 2.24433 .80428 .303 -.7309 5.2196 
SILY -1.64600 .80428 1.000 -4.6212 1.3292 
PNLD -.01100 .80428 1.000 -2.9862 2.9642 
MMLD .99567 .80428 1.000 -1.9796 3.9709 
MMHD .39367 .80428 1.000 -2.5816 3.3689 
MMLD N -2.10700 .80428 .424 -5.0822 .8682 
TAA 1.24867 .80428 1.000 -1.7266 4.2239 
SILY -2.64167 .80428 .114 -5.6169 .3336 
PNLD -1.00667 .80428 1.000 -3.9819 1.9686 
PNHD -.99567 .80428 1.000 -3.9709 1.9796 
MMHD -.60200 .80428 1.000 -3.5772 2.3732 
MMHD N -1.50500 .80428 1.000 -4.4802 1.4702 
TAA 1.85067 .80428 .783 -1.1246 4.8259 
SILY -2.03967 .80428 .499 -5.0149 .9356 
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PNLD -.40467 .80428 1.000 -3.3799 2.5706 
PNHD -.39367 .80428 1.000 -3.3689 2.5816 
MMLD .60200 .80428 1.000 -2.3732 3.5772 
TBARS N TAA -29.66667
*
 5.48718 .002 -49.9650 -9.3683 
SILY -.33333 5.48718 1.000 -20.6317 19.9650 
PNLD -7.66667 5.48718 1.000 -27.9650 12.6317 
PNHD 1.00000 5.48718 1.000 -19.2983 21.2983 
MMLD 7.83333 5.48718 1.000 -12.4650 28.1317 
MMHD -.75000 5.48718 1.000 -21.0483 19.5483 
TAA N 29.66667
*
 5.48718 .002 9.3683 49.9650 
SILY 29.33333
*
 5.48718 .002 9.0350 49.6317 
PNLD 22.00000
*
 5.48718 .027 1.7017 42.2983 
PNHD 30.66667
*
 5.48718 .001 10.3683 50.9650 
MMLD 37.50000
*
 5.48718 .000 17.2017 57.7983 
MMHD 28.91667
*
 5.48718 .002 8.6183 49.2150 
SILY N .33333 5.48718 1.000 -19.9650 20.6317 
TAA -29.33333
*
 5.48718 .002 -49.6317 -9.0350 
PNLD -7.33333 5.48718 1.000 -27.6317 12.9650 
PNHD 1.33333 5.48718 1.000 -18.9650 21.6317 
MMLD 8.16667 5.48718 1.000 -12.1317 28.4650 
MMHD -.41667 5.48718 1.000 -20.7150 19.8817 
PNLD N 7.66667 5.48718 1.000 -12.6317 27.9650 
TAA -22.00000
*
 5.48718 .027 -42.2983 -1.7017 
SILY 7.33333 5.48718 1.000 -12.9650 27.6317 
PNHD 8.66667 5.48718 1.000 -11.6317 28.9650 
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MMLD 15.50000 5.48718 .284 -4.7983 35.7983 
MMHD 6.91667 5.48718 1.000 -13.3817 27.2150 
PNHD N -1.00000 5.48718 1.000 -21.2983 19.2983 
TAA -30.66667
*
 5.48718 .001 -50.9650 -10.3683 
SILY -1.33333 5.48718 1.000 -21.6317 18.9650 
PNLD -8.66667 5.48718 1.000 -28.9650 11.6317 
MMLD 6.83333 5.48718 1.000 -13.4650 27.1317 
MMHD -1.75000 5.48718 1.000 -22.0483 18.5483 
MMLD N -7.83333 5.48718 1.000 -28.1317 12.4650 
TAA -37.50000
*
 5.48718 .000 -57.7983 -17.2017 
SILY -8.16667 5.48718 1.000 -28.4650 12.1317 
PNLD -15.50000 5.48718 .284 -35.7983 4.7983 
PNHD -6.83333 5.48718 1.000 -27.1317 13.4650 
MMHD -8.58333 5.48718 1.000 -28.8817 11.7150 
MMHD N .75000 5.48718 1.000 -19.5483 21.0483 
TAA -28.91667
*
 5.48718 .002 -49.2150 -8.6183 
SILY .41667 5.48718 1.000 -19.8817 20.7150 
PNLD -6.91667 5.48718 1.000 -27.2150 13.3817 
PNHD 1.75000 5.48718 1.000 -18.5483 22.0483 
MMLD 8.58333 5.48718 1.000 -11.7150 28.8817 
SOD N TAA 99.93548
*
 13.83137 .000 48.7701 151.1009 
SILY 9.52021 13.83137 1.000 -41.6452 60.6856 
PNLD 28.47414 13.83137 1.000 -22.6913 79.6396 
PNHD 21.48081 13.83137 1.000 -29.6846 72.6462 
MMLD 28.45548 13.83137 1.000 -22.7099 79.6209 
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MMHD 5.19114 13.83137 1.000 -45.9743 56.3566 
TAA N -99.93548
*
 13.83137 .000 -151.1009 -48.7701 
SILY -90.41527
*
 13.83137 .000 -141.5807 -39.2498 
PNLD -71.46133
*
 13.83137 .003 -122.6268 -20.2959 
PNHD -78.45467
*
 13.83137 .001 -129.6201 -27.2892 
MMLD -71.48000
*
 13.83137 .003 -122.6454 -20.3146 
MMHD -94.74433
*
 13.83137 .000 -145.9098 -43.5789 
SILY N -9.52021 13.83137 1.000 -60.6856 41.6452 
TAA 90.41527
*
 13.83137 .000 39.2498 141.5807 
PNLD 18.95393 13.83137 1.000 -32.2115 70.1194 
PNHD 11.96060 13.83137 1.000 -39.2048 63.1260 
MMLD 18.93527 13.83137 1.000 -32.2302 70.1007 
MMHD -4.32907 13.83137 1.000 -55.4945 46.8364 
PNLD N -28.47414 13.83137 1.000 -79.6396 22.6913 
TAA 71.46133
*
 13.83137 .003 20.2959 122.6268 
SILY -18.95393 13.83137 1.000 -70.1194 32.2115 
PNHD -6.99333 13.83137 1.000 -58.1588 44.1721 
MMLD -.01867 13.83137 1.000 -51.1841 51.1468 
MMHD -23.28300 13.83137 1.000 -74.4484 27.8824 
PNHD N -21.48081 13.83137 1.000 -72.6462 29.6846 
TAA 78.45467
*
 13.83137 .001 27.2892 129.6201 
SILY -11.96060 13.83137 1.000 -63.1260 39.2048 
PNLD 6.99333 13.83137 1.000 -44.1721 58.1588 
MMLD 6.97467 13.83137 1.000 -44.1908 58.1401 
MMHD -16.28967 13.83137 1.000 -67.4551 34.8758 
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MMLD N -28.45548 13.83137 1.000 -79.6209 22.7099 
TAA 71.48000
*
 13.83137 .003 20.3146 122.6454 
SILY -18.93527 13.83137 1.000 -70.1007 32.2302 
PNLD .01867 13.83137 1.000 -51.1468 51.1841 
PNHD -6.97467 13.83137 1.000 -58.1401 44.1908 
MMHD -23.26433 13.83137 1.000 -74.4298 27.9011 
MMHD N -5.19114 13.83137 1.000 -56.3566 45.9743 
TAA 94.74433
*
 13.83137 .000 43.5789 145.9098 
SILY 4.32907 13.83137 1.000 -46.8364 55.4945 
PNLD 23.28300 13.83137 1.000 -27.8824 74.4484 
PNHD 16.28967 13.83137 1.000 -34.8758 67.4551 
MMLD 23.26433 13.83137 1.000 -27.9011 74.4298 
CAT N TAA 281.79123
*
 70.83483 .029 19.7570 543.8255 
SILY 123.72587 70.83483 1.000 -138.3084 385.7601 
PNLD 35.20223 70.83483 1.000 -226.8320 297.2365 
PNHD 30.91243 70.83483 1.000 -231.1218 292.9467 
MMLD 117.37303 70.83483 1.000 -144.6612 379.4073 
MMHD 52.03363 70.83483 1.000 -210.0006 314.0679 
TAA N -281.79123
*
 70.83483 .029 -543.8255 -19.7570 
SILY -158.06537 70.83483 .893 -420.0996 103.9689 
PNLD -246.58900 70.83483 .077 -508.6233 15.4453 
PNHD -250.87880 70.83483 .068 -512.9131 11.1555 
MMLD -164.41820 70.83483 .753 -426.4525 97.6161 
MMHD -229.75760 70.83483 .124 -491.7919 32.2767 
SILY N -123.72587 70.83483 1.000 -385.7601 138.3084 
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TAA 158.06537 70.83483 .893 -103.9689 420.0996 
PNLD -88.52363 70.83483 1.000 -350.5579 173.5106 
PNHD -92.81343 70.83483 1.000 -354.8477 169.2208 
MMLD -6.35283 70.83483 1.000 -268.3871 255.6814 
MMHD -71.69223 70.83483 1.000 -333.7265 190.3420 
PNLD N -35.20223 70.83483 1.000 -297.2365 226.8320 
TAA 246.58900 70.83483 .077 -15.4453 508.6233 
SILY 88.52363 70.83483 1.000 -173.5106 350.5579 
PNHD -4.28980 70.83483 1.000 -266.3241 257.7445 
MMLD 82.17080 70.83483 1.000 -179.8635 344.2051 
MMHD 16.83140 70.83483 1.000 -245.2029 278.8657 
PNHD N -30.91243 70.83483 1.000 -292.9467 231.1218 
TAA 250.87880 70.83483 .068 -11.1555 512.9131 
SILY 92.81343 70.83483 1.000 -169.2208 354.8477 
PNLD 4.28980 70.83483 1.000 -257.7445 266.3241 
MMLD 86.46060 70.83483 1.000 -175.5737 348.4949 
MMHD 21.12120 70.83483 1.000 -240.9131 283.1555 
MMLD N -117.37303 70.83483 1.000 -379.4073 144.6612 
TAA 164.41820 70.83483 .753 -97.6161 426.4525 
SILY 6.35283 70.83483 1.000 -255.6814 268.3871 
PNLD -82.17080 70.83483 1.000 -344.2051 179.8635 
PNHD -86.46060 70.83483 1.000 -348.4949 175.5737 
MMHD -65.33940 70.83483 1.000 -327.3737 196.6949 
MMHD N -52.03363 70.83483 1.000 -314.0679 210.0006 
TAA 229.75760 70.83483 .124 -32.2767 491.7919 
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SILY 71.69223 70.83483 1.000 -190.3420 333.7265 
PNLD -16.83140 70.83483 1.000 -278.8657 245.2029 
PNHD -21.12120 70.83483 1.000 -283.1555 240.9131 
MMLD 65.33940 70.83483 1.000 -196.6949 327.3737 
GPX N TAA 20.12164 13.43171 1.000 -29.5653 69.8086 
SILY -8.78836 13.43171 1.000 -58.4753 40.8986 
PNLD 9.55164 13.43171 1.000 -40.1353 59.2386 
PNHD -2.80170 13.43171 1.000 -52.4887 46.8853 
MMLD -.50836 13.43171 1.000 -50.1953 49.1786 
MMHD -10.44170 13.43171 1.000 -60.1287 39.2453 
TAA N -20.12164 13.43171 1.000 -69.8086 29.5653 
SILY -28.91000 13.43171 1.000 -78.5970 20.7770 
PNLD -10.57000 13.43171 1.000 -60.2570 39.1170 
PNHD -22.92333 13.43171 1.000 -72.6103 26.7636 
MMLD -20.63000 13.43171 1.000 -70.3170 29.0570 
MMHD -30.56333 13.43171 .822 -80.2503 19.1236 
SILY N 8.78836 13.43171 1.000 -40.8986 58.4753 
TAA 28.91000 13.43171 1.000 -20.7770 78.5970 
PNLD 18.34000 13.43171 1.000 -31.3470 68.0270 
PNHD 5.98667 13.43171 1.000 -43.7003 55.6736 
MMLD 8.28000 13.43171 1.000 -41.4070 57.9670 
MMHD -1.65333 13.43171 1.000 -51.3403 48.0336 
PNLD N -9.55164 13.43171 1.000 -59.2386 40.1353 
TAA 10.57000 13.43171 1.000 -39.1170 60.2570 
SILY -18.34000 13.43171 1.000 -68.0270 31.3470 
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PNHD -12.35333 13.43171 1.000 -62.0403 37.3336 
MMLD -10.06000 13.43171 1.000 -59.7470 39.6270 
MMHD -19.99333 13.43171 1.000 -69.6803 29.6936 
PNHD N 2.80170 13.43171 1.000 -46.8853 52.4887 
TAA 22.92333 13.43171 1.000 -26.7636 72.6103 
SILY -5.98667 13.43171 1.000 -55.6736 43.7003 
PNLD 12.35333 13.43171 1.000 -37.3336 62.0403 
MMLD 2.29333 13.43171 1.000 -47.3936 51.9803 
MMHD -7.64000 13.43171 1.000 -57.3270 42.0470 
MMLD N .50836 13.43171 1.000 -49.1786 50.1953 
TAA 20.63000 13.43171 1.000 -29.0570 70.3170 
SILY -8.28000 13.43171 1.000 -57.9670 41.4070 
PNLD 10.06000 13.43171 1.000 -39.6270 59.7470 
PNHD -2.29333 13.43171 1.000 -51.9803 47.3936 
MMHD -9.93333 13.43171 1.000 -59.6203 39.7536 
MMHD N 10.44170 13.43171 1.000 -39.2453 60.1287 
TAA 30.56333 13.43171 .822 -19.1236 80.2503 
SILY 1.65333 13.43171 1.000 -48.0336 51.3403 
PNLD 19.99333 13.43171 1.000 -29.6936 69.6803 
PNHD 7.64000 13.43171 1.000 -42.0470 57.3270 
MMLD 9.93333 13.43171 1.000 -39.7536 59.6203 
*. The mean difference is significant at the 0.05 level. 
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B3 / Gene expression analysis using Unpaired T-test  
1- Comparison between N and TAA 
 
2- Comparison between PN and TAA 
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3- Comparison between MM and TAA 
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Appendix C: Ph.D project selected photographs 
 
 
  
 
Figure C1: Animal house experiment 
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Figure C2: Flash Column Chromatography and Thin layer Chromatography plate. 
 
Figure C3: Immunomodulatory test photographs. 
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Figure C4: Histopathology slide preparation  
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Appendix D: Additional outputs of the Ph.D project 
1. PUBLICATIONS 
     A/ Published articles 
1) Zahra A. Amin, Mehmet Bilgen, Mohammed A. Alshawsh, Hapipah M. 
Ali, A. Hamid A. Hadi, and Mahmood A. Abdulla (2012). Protective 
Role of Phyllanthus niruri  Extract against Thioacetamide-Induced Liver 
Cirrhosis in Rat Model. Evidence-Based Complementary and Alternative 
Medicine. doi:10.1155/2012/241583.  (ISI cited journal, IF: 4.774, 
ranking: Q1) 
2) Alnajar, Zahra A. Amin; Abdulla, Mahmood A.; Ali, Hapipah M.; 
Alshawsh, Mohammed A.; Hadi, A. Hamid A. 2012. "Acute Toxicity 
Evaluation, Antibacterial, Antioxidant and Immunomodulatory Effects 
of Melastoma malabathricum ." Molecules 17, no. 3: 3547-3559. (ISI 
cited journal, IF: 2.386, ranking: Q2)  
3) Amin, Z. A., Abdulla, M. A., Ali, H. M., Alshawsh, M. A. and Qadir, S. 
W. (2012), Assessment of In vitro  antioxidant, antibacterial and immune 
activation potentials of aqueous and ethanol extracts of  Phyllanthus 
niruri. J. Sci. Food Agric. doi:  10.1002/jsfa.5554. (ISI cited journal, IF: 
1.36, ranking: Q1) 
 
B/ Submitted manuscripts  
1) Amin, Z. A., Abdulla, M. A., Ali, H. M., Alshawsh, M. A. Gene 
expression profiling reveals the underlying molecular mechanism of the 
hepatoprotective effect of Phyllanthus niruri  on thioacetamide induced 
hepatotoxicity on Spargue Dawely rats. Phytomedicine, Ms. Ref. No.:  
PHYMED-D-12-01106. (ISI cited journal, IF: 2.66, ranking: Q1)  
 
2) Amin, Z. A., Abdulla, M. A., Ali, H. M., Alshawsh, M. A. 
"Hepatoprotective efficacy of Melastoma malabathricum against 
thioacetamide induced hepatotoxicity in Sprague Dawley rats and 
profiling of TGFβ, Collα, MMP2 and TIMP1 genes. PLOS ONE,  
manuscript number: PONE-D-12-38718.  (ISI cited journal, IF: 4.3, 
ranking: Q1) 
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2. ORAL PRESENTATIONS 
1) Oral presentation in the 4th Kurdistan Conference on Biological 
Sciences held from 8th – 10th May 2012, Duhok, Iraq.  
2) Oral presentation in the 3 rd International Graduate Conference on 
Engineering, Sciences and Humanities (IGCESH) 2010 held from 2
nd
 -4
th
 
Nov. 2010, at Universiti Teknologi Malaysia, Johor Bahru, Malaysia.  
 
3. POSTER PRESENTATIONS 
1) Poster presentation in the 15 th Biological Sciences Graduate Congress 
2010 held from 15
th
 -17
th  
Dec 2010 at Institute of Biological Sciences, 
Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia. 
2) Poster presentation in the Malaysia Technology Expo 2010 (Malaysian 
Association of Research Scientists) held from 4
th
 - 6
th
 Feb 2010, PWTC, 
Kuala Lumpur, Malaysia.  
3) Poster presentation in the 21st International Invention, Innovation & 
Technology Exhibition ITEX 2010, held from 14
th
 - 16
th
 May 2010 
Kuala Lumpur, Malaysia.  
4) Poster presentation in the BioMalaysia 2010 Conference & Exhibition 
held from 1
st
 -3
rd
 Nov 2010, at Convention Centre, Kuala Lumpur, 
Malaysia. 
5) Poster presentation in the University of Malaya Innovation and 
Creativity Expo 2010 held from 1
st
 -3
rd
 April 2010, at Dewan Tunku 
Canselor (DTC) University of Malaya, Kuala Lumpur, Malaysia.  
4. AWARDS 
1) Silver Medal, Preventive Effect of Ethanolic Extract of Phyllanthus 
niruri on Thioacetamide-induced Liver Cirrhosis in Rats. INVENTION 
& INNOVATION Award, 21st International Invention, Innovation & 
Technology Exhibition ITEX 2010 held from 14
th
 - 16
th
 May 2010 Kuala 
Lumpur, Malaysia.  
2) Bronze Medal, Hepatoprotective Activity, Prophylactic and Therapeutic 
of Skin Diorders by Phyllannthaceae Extract. Bio  Inno Awards Bio 
Malaysia 2010 Conference & Exhibition held from 1
st
 – 3 rd Nov 2010 at 
Convention Centre, Kuala Lumpur, Malaysia.  
